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1. INTRODUCTION 
  Siddha system is one of the unique systems of Indian medicine. Sridhar’s are 
believed to be the founders of siddha medicine.They are used the herbs, metals, 
minerals. It’s used for better health and helps to live the mankind for more than 
thousands of years.  
  Siddha medicine is a precious less medicine in the world and considered by 
many to be the mother of all medicine Significantly one the definition off the siddha 
medicine is invasion of death ‘that which ensures preventive against mortality’’-
Thirumoolar The concept of siddha system is based on fundamental principles of five 
basic elements of the universe 98- thathuvams, three humours, and seven thathus 
(physical constituents of the body) The three humors namely vat ham ,pitham,and 
kabam exists in their appropriate ratio  When the harmony of the above said humours 
gets deranged owing to a relative increased(or)decreased of any one or more of the 
principle humours, disease is caused the alteration in the normal ratio produced 
disease.the sign and symptoms are produced according to the particular deranged 
kuttrams. 
  Siddha system of medicine is to give healthiness to an individual siddha 
system is differ from the other system medicine by giving absoulute physical 
,mental,and social well being of an individual by its various tools like medicine, 
meditation, yoga, varma,massage,and its unique social and preventive medicine 
which is quoted by ‘Theraiyar pini anuga vithi’ 
  “Health is a state of complete physical, mental and social well being and not 
merely an absence of disease” is the widely accepted definition of health give by 
WHO(World health organization) 
  Thirumoolar quotes that 
“lXh<hK!dmz<Ofib<!lVf<okeziGl<!
lXh<hK!dtofib<!lVf<okes<siZl<!
lXh<hK!-eqOfib<!uivikqVg<g!
lXh<hK!sijuBl<!lVf<okeziOl”!
   It can be thus summarized that the siddha  system is largely focused on 
promotive and preventive health. 
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  According the siddha system of medicine knee pain is the major symptom of 
keel vayu. The word keel means the hinge joint and the word vaayu means the vali 
or vatham. 
  The increased vali or vatham affects the joint producing knee pain.Azhal keel 
vaayu comes under the 10 classification of keel vaayu. Azhal keel vaayu is 
characterized by symptoms like joint pain,swelling,tenderness,stiffness and restricted 
movemend with a characteristic sound and therefore it can be compared with 
Osteoarthritis. 
 
Osteoarthritis: 
        Osteoarthritis is a chronic degenerative disorder of multi factorial etiology 
characterized by loss of articular cartilage,hypertrophy of bone at the margins, 
subchondral sclerosis,and range of biochemical and morphological alterations of the 
synovial membrane and joint capsule. Typical clinical symtoms are pain ,particularly 
after prolonged activity and weight bearing; whereas stiffness is experienced after 
inactivity. Classified as: Idiopathic (localized or generalized) or secondary (traumatic, 
congenital, medabolic, endocrine, neuropathic and other medical causes) 
characterized by focal and progressive loss of hyaline cartilage of joints, underlying 
bony changes. Symptoms are pain, swelling, and stiffness. 
  It is second most common rheumatological problem and it’s the most frequent 
joint disease with prevalence of 22%to39%in India. Hence the author is interested to 
try effective remedy to this patient as said in siddha literature with the application of 
basic principles of siddha and also supporting by siddha and modern diagnostic 
parameters. 
  The medicine chosen of this disease are; 
   ERANDAMOOLA CHOORANAM- INTERNAL 
                  (Ref-Anuboga vaithiya theva ragasiyam) 
KUNGILIA THYLAM- EXTERNAL 
                   (Ref-Marunthu sei eyalum kalaium) 
  The above medicine contain ingredients which have anti vatha 
property.considering this they are chosen as trial medicine in this study.Pattru is one 
of the best external therapies in siddha system of medicine and the effectiveness of 
pattru in reduced pain in azhal keel vaayu is also evaluated along with trial medicines 
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2. AIM AND OBJECTIVE 
 
AIM: 
  Phase II  clinical observation criteria based study of Azhal keel vayu (OSTEO 
ARTHERITIS) and the drug choice ERANDA MOOLA CHOORANAM (internal) 
and External KUNGILIA THYLAM and External therapy PATTRU 
 
OBJECTIVE:  
PRIMARY OBJECTIVE:   
  To evaluate the clinical efficacy of “ERANDA MOOLA CHOORANAM” 
(INT.) and “KUNGILIA THYLAM” (EXT.) PATTRU [EXTERNALTHERAPY] in 
the treatment of “AZHAL KEEL VAYU” (OSTEO ARTHRITIS) for the reduction 
of pain and swelling and to improve the range of movements. 
 
SECONDARY OBJECTIVE:   
• To evaluate reduction in restriction of movements. 
• To evaluate effect of varmam and asanam along with trial medicines. 
• To study the siddha principles neerkuri and neikuri before and after treatment.  
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3.REVIEW OF LITERATURE 
SIDDHA ASPECT 
  The concept of siddha system are based on fundamental principles of five 
basic elements of the universe,96- thathuvam ,humours, and seven thathus (physical 
constituents of the body) 
  Vatham, pitham ,kabam, are called as three humours of the humen system.In 
normal person these three humours always exit in their appropriate ratio.when the 
harmony of the above said humours gets deranged owing to a relative increased or 
decreased of any one or more of the principal humours ,disease is caused. 
    As illustrated in Indian Materia Medica Vol II, The theory of vatham, 
pitham, kabam begins where modern physiology ends. 
     The theory of vatham, pitham, kabam was great discovery,which is 
unfortunately misunderstood by western scholars judging by the wrong mercenary 
translation rendring these are wind,bile,and phlegm. 
  It must be remembered that the theory of vatham,pitham, and kabam not only 
mean the old exploded humoral theory. 
     Tha vatham  not only simply imply “Wind” but also comprehends all the 
phenomena which comes under the functions of the Central and sympathetic nervous 
systems and the function of vatham is controlled by central nervous system as quoted 
in the udal thathukkal text book by Prof.Dr.P.M.Venugopal, H.P.I.M., 
        Like that,the term ‘Pitham’ not only mean ‘Bile’but signifies the function of 
thermogenesis (or) heat production and metabolism, comprehending in its scop the 
process of digestion, coloration of blood and formation of various secretion and 
excretion which are either the means or end of tissue combustion and all theas 
function are controlled by Autonomus nerve system. 
 The ‘kabham’ not only means ‘phlegm’ but it is used primarily to imply the 
function of thermotaxis (or) heat regulations and secondarily formation of the 
various preservative fluids (e.g) mucus, synovial, and its functions are maintained by 
the cell 
Ik;G+jk; Njfj;jpw;F cs;s xw;Wikahtd; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;  
 “mz;lj;jpy; cs;sNj gpz;lk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
 gpz;lj;jpy; cs;sNj mz;lk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
 mz;lKk; gpz;lKk; xd;Nw; ; ; ; ;; ; ; ; ;; ; ; ; ;  
 mwpe;Jjhd; ghHf;Fk; NghNj; ; ; ;; ; ; ;; ; ; ; ”      - rl;lKdp;;;  
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  gpugQ;rk; Ik;G+jkakhdJ. Njhd;wp> epiyj;J> mope;J mg;ghy; kWgbAk; 
Njhd;wp epiyj;J mope;J NghFk; nghUl;fs; ahTk; Xhplj;jpy; xLq;Fk;.  
,JNt gug;gpuk;kk; vd;gH.  Njhd;Wk;NghJk; mt;tplj;jpypUe;Nj gilj;jy;> 
fhj;jy;> mopj;jy; vd;Dk; rf;jpfSf;fpzq;f epfOk; ,t;Tyfk; 
Ik;G+jkakhdJ vd;gH.  NjfKk; Ik;G+jf; nfhs;iff;F tpyf;fpy;iy. 
  
“epyk; ePHjPtsp tpRk;Nghile;Jk;; P P ; ; ;; P P ; ; ;; P P ; ; ; 
 fye;jkaf; fKyfk; ,J; ; ;; ; ;; ; ; ” 
- Neha;ehly; Neha;Kjy;ehly; gFjp; ; ; ; ;; ; ; ; ;; ; ; ; ;  
1. Earth (epyk <*< << !
 Gives shape to the body and release its energy. 
 Bones, muscles and tissues represent it in the body. 
2. Water (ePH)PPP  
 Makes the earth supple and helps in the transmission of energy, serum, lymph, 
saliva etc.!
 Represent it in the body.!
4/!Fire (jP)PPP !
 Steadies the form of the body and gives vigour and stimulation!
 Digestion and circulation represent it in the body.!
5/!Air (tsp)!
 Ignites the fire and works as a life carrier and its he support of all contact and 
exchange!
 Respiration and nervous system represent  in the body.!
6/!Ether (tprk;G);;; !
 Ether is the creater of life itself in the body. 
 A harmonious, cambination and function of these five elements in the body 
produce a healthy and beautiful life. 
 Man has gross physical body and subtle physical body is immediately behind 
the gross physical body and is closely connected with it. 
Vatham  = Air + Ether 
  In kumba vatham both air and ether are affected 
 The life-force which is different from material energy derived from food, 
pervades the gross physical through the subtle physical. 
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Ik;G+jq;fl;Fk;> mWRitfSf;F Ks;s xw;Wikahtd:; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ;  
  
“kz;ZlNd Gdy; jPf;fhy;; ; P ; ;; ; P ; ;; ; P ; ; 
  Kiwahfr; Nrh;e;jpl;l; ; ; ;; ; ; ;; ; ; ; hy; tUNk ,dpg;G; ;; ;; ;  
 jpz;zkpyk; JtHg;gpurk;; ; ; ;; ; ; ;; ; ; ; 
  rjhfjpNah lhHjPtpz; jplkh Kiwg;Gk;P ; ; ;P ; ; ;P ; ; ; 
 vz;zhpa frg;G Kz;lhw;; ; ; ;; ; ; ;; ; ; ; 
  jz;zPhpy; fdtpizg;gh nyOkh Kth;g;G; P ; ; ; ;; P ; ; ; ;; P ; ; ; ;  
 cz;zhpa mWRitapd;; ;; ;; ; 
  gpwg;gpnjDk; FUrpj;jUiuj;j kiwNa; ; ; ;; ; ; ;; ; ; ; ” 
. Njhw;wf;fpuk Muha;r;rpAk;> rpj;jkUj;Jt tuyhWk;.; ; ; ; ; ; ; ;; ; ; ; ; ; ; ;; ; ; ; ; ; ; ;  
 
Siddhars are most spiritual scientist in the world he explored. 
 The food we have take six types of taste. 
1. Sweet (,dpg;G) 
2. Sour ( Gspg;G) 
3. Salt (cg;G) 
4. Bitter (ifg;G) 
5. Pungent (fhHg;G) 
6. Astringent (Jth;g;G* 
  Each of it mixture of 2 basic materials, 
  ,dpg;G  - kz; + ePH 
  Gspg;G  - kz; + jP 
cg;G  - ePH + jP 
ifg;G  - fhw;W + Mfhak; 
fhHg;G  - jP + Mfhak; 
Jth;g;G - kz; + Mfhak; 
  This six tastes are divided by the thiridhosam (vatham, pitham, kabam) 
Which are the pillar for support our body structure. 
  thA - thjk; 
  NjA - gpj;jk; 
  mg;G - fgk; 
   These are the alteration method in the level of Thiridhosha.  It may affects the 
normal function of the body. 
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kpfpDk; FiwapDk; Neha; nra;Ak; E}NyhH; ; ; ; ;; ; ; ; ;; ; ; ; ;  
tspKjyh ntz;zpa %d;W ; ;; ;; ;  
- jpUf;Fws;; ;; ;; ; 
The normal value of thiridhosa vadham, pitham, kabam – 1: ½ : ¼ 
 toq;fpa thjk; khj;jpiu nahd;whfpy;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
 joq;fpa gpj;je; jd;dpiy thrp; ; ; ;; ; ; ;; ; ; ;  
 moq;Fq; fge;jhdlq;fpNa fhNyhby;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
 gprq;fpa rPtHf;Fg; gprnfhd;Wkpy;iyNa; P ; ; ; ;; P ; ; ; ;; P ; ; ; ;  
- Fzthflk;;;; 
  Synonyms of the literature, Three dhosas due to irregular diet & behavior.  In 
the keel vatham disease, the chief deranged factor among the Thirithathu is the 
vatham. 
  d{U! osbz<! Ngqbux<xqe<! liXhiMgtiz<?! Jl<H,klblie! WP!
dmz<kiKg<gtiz<! Ne! dmzqx<G! utq?! npz<?! Jbl<! we<x! &e<X! dbqi<!
kiKg<gt<!lqGf<Oki!Gjxf<Oki!Ofib<!Wx<hce<!Jl<H,k!nch<hjmbqz<!d{<mie!
nXSjugtie!lVf<K!ohiVm<gjt!ogi{<M!hiqgiqg<g!Ou{<Ml</!
 
Thannilai valarchi 
(Accumulation and excitation) 
 The stage where the humour accumulate in a particular part as stagnant is 
called Thannilai valarchi. 
 When the stagnant humour accumulated and permeated a structure there is an 
excitement from eversion towards similar and attraction towards contraries.  
This is known as “Prakobam”. 
Piranilai Valarchi (Spreading) 
 This is the stage where the excited humour extends by viyana to another part.  
the derangement of kutram becomes located in parts of the body.  And being to cause 
disease of joints, blood, stomach, bladder and soon. 
 
I. Vatham 
The term vatha denotes 
 Vayu 
 Dryness 
 Pain 
 Flatulence and 
 Lightness 
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Location of vatham 
 Vatham is located in the hip, below the adbomen, moolatharam and sexual 
organs.  It is also said that vatha is settled in various places including bone, joints, 
nerves, vessels, hair follicles, muscles, sperm, urine and stools. 
Funtion of vatham 
 The function of vatha one respiration stimulate the body and soul, voiding of 
excreta refreshness and proper harmony of the seven thathu. 
Effects of vitiated vatha 
 Vayu pain, exquisite pain, extreme dryness, palpitation, dislocation of the 
joints, dysfunction of the sexual organs, constipation, dysuria, thirst, pain in the long 
bone.  Unable to flexion and extension of the limbs, dark complexion and emaciation 
are the main ill effects of the vitiated vatha. 
 
II. Pitham 
 The term pitham denotes gastric juice, bile, energy, heat and anger etc. 
Location of pitha 
 Head, heart, bladder, abdomen, umbilicus, stomach, saliva, sweat, blood, eyes 
and skin are the sites of pitham. 
Effects of vitiated pitham 
 Excessive heat in the body, improper digestion, excessive sweat, giddiness, 
syncope and immortal behaviours are some of the ill effects of vitiated. 
 
III.Kabam 
Location of kabam 
 The kabam is located in the tongue, chest, blood, bone marrow, bones, nerves, 
brain, large intestine, eyes and joints. 
Functions of kabam 
 The important functions of kabam are maintaining the unctuous and viscosity 
and proper functioning of the joints. 
Effects of vitiated kabam 
 Pain in the long bones, dysfunction of the joints, improper digestion, 
excessive sleep and inhibition of understanding capacity. 
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gQz<!uiB;Q <Q <Q < !
 According to sabapathy manuscript  Azhal keel vayu comes under the 
classification of ten keel vayus.In keel vayu the mostly deranged factor is vatham. So 
keel vayu comes under the vatha disease according to thiridosha theory It is also 
confirmed by Agasthiyar Gunavagadam. 
 
“jhdhf fPy;thj Nuhfk; NgiuP ; ;P ; ;P ; ;  
 Neha; jdf;F ghfpaha; thjNuhf nkd;gh;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
El;gKs;s thjNuhf nkz;gJe; jhd; ; ; ; ; ;; ; ; ; ;; ; ; ; ;  
Ma;e;njLj;J ,jw;Fs;Ns mlf;fk; ghU.     ; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ;  
 - mfj;jpah; Fzthflk; ;; ;; ; ; 
 
  Njiuah; fhg;gpaj;jpy; thjk; 81 tifapy; fPy;thjk; 
njhFf;fg;gl;Ls;sJ. A+fp itj;jpa rpe;jhkzpapy; thjk; 80 tifahfTk;> 
 TV rhk;grptk;gps;is E}ypy; fPy;thA!causes “Painful inflammation with 
swelling affecting the muscle & joints of the human body.  
 
NtWngah;fs;; ;; ;; ; 
 re;Jtyp>  
 %l;Ltyp> 
 Nkf#iy> 
 Klf;FthA>  
 Mkthjk;>  
 re;Jthjk;>  
 #iyf;fl;L>  
 re;jpf rpNyj;Jk Nuhfk;> 
 thj#iy>  
 thANuhfk; 
 
fhuz ngah;fs;;; ;; ;; 
Neha;fhuzk;   - Nkf#iy 
Kf;Fw;w epiy khWghL - thj#iy> re;jpf rpNyj;JkNuhfk;>  
re;Jthjk; 
,lj;ijf; nfhz;L  - %l;Ltyp> re;Jtyp 
FwpFzq;fis nfhz;L  - #iy fl;L> Klf;F thjk; 
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sf<<<<Kuikl<;<<< !
!! “Lm<mKgMgMk<K!< << << < Gxqk<Kmlegxqfih<Ohiz<< < << < << < <!
! gm<Mxfmg<ogi{<{iK!guqp<f<kih<OhiZ< < < < < << < < < < << < < < < < !
! lqm<mOuouXkQKOfiui!bqkqe<Gmr<g{<m<kigqz<< Q < < < < << Q < < < < << Q < < < < <!
! okim<MxLmr<uik!G{oles<osiz<zziOl< < < << < < << < < < ” 
      .B,gqLeq!juk<kqb!giuqbl<!2111< << << < !
Lmg<Guikl<;< << << < !
!! “sf<jkh<hx<xquqmilz<fqe<X!sib<Ofvk<kqz<!uqmilz<efqe<X< < < < < < < < < << < < < < < < < < << < < < < < < < < < !
! ofif<kh<hcObkie<ux<xq!Ofig<gr<ogm<MKtkig<G< < < < < < < << < < < < < < << < < < < < < < !
! lqf<khmO<<< bbqmXh{<[!lqK<<< UVjllixiK!
! uf<khcObisg<gqfqx<gqz<!uVf<KR<sf<KuiklqOk< < < < < < << < < < < < << < < < < < < ” 
.B,gqLeq!juk<kqb!giuqbl<!2111< << << < !
Description of  the nomenclature 
 Azhal keel vayu = Azhal + keel + Vayu 
 Azhal - Pitham 
 Keel - Joint 
 Vayu - Vatham 
 Initially the joint is affected by the vitiated vatham. Pitham, and kabam, 
accompany later. It is a disease which is common in pitha kalam (middle 1/3 of the 
lifespan). 
 
Neha; ,ay;; ;; ;; ; 
 ,jid rghgjp ifNal;by;> 
 “tspAike; jd;dpiy nfl;L; ; ;; ; ;; ; ;  
 typAld; tPf;fr; P ;; P ;; P ; ; RuKk; fha;e;J; ; ; ;; ; ; ;; ; ; ;  
 %l;Lf;fs; NjhWk; KLf;fpNa nehw;J; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;  
 %l;Lf;fs; jd;dpy; ePUk; Rue;J; ; ; ; ; P ; ;; ; ; ; ; P ; ;; ; ; ; ; P ; ;  
 jhq;nfhzh typAkh nehe;jpLkk;Nk; ; ;; ; ;; ; ; ” 
 
!! gQz<uiB! OfibieK! uzq?! uQg<gl<?! Gk<kz<?! &m<Mgjt! njsg<g! sqvll<?!
uqjxh<Hk<ke<jl?! sqz! Ofvr<gtqz<! nz<zK! sqz! Ofib<! fqjzgtqz<! Svl<?!
hsqbqe<jl?! Osijg! Ngqb! GxqG{r<gjt! djmbkiGl</ 
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Noi Enn (Classification) 
 Keel vayu is classified into 10 types according to siddha maruthuvam 
textbook. 
 Vali Keel vayu 
 Azhal Keel vayu 
 Iya Keel vayu 
 Vali azhal Keel vayu 
 Vali iya Keel vayu 
 Azhal vali Keel vayu 
 Azhal iya Keel vayu 
 Iya vali Keel vayu 
 Iya azhal Keel vayu 
 Mukkutra Keel vayu 
In theraiyar vagadam among the 81 vatha diseases following are joint diseases. 
 Sooriya vatham 
 Seetha vatham 
 Mozhi vatham 
 Kuthi vatham 
 Santhu vatham 
 Vasi vatham 
 Kendai vatham 
 Sathi vatham 
 Thombai vatham 
 Kotai vatham 
In the text Athma rakshamirtham, the following are described as joint diseases 
 Muzhanthai vatham 
 Mudakku vatham 
 Kendaikal vatham 
 Santhu vatham 
 Thoal vatham 
 Muzhi vatham 
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Neha;tUk; top; ;; ;; ;  
        
 
 
!
!
!
! ! !
! ! !
 
!! d{U! lx<Xl<! gizliXhiMgtiZl<! hpg<gupg<gr<gtiZl<! gzuqbiz<!
hqxf<k! Olg! Ofib<g<G! Kj{bigUl<! kib<! kf<jkbi<! upqbigUl<!
Sx<XHxs<S,p<fqjzgtiZl<! Lg<Gx<xr<gtqz<! OuXhiM! d{<migq! Ofijb!
Wx<hMk<Kl</!
Rit: 
     GspJth; tpQ;Rq;fwp ahw;G+hpf; Fk;thk;; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ; 
  xspAth;ifg; Ngwpy; gpj;Jr; rPWk; ; ; ; ; ; P ;; ; ; ; ; P ;; ; ; ; ; P ; - fpspnkhopNa 
  fhHg;gpzpg;G tpQ;rpw; fgk;tpQ;R rl;bujr;; ; ; ; ; ; ; ;; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; 
  Nrug; Gzh; NehaZfhNj.; ;; ;; ;  
 
  vd;gjpdhy; Gspg;G> Jth;g;G mjpfKs;s czTfshy; thjk; 
kpFjpg;gLk;. 
 
d{U;   
 “tspjU fha;fpoq;F tiutpyh japyy; Nfhio; ; ;; ; ;; ; ;  
 Kspjaph; Nghd;kpFf;F Kiwapyh Tz;b Nfhly;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
Fsph;jU tspapw; Nwfq; Fdpg;Gw Tyty; ngz;bh;; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ; 
 FspjU kaf;fk; ngw;NwhH fbnray; fUtpahkhy;; ; ; ; ;; ; ; ; ;; ; ; ; ;”. 
        - rghgjp ifNaL 
taJ 
czT 
gof;ftof;fk; 
 
tpahdd; 
mghdd; 
rkhdd; 
 
fgk; gpj;jk; 
 
re;jpfk; rhjfk; 
 
moy; fPy;thA 
uikl<!
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“njhopy;ngW ifg;Gf; fhHj;jy;> JtHj;jy; tpQ;RfpDQ; NrhWk;; ; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ; ; 
gioajhk; tuF kw;iwg; ige;jpid aUe;jpdhYk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
vopy; ngwg; gfYwq;fp ,utpdpYwq;fsj;jhYk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
kio epfh; FoypdhNy thjq;Nfh gpf;Fq;fhNz; ; ; ;; ; ; ;; ; ; ; ” 
- guuhr Nrfuk;;;; 
  ifg;G> Jth;g;G> fhHg;G> gjhHj;jq;fis kpFjpahf cz;zy;> gioa 
NrhW> tuF> jpiz cz;zy;> gfypy; cwq;fp ,utpy; tpopj;jpUj;jy; Mfpa 
fhuzq;fspdhy; thjk; kpFjpg;gLk;. 
ngg<!giv{l<;< << << < !
Ogit<gTg<Gl<!hq{qgTg<Gl<!dt<t!yh<Hjl;< < < < < < << < < < < < << < < < < < < !
!
      “$Wnkhd;W %d;Wld; FyT ehiye; NjopYk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
 Fw;wkhk; eyj;jpDk; nfhuk; gd;dpuz;bYk;; ; ; ; ; ; ; ;; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; 
 NruNt Gjd;jhWNkh ;;; rPhpaNkid epd;wpby;P ; ;P ; ;P ; ; 
 nrg;nghzhj jPikNahL nra;Ak; gr;re;jhWk;; P ; ; ; ; ;; P ; ; ; ; ;; P ; ; ; ; ; 
 neLe;Jf;f kpf;fthk; elf;fw;jhJ njhopy;jhk;; ; ; ; ; ; ; ;; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; 
 epj;ijahF fPy;gpbg;G ePL nka;apy; Njhd;Wkhk;; P ; ; P ; ; ; ;; P ; ; P ; ; ; ;; P ; ; P ; ; ; ; 
 hpaq;fs; Nrjkha; fhy;taJ FiwAkhk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
 fz;LzHe;J fzpj ty;Nyhd; fUj;Jld; nrg;gpdNu.; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ;    
       - kzpke;jpu itj;; ;; ;; ;jpaNuhfk;;;; 
gqvgikqgt<! lg<gtqe<! ose<lif<kqv! fz<uqje! kQuqjeg<Ogx<h! njlBOl!
nz<zilz<!OuXuqkl<!Ngi/!nu<uqjeh<!hbeqe<!giiqbOl!hq{q/!-KUl<!gVuqz<!
njlh<H/! gQz<hqch<H! Lkzqb! uikOfib<gt<! d{<mig! gqvgfqjzgTl<?!
Ogit<gTl<!giv{ole!l{qlf<kqv!juk<kqb!F~z<!%xqBt<tK/!
 
Neha; ;;; tUk; fhuzq;fs; gw;wp guuhr Nrfuj;jpd;gb>; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;  
 “fhzNt kpfTz;lhYq; fUJgl;bdp tpl;lhYk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
 khd;idahH fz; Nkhfkwf;fpD kpFe;jpl;lhYk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
Mzt kyq;flk;ik aq;fNd tplhjjhYk;; ; ; ;; ; ; ;; ; ; ; 
 thDjd; kley; yhNs thjq;Nfh gpf;Fq; fhNd; ; ; ; ;; ; ; ; ;; ; ; ; ; ” 
gak;> vy;NyhhplKk; Nfhgk; nfhs;sy;> kpFjpahf Xly;> kpFe;j Jf;fk;> jpdKk; 
clypd;Nky; fhw;Wg;gly; Nghd;wtw;whYk;> 
 “fhyq;fz; khwpAz;Zq; fhhpaj; jhYe; jz;zPH; ; ; ; ; ; ; P; ; ; ; ; ; ; P; ; ; ; ; ; ; P  
 rhyNt aUe;jpdhYe; re;jpYl; fhHe;jhYk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
 Nfhykhk; Gspg;G nea;ia tUe;jpdhYk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
 thy;thH Kiy ey;yhNs thj Kw;gtpf;Fq; fhNz; ; ; ; ;; ; ; ; ;; ; ; ; ; ” 
       - guuhrNrfuk;;;; 
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uik!Ofib<!uVukx<G!< << << < giv{l<;<<< !
  “uikOlhqxh<hkx<G!uxm<sqbiV< < << < << < < !
!! likziz<Gtqk<kqbiZ!lkqZXl<uikOvigl<< < < << < < << < < <!
! fQkqOsvkeqZt<t!fqxr<G{lqkx<GL{<MQ < < < <Q < < < <Q < < < < !
!! ! ! ! ! ! .!B,gqLeq!juk<kqb!giuqbl<< << << <!
uikl<! hqxh<hkx<G! giv{l<!dmz<! uxm<sqbjmukiGl</!dmz<! lqgUl<! Gtqi<f<K!
gi{h<hm<mZl<!uikOvigl<!d{<miGl</!-kx<gie!keq!G{L{<M!fl<!dmzqz<!
-k<kjgb!G{r<gt<!-vf<kiZl<!uikG{l<!lqg<g!dmz<!we<X!%xzil</!
     “vd;dNt thjk; jhnzd;gjhFk;; ; ; ;; ; ; ;; ; ; ; 
 ,fj;jpNy kdpjh;fSf;F nra;AthW; ; ; ;; ; ; ;; ; ; ;  
 gpd;dNt nghd;jidNa Nrhuq; nra;J>; ; ; ;; ; ; ;; ; ; ;  
 nghpNahHfs; gpuhkziuj; J}$bzpj;Jk;>; ; ; ;; ; ; ;; ; ; ;  
 td;Njtw; nrhj;jpw; NrhuQ; nra;J; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;  
 khjh gpjh FUit kwe;j NgHf;Fk;; ; ;; ; ;; ; ; 
fd;dNt Ntfj;ij epe;ij nra;jy;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
 fhaj;jpy; fye;jpLNk thje; jhNd; ; ; ;; ; ; ;; ; ; ; ”  
      - A+fp rpe;jhkzpghly; 243; ;; ;; ;  
“jhndd;w frg;NghL Jth;g;Giwg;G; ; ; ; ;; ; ; ; ;; ; ; ; ;  
rhjfkha; neQ;nrYr; rikj;j tz;zk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
Mndd;w thwpdJ nghrpj;jyhYk;; ; ;; ; ;; ; ; 
Mfhaj; NjwyJ Fbj;jhYk;; ; ;; ; ;; ; ; 
ghndd;w gfYuf;f kpuhtpopg;G; ; ;; ; ;; ; ;  
gl;bdpNa kpfAWjy; ghunka;jy;; ; ; ;; ; ; ;; ; ; ; 
Njndd;w nkhopahHNks; rpe;ijahjy;; ; ; ;; ; ; ;; ; ; ; 
rPf;fpukha; thjkJ nrdpf;Fe; jhNdP ; ; ; ;P ; ; ; ;P ; ; ; ; ”. 
  jha;> je;ij> FU ,th;fis kwj;jy;> Ntjj;ijg; gopj;jy;> frg;G> 
Jth;g;G> ciwg;G Nrh;e;j czit mUe;Jjy;> Mwpd czit cz;zy;> 
Njq;fpa ePH> yhfphpahidfs;> rhuhak; Fbj;jy;> gfypy; J}q;fp ,utpy; 
tpopj;jpUj;jy;> mjpfkhf gl;bdp fplj;jy;> kpFe;j Rikiaj; J}f;Fjy;> 
ngz;zpd; Nky; rjhepidg;Gf; nfhs;sy; Mfpa fhuzq;fshy; thjNeha; 
cz;lhFk;. 
“tspAike; jd;dpiy nfl;L; ; ;; ; ;; ; ;  
typAld; tPf;fr; RuKk; fha;e;J; P ; ; ; ; ;; P ; ; ; ; ;; P ; ; ; ; ;  
%l;Lfs; NjhWk; KLf;fpNa nehe;J; ; ; ; ;; ; ; ; ;; ; ; ; ;  
%l;;;;Lfs; jd;dpy; ePUk; Rue;J; ; ; P ; ;; ; ; P ; ;; ; ; P ; ;  
jhq;nfhzh typAkh nehe;jpLkk;Nk; ; ;; ; ;; ; ; ” 
      - rghgjp ifNa 
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Following precipitating factors are caused the disease, 
 Increased intake of tuber 
 Wandering of chill weather 
 Drenching in Rain 
 Living in hilly region 
 Excessive sexual intercourse 
 Hereditary 
 Excessive intake of bitter, astringent, acrid taste food, intake of varagu thinai 
and altered sleep pattern also contribute to vatha disease. 
Environmental factors (Gw#o;epiyfs;); ;; ;; ; !
! “thj th;j;jid fhyNkNjh ntd;dpy;; ; ; ;; ; ; ;; ; ; ; 
 kUTfpd;w Mdp fw;flkhFk;; ; ;; ; ;; ; ; 
 Mjitg; ;;; grpNahL fhHj;jpif jd;dpy;; ; ;; ; ;; ; ; 
 mlUNk kw;w khjq;fs; jd;dpy;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
 NghfNs rkpf;Ffpd;w fhykhFk;.; ; ;; ; ;; ; ; ” 
 nghUe;jpNa apth; njhopy; jhd; fz;bwj;jy;; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ; 
 fhjNt fz;%ly; iffhy; irj;jy;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
 fbe;Njhl;l Klf;fnyhL ePl;lntd;Nd; ; ; P ; ;; ; ; P ; ;; ; ; P ; ; ”. 
- A+fp rpe;jhkzpghly;; ;; ;; ; 
  From the month of Aani to Karthigai (June to December), vatha diseases are 
precipitated, hence the seasonal factors are involved and facilitate the vatha diseases. 
“gJkj;ij G+f;f itf;Fk; ghDkpf;f fhAk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
 KJNtdp ypw;G tpe;ePH Kw;Wk; ; ; P ; ;; ; P ; ;; ; P ; ; - fJnkd 
 tw;Wk; fg/Fk; thAkpFk; tho;khe;jPHf;; ; ; ; ; ; P ;; ; ; ; ; ; P ;; ; ; ; ; ; P ; 
Fw;w eypf; Nfjp; ;; ;; ; njd; NwhJ;;; ” 
      - kUj;Jth; jdpg;ghly;; ; ; ;; ; ; ;; ; ; ; 
tpsf;fk;; ;; ;; ; 
 KJNtdpy; fhyj;jpy;> #hpantg;gj;jpd; fhuzkhf ngUk; thhpahf 
ePHMtpahf;fg;gl;L G+kpapy; twl;rp epyTk;.  mJNghy; ekJ clypy; twl;rp 
Vw;gl;L tspNeha; tUtjw;F VJthfpwJ. 
 
gof;ftof;fq;fs;; ; ; ;; ; ; ;; ; ; ; 
 “nta;apypy; elf;ifahYk; ; ; ; ;; ; ; ;; ; ; ; kpfj;jz;zPH; ; P; ; P; ; P  
 nra;apio kfspiur; Nrh;e;jD gtpf;ifahYk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
 igaNd cz;ikahYk; ghfw;fha; jpd;ifahYk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
 ijaNy thjNuhfk; rdpf;Fnkd; wwpe;J nfhs;Ns; ; ; ; ;; ; ; ; ;; ; ; ; ; ” 
      - Njiuah; thflk;; ;; ;; ; 
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 #hpa ntg;gj;jpy; mjpf njhiytpy; elj;jy; 
 mjpf jz;zPH Fbj;jjhYk; 
 mjpfsT ghfw;fha; cz;ZtjhYk; 
 mjpfsT fhkk; Ja;g;gjhYk; tspNeha; Vw;gLk;. 
 
Diet 
  “tspjU fha; fpoq;F; ;; ;; ;  
  tiutpyh japyy; Nfhi;;;  
  Kspjaph; Nghd;kpFf;F; ; ;; ; ;; ; ;  
  Kiwapyh Tz;b Nfhly;; ;; ;; ; 
  Fsph;jU tspapw; Nwfq;; ; ;; ; ;; ; ; 
  Fspg;Gw Tyty; ngz;bH; ; ;; ; ;; ; ;  
  fspj;jU Kaf;fk; ngw;NwhH; ; ; ;; ; ; ;; ; ; ;  
  fbnray; fUtpahky;;; ;” 
  Diet and health which gives rise to vatha dhosa (ie) excessive intake of potato 
like roots and banana, excessive intake of cold substances like curd, exposure to cold, 
staying in hill station which increase kabam causes this disease.  Further this disease 
is followed by megha noi and may be hereditary. 
 
Physical factors 
 “gfuNt thjkJ Nghfpj;jg;Ngh; ;; ;; ;  
  gz;ghf ngz;Nghfk; mJjhd; nra;apy;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
 jfhNt ntFJ}u topelf;fpy;; ;; ;; ; 
  espuhd fhw;WNk gdpNky; gl;lhy;; ; ; ;; ; ; ;; ; ; ; 
 epfuNt fha;fs; fdpfpoq;F jd;id; ; ; ;; ; ; ;; ; ; ;  
kpf tUe;jp kPwpNa japh;jhd; nfhz;lhy;; P ; ; ; ;; P ; ; ; ;; P ; ; ; ; 
KfuNt KJnfYk;ig KWf;fp ; ;; ;; ; nehe;J;;;  
  Koq;fhYk; fZf;fhYk; fLg;Gz;lhFk;.; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ;  
      - A+fp rpe;jhkzp;;;  
  Indulging in the sexual act during vitiation of vatha, walking for a long 
distance, exposing to dampness and cold, harmful combination like taking excessive 
curd after eating fruits, vegetables and tubers causes toxic factors which affects bone 
and muscle. 
 “jhndd;w frg;NghL Jth;g;G ifg;G; ; ; ; ;; ; ; ; ;; ; ; ; ;  
  rhjfkha; kpQ;RfpDk; rikj;j td;dk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
 Mndd;w MwpdJ Grpj;j yhDk;; ; ;; ; ;; ; ; 
  Mfhaj; NjwyJ> Fbj;jyhYk;; ; ;; ; ;; ; ; 
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 ghndd;w gfYwf;f kpuhtpopg;G; ; ;; ; ;; ; ;  
  gl;bdpna kpfTWjy; ghunka;jy;; ; ; ;; ; ; ;; ; ; ; 
 Njndd;w nkhopahH Nkw;rpe;ij ahjy;; ; ; ;; ; ; ;; ; ; ; 
  rPf;fpukha; thjkJ nrdpf;Fe;jhdP ; ; ; ;P ; ; ; ;P ; ; ; ;  
- A+fp rpe;jhkzp;;;  
  Intake of food item which are excess bitter, astringent and pungent tastes, 
intake of old cookded food items, drinking rain water, sleeping during day time and 
wakening at night, undue starving, strain due to excessive weight lifting and sexual 
perversion. 
According to Pararasa sekaram 
 njhopy; ngWifg;Gf; fhHj;jy; Jth;j;jy; tpQ;RDQ;NrhWk;; ; ; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ; ; ; 
  gioajhk; tuF kw;iwg; ige;jpidaUe;jpdhYk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
 vopy; ngwg; gfYwq;fp ,utpdpYwq;fhjyhYk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
  kio epfh; FoypdhNy thjq;Nfh gpf;Fq;fhNz; ; ; ;; ; ; ;; ; ; ;  
! !
  Excessive intake of bitter, astringent, pungent taste diet, day sleeping, 
wakening during night intake of old cooked food items. 
 
  fhyq;fspd; khwpGz;Zk; fhhpaj; jhYe;jz;zPH; ; ; ; ; ; ; P; ; ; ; ; ; ; P; ; ; ; ; ; ; P  
  rhyNt aUe;jpdhYQ; re;jpap ; ; ;; ; ;; ; ; Yl;fhHe;jhYk;; ; ;; ; ;; ; ; 
 Nfhykhk; Gspg;G nea;iaf; Fiwtw teUe;jpdhYk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
  thyhH Kiyey;yhNs thjKjw; gtpf;Fq;fhNz; ; ; ;; ; ; ;; ; ; ;  
  Sitting in cold breeze, excess intake of sour and ghee in food items. 
 
In theraiyar vagadam 
 nta;apypy; elf;ifahYk; kpfj;jz;zPH Fbf;ifahYk;; ; ; ; ; ; P ; ;; ; ; ; ; ; P ; ;; ; ; ; ; ; P ; ; 
  nra;apio kfsp;;; iur; Nrh;e;jd gtpf;ifahYk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
 igaNd cz;ikahYk; ghfw;fha; jpd;ifahYk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
  ijaNy thjNuhfk; rdpf;F nkd;wwpe;J nfhs;Ns.; ; ; ; ;; ; ; ; ;; ; ; ; ;  
- Njiuah; thflk;; ;; ;; ; 
   Excessive walking in hot sun, excessive intake of water, over sexual 
indulgence, intake of bitter gourd etc.  May play a disturbing role in the normal 
functions of vatham. 
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Internal causes 
Kanma as a cause 
 In siddha system, many diseases are said to be precipitated by kanma, which 
means the deeds, good or bad committed by an individual in his previous and present 
births.  Vatha diseases, according to agasthiyar kanma kandam – 300 may also 
precipitated by kanma. 
 
Vadha kanma varalaru 
 E}yd;w thjk; te;j tdfjhNdJ; ; ;; ; ;; ; ;  
  Jz;ikaha;f; fd;kj;jpd; tifiaf; NfS; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ;  
 fhypNy Njhd;wpaJ fLg;gNjJ; ;; ;; ;  
  iffhypy; Klf;fpaJ tPf;fNkJ; ; P ;; ; P ;; ; P ;  
 NfhypNy gLfpd;w ;;; tpUl;rkhd;;;  
  Foe;ij kue;jid ntl;ly; Nky; Njhy; rPty;; ; ; ; ; ; P ;; ; ; ; ; ; P ;; ; ; ; ; ; P ; 
 E}ypNy rPt Ie;J fhy; Kwpj;jy;P ; ; ; ;P ; ; ; ;P ; ; ; ; 
  ey;y nfhk;G jioKwpj;jy; etpj;jy; jhNd; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;  
       - mfj;jpah; fd;k fhz;lk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
  If attribute the following psychological factors such as removing the bark of 
living trees, breathing the legs of the animals, cutting the trees in the living branches 
and removing leaves. 
 
Due to karmic law 
 me;jzH fw;G khjh; mUspa rhaj;jhYk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
  Ke;jpa tpidahYk; KfpHfh;g;g Nkfj;jhYk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
 rpe;ijapw; nfhLikahYk; rptFU epe;ijahYe;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
  njhe;jkhk; tpahjpahYk; Njh; ; ;; ; ;; ; ; d;wpLk; FiyjhNd.; ;; ;; ;  
- mfj;jpah;; ;; ;; ; 
Clinical features of keelvayu 
“gpj;j fPy;thA jd;dhw; gpwq;F fPy;%l;L tPq;fpr;; P ; ; ; ; P ; ; P ; ;; P ; ; ; ; P ; ; P ; ;; P ; ; ; ; P ; ; P ; ; 
rpj;jh; nry; kUj;Jtj;JQ; rPHglhjd;dkj;jhy;; ; ; ; ; ; P ; ; ;; ; ; ; ; ; P ; ; ;; ; ; ; ; ; P ; ; ; 
jj;jW fha;r;ry; fz;L rhyNt jidjhd; je;Nj; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ;  
nkj;jw rpfpr;ir jd;dhy; nkd;Nky; ePq;Fkg;gh; ; ; ; ; ; P ; ;; ; ; ; ; ; P ; ;; ; ; ; ; ; P ; ; ” 
- rghgjp ifNaL 
 
 %l;Lfspy; tPf;fk; cz;lhFk;;;; 
 %l;Lfspy; typ fhzg;gLk; 
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 jPf;Fw;w kpFjpahy; fPy;fspy; gir twz;L> giraw;w fPy; mirAk; 
Nghnjy;yhk; typ cz;lhFk;. rpy Ntisfspy; fPy;fs; nghUj;Jfs; 
xd;Nwhnlhd;W xl;bf; nfhz;L elf;f Kbahky; fhzg;gLk;. 
 
Ofib<!fqkier<gt<!we<El<!F~zqz<< < < < < << < < < < << < < < < <!
!! “giz<!jgBjtf<K!kqlqV{<mib<g<!g{<[f<Kr<gqs<!Osihqk<Kg<!< < < < < < < < < < << < < < < < < < < < << < < < < < < < < < < !
! OgizR<!osb<Blr<golz<zil<!Gk<Kl<!sx<Ox!ger<ogit<Tl<< < < < < < < < < < << < < < < < < < < < << < < < < < < < < < <!
! sQzlqGf<K!fQi<gi{qx<!sqX!LMg<GoleQ < Q < < <Q < Q < < <Q < Q < < < !
! uizkmr<guii<!GpOz!uVk<Kl<!uikOviglqOk< < < << < < << < < < ”!
!
 giz<?!jg!djtkz<!
 klqi<kz<!
 g{<K~r<gz<!
 nr<golz<zil<!Gk<kz<?!gek<kz<!
 sqXfQi<!gm<mz<!
!
lx<x!Ofib<gtqe<!hqe<uqjtU;< < < << < < << < < < !
!! “okiz<jz!osb<b!-e<Xl<!ouG!uik!Ofib<gt<!
! ! okiz<Zzgqz<!lif<kVg<Gg<!gi{<hK{<M!
! wz<jzbqz<zi!uikOfib<!ofi<jlk<ke<je!
! ! -bz<hig!nxqf<kqmOu!uqhvr<gOt”!
!
!! se<eq?! &jtOfib<?! hqVg<gOfib<gt<?! k{<Mum! Ofib<gt<?! S,kl<?! ur<gl<?!
Ngqb!lVf<Kgjt!LjxOgmig!hbe<hMk<KukiZl<!uikOfib<gt<!d{<miGl</!
uikl<!lqG!G{l<!
!! nxqbuql<!&e<xqe<!ke<jl!osie<eiv<ff<kq!
! wxqb!fz<uik!olxqg<Gr<!G{r<OgT!
! Gxqobe<g<!jggiz<!Gjts<S!uqzisf<K!
! hxqobe!ofif<Klx<!hs<js!H{<{iGOl!
!! H{<{ib<!uzqg<Gl<!ohiVLl<!GmOzick<!
! k{<{i!lzk<jkk<!kl<hqg<Gl<!Ohig<gK!
! Y{<{i!NseLxOu!Svg<gqMl<!
! l{<{ii<!Gtqi<sQMl<hVk<kqMl<!uikOl” 
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gpzpawpKiwik 
 cliyg; gpzpj;jyhy; Nehiaj;  njhpe;J nfhs;Sfpd;w xOf;fk; 
vdg;gLk;. 
 nghwpahw;Nwh;jy; 
 Gydhywpjy; 
 Tpdhjy; 
nghwpahy; mwpjy;; ;; ;; ; 
! It means examining the patient by the physician for proper diagnosis.  “Pori” 
is considered “Five sense organs” namely, 
1. nka <!)skin) 
2. tha;!)Tongue) 
3. fz;!)Eye) 
4. %f;F!)Nose) 
5. nrtp!)Ear) 
QhNde;jphpaq;fspd; Ma;T; ; ; ;; ; ; ;; ; ; ;  
nrtp xyp mwpa nra;jy; ,ay;G 
nka; clypy; Cw;iw mwpjy; Koq;fhy; %l;Lfspy; 
tPf;fk;> typ 
fz; xspia mwpa nra;jy; ,ay;G 
ehf;F Ritia mwpa nra;jy; ,ay;G 
%f;F thrid Efu nra;jy; ,ay;G 
 
fd;Nke;jphpaq;fspd; Ma;G; ; ; ; ;; ; ; ; ;; ; ; ; ;  
tha; trdpf;fr;nra;Ak; ,ay;G 
if ,LjYk;> Vw;wYk;nra;Ak; ,ay;G 
fhy; elf;fr;nra;Ak; Koq;fhy; %l;Lfspy; 
typ> elf;f rpukk; 
vUtha; kyj;ij fopf;Fk; kyr;rpf;fy; 
fUtha; fU> Rf;fpyj;ijf; fopf;Fk; ,ay;G 
 
vz;tifj;Njh;T; ; ;; ; ;; ; ;  
“thjj;jpy; Nrj;Jk khfpy; typNahL tPf;fKz;lhk;; ; ; ; P ; ; ;; ; ; ; P ; ; ;; ; ; ; P ; ; ;” 
- mfj;jpah; ehb; ;; ;; ;  
“mwpe;JghH thjNk jdpj;jhdhy;; ; ;; ; ;; ; ; 
rhpe;jplNt fhy; Klf;Fk;; ; ; ;; ; ; ;; ; ; ;”. 
- mfj;jpah; uj;jpd RUf;fk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
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“fhzg;gh ;;; thj kPwpy; fhy;iffs; nghue;jp NehFk;P ; ; ; ; ;P ; ; ; ; ;P ; ; ; ; ; 
thjk;> thjgpj;jk;> gpj;jthjk; ; ; ; ; ;; ; ; ; ;; ; ; ; ; - fhtpaehb 
1. ];ghprk; - ghjpf;fg;gl;Ls;s %l;L gFjpapy;  
kpj ntg;gkhfNth> ,ay;ghfNth fhzg;gLk;. 
2. eh  - ,ay;G> thjNehapy; eh Jbj;J ,Uf;Fk;. 
3. epwk;  - ,ay;G> khepwk; 
4. nkhop  - rkxyp 
5. tpop  - ,ay;G> thjNehapy; tpop fWj;J  
    ,ikjbj;jpUf;Fk;. 
6. kyk;  - ghjpg;G (kyr;rpf;fy; fhzg;gLk;) 
7. %j;jpuk; - fLg;Gld; nfhQ;rkhf ,wq;Fk;. 
 
Neikkuri 
 “mUe;J khwpujKk; mtpNuhjkjha;; ; ;; ; ;; ; ; 
 m/fy; myh;jy; mfhyT+z; jtph;jow;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
 Fw;ws tUe;jp cwq;fp itfiw; ; ;; ; ;; ; ;  
 Mbf; fyrj; jhtpNa fhJnga;; ; ;; ; ;; ; ; 
 njhU %$Hj;jf; fiyf;Fl; gLePhpd;; ; ; ; P ;; ; ; ; P ;; ; ; ; P ; 
 epwf;Fwp nea;f;Fwp epUkpj;jy; flNd; ; ; ; ;; ; ; ; ;; ; ; ; ; ” 
- rpj;j kUj;Jthq;fr;RUf;fk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
 
vz;nza; tpl;Lg; ghHf;Fk; ePhpd;tpop; ; ; ; ; ; P ;; ; ; ; ; ; P ;; ; ; ; ; ; P ;  
 
 epwf;Fwpf; Fiuj;j epUkhz ePhpw;; ; ; P ;; ; ; P ;; ; ; P ; 
 rpwf;f ntz;nza;NahH rpWJsp eLtpLj;; ; ; ;; ; ; ;; ; ; ; 
 njd;Wwj; jpwe;njhyp Vfhjioj;jp; ; ; ;; ; ; ;; ; ; ;  
 dpd;wjptiy Nghk; ; ;; ;; ; newptpopawpTk;;;; 
 nrd;wJ GfYQ; nra;jpia AzNu; ; ;; ; ;; ; ;  
- Neha;ehly; Neha;Kjy;ehly; gphpT; ; ; ; ;; ; ; ; ;; ; ; ; ; -1 
 
“muntd ePz;bd;/Nj thjk;P ; ; ;P ; ; ;P ; ; ; 
  MopNghw; gutpd; m/Nj gpj;jk;; ; ; ;; ; ; ;; ; ; ; 
Kj;njhj;J epw;fpd; nkhopt njd; fgNk; ; ; ; ;; ; ; ; ;; ; ; ; ;  
  mutpy; MopAk; Mopapy; muTk;; ; ; ;; ; ; ;; ; ; ; 
mutpd; Kj;Jk; Mopapy; Kj;Jk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;” 
- rpj;j kUj;Jt Neha;ehly; Neha; ; ; ; ; ;; ; ; ; ;; ; ; ; ;  
  Kjdhly; jpul;L ; ;; ;; ;  
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Neerkkuri 
“te;j ePHf;fhp nail kzk; Eiu vQ;rny; P ; ; ;; P ; ; ;; P ; ; ;  
 iwe;jpa Ysit aiwFJ KiwNa;;; ” 
- rpj;j kUj;Jthq;fRUf;fk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
 
Urine is examined for the following Neerkuri 
 Niram  - Colour 
 Edai  - Specific gravity 
 Manam  -  Smell 
 Nurai  - Frothy nature 
Enjal   -  Quantity of urine voided 
  In Azhal Keel vaayu straw or hay coloured urine was noticed in Neerkuri. 
PARUVA KAALAM 
  Siddhars are classified a year into six seasons, 
Kaalam Kutram Suvai 
Kaarkaalam   
Aavani & Purattasi 
(Aug 16 – Oct 15) 
Vatham (Vetrunilai valarchi) 
Pitham (Thanilai valarchi) 
Enippu 
Pulipu 
Uppi 
Koothirkaalam 
Iypassi & Karthigai 
(Oct 16 – Dec 15) 
Vatham (-) 
(Thanilai adaithal 
Pitham 
(Vetrunilai valarchi) 
Enippu 
Kaippu 
Thuvarppu 
Munpanikalam 
(Margazhi & Thai 
(Dec 16 – Feb 15) 
Pitham 
(Thanilai adaithal) 
Enippu 
Pulippu 
Uppu 
Pinpani kaalam 
Massi & Panguni 
(Feb 16 – Apr 15) 
Kabam 
(Thanilai valarchi) 
Enippu 
Pulippu 
Thuvarppu 
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7 cly; jhJf;fspd; Ma;T; ; ; ;; ; ; ;; ; ; ;  
t.vz;;;; cly;jhJf;fs;; ; ;; ; ;; ; ; njhopy;;;; moy;fPy;thAtpy; ; P ; ;; P ; ;; P ; ;
fhzg;gLtJ;;;  
1. rhuk; cliy> kdij 
Cf;fKwr;nra;jy; 
ghjpg;G 
2. nre;ePh; mwpT> td;ik> xsp nrUf;F 
,itfis epiyf;fnra;jy; 
,ay;G 
3. Cz; clypy; cUtj;ij mikj;jy;> 
vd;ig tsh;j;jy; 
ghjpg;G 
4. nfhOg;G cWg;Gfs; ,aq;f mtw;wpw;F 
nea;g;G gir Cl;LtJ 
ghjpg;G (fPy;fspy; 
nea;g;G gir 
Fiwjy;) 
5. vYk;G cly; mirtpw;F 
mbg;gilahapUj;jy; 
ghjpg;G 
6. %is vd;Gf;Fs; epiwe;J td;ikAk;> 
nkd;ikAk; jUtJ 
ghjpg;G 
7. ntz;zPH fUNjhw;wj;jpw;F Kjyha; 
epw;gJ 
,ay;G 
 
In Azhal keel vayu,  
 Saaram, kozhuppu, Oon and Enbu thathukkal are chiefly affected. 
Kf;Fw;w NtWghL; ;; ;; ;  
tspkpF tghd tpahd 
  thAf;f sjpf hpf;Fk;; ; ;; ; ;; ; ; 
,skpf kyePHf; fl;Lk;P ; ; ;P ; ; ;P ; ; ; 
  ,ak;gpa tghdd; nra;Ak;; ; ; ;; ; ; ;; ; ; ; 
thjk;;;; 
t.vz;;;; thjk;;;; njhopy;;;; moy;fPy; thAtpy; ; P ; ;; P ; ;; P ; ;
ghjpf;fg;gl;l Fw;wk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
1. gpuhzd; %r;R thq;fy; tpLjy; 
nra;Ak; 
,ay;G 
2. mghdd; fPo;Nehf;fp kyj;ijj; 
js;Sk; 
ghjpg;G (kyf;fl;L) 
3. tpahdd; cWg;Gfis ePl;b 
klf;f nra;Ak; 
ghjpg;G (fhy;fis ePl;b 
klf;frpukk;) 
4. cjhdd; cztpd; rhuj;ij 
clypy; epwj;jk; 
,ay;G 
5. rkhdd; kw;w thAf;fis ghjpg;G (kw;w thAf;fs; 
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rhpgLj;Jk; ghjpg;G) 
6. ehfd; vy;yh fiyAk; fw;Fk; 
gb nra;jy; 
,ay;G 
7. $Hkd; fz;fis jpwf;fTk; 
%lTk; nra;Ak; 
,ay;G 
8. fpUfud; ehtpw; frpitAk; 
ehrpapw; frpitAk; 
cz;lhf;Fk; 
,ay;G 
9. Njtjj;jd; Nrhk;gy;> cly; 
Khpj;jy; cz;lhf;Fk; 
ghjpg;G (taJ 
fhuzj;jhy;) 
10. jdQ;nrad; ,we;j gpd; %d;whk; 
ehs; jiyntbj;J 
ntspNaWk; 
- 
    
 
gpj;jk;; ;; ;; ; 
t.vz;;;; gpj;jk;; ;; ;; ; njhopy;;;; moy;fPy; thAtpy; ; P ; ;; P ; ;; P ; ;
ghjpf;fg;gl;l Fw;wk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
1. mdw;gpj;jk; cz;l czT 
nghUis nrhpf;Fk; 
gb nra;Ak; 
ghjpg;G (grpapd;ik> 
czT nrhpahik) 
2. ,uQ;rfk; nre;ePiu 
kpFjpgLj;Jk; 
ghjpg;G (nre;ePh; 
FiwT) 
3. rhjfg;gpj;jk; tpUg;gkkhd 
njhopiy nra;J 
Kbf;Fk; 
ghjpg;G (fhy;fis 
ePl;b> klf;f rpukk;) 
4. MNyhrfgpj;jk; fz;fSf;F 
nghUis 
njhptpf;Fk; 
,ay;G 
5. gpuhrf gpj;jk; NjhYf;F xypia 
nfhLf;Fk; 
,ay;G 
 
Iak;;;; 
t.vz;;;; fgk;;;; 
njhopy;;;; moy;fPy;thAtpy; ; P ; ;; P ; ;; P ; ;
ghjpf;fg;gl;l Fw;wk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
1. mtyk;gfk; 
kw;w ehd;F Iaq;fSf;Fk; 
gw;W NfhlhapUf;Fk; 
ghjpg;G 
2. fpNyjfk; nrhpj;jy; ,ay;G 
3. Nghjfk; Ritia mjpfhpf;Fk; ,ay;G 
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4. jw;gfk; fz;fSf;F Fsph;r;rp ,ay;G 
5. re;jpfk; 
fPy;fspy; epd;W ,aw;ifaha; 
vy;yhf; fPy;fisAk; 
xd;Nwhnlhd;W nghUj;jp jsu 
nra;Ak; 
ghjpg;G (ePl;b klf;f 
rpukk;) 
 
Neha;fzpg;G tpthjk;; ; ;; ; ;; ; ; 
tspf;fPy;thA; P ;; P ;; P ;  
typf;Fj;jy; tPf;fq;fhZk; tha;j;njhz;il twl;rp fha;r;ry;; ; ; P ; ; ; ; ; ; ; ; ; ;; ; ; P ; ; ; ; ; ; ; ; ; ;; ; ; P ; ; ; ; ; ; ; ; ; ; 
jiytyp khHJbg;Gj; jhq;nfhzh typ tPf;fe;jhd;; ; ; P ; ; ;; ; ; P ; ; ;; ; ; P ; ; ; 
epyT fhq;fZf; Fwq;F ePL Njhs; Koq;iff; fhw;fhk;; ; ; P ; ; ; ; ;; ; ; P ; ; ; ; ;; ; ; P ; ; ; ; ; 
kyf; Flw;fl;L Nth;it thjf;fPy; thA tpjhNk; ; ; ; ; P ;; ; ; ; ; P ;; ; ; ; ; P ;  
       - rghgjp ifNaL 
mwpFwpfs;;;; 
 jhq;fKbahj typ 
 fhy;tpuy; 
 Koq;fhy; %l;L 
 ,Lg;G %l;L 
 Koq;if %l;L 
 Njhs; %l;L 
 ,k;%l;Lfspy; tPf;fk; 
 tha; twl;rp> Ruk;> jiytyp> glglg;G> kyr;rpf;fy;> tpah;j;jy; Mfpa 
mwpFwpfs; cs;sd. 
Iaf;fPy;thA; P ;; P ;; P ;  
“fUjUq; fgf;fpy; thA fz;bbd; cly; ,isf;Fk;; ; ; ; ; ; ; ;; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; 
cUnkypthf;Fq; nfhs;Sk; cz;biar; RUf;F kp; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ; d;ge;; ;; ;; ; 
jUJapy; ePq;F Kl;bw; ehq;nfhzh tYitahf;Fk;; P ; ; ; ; ; ;; P ; ; ; ; ; ;; P ; ; ; ; ; ; 
,UkNy tpf;fy; the;jp> Nrhig ghz;nlOg;Gk; ghNu.; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;  
    
- rghgjpifNaL 
mwpFwpfs;;;; 
 %l;Lfspy; jhq;fKbahj typ 
 cly;nkypT 
 grpapd;ik 
 tpf;fy; 
 the;jp 
 ghz;L 
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3. tspIaf; fPy;thA; P ;; P ;; P ;  
“mitak; thjf; fgf;fPy; thAthd; typ kpFe;Nj; ; ; P ; ; ;; ; ; P ; ; ;; ; ; P ; ; ;  
caq;F ;;; ePH Nfhj;J fPy;fs; xhpapd; jiyNghw; fhZk;P ; P ; ; ; ; ;P ; P ; ; ; ; ;P ; P ; ; ; ; ; 
eaq;nfhs;s Klf;fy; ePl;ly; ez;zplh nka;Aq; fhAk;>; ; ; ; P ; ; ; ; ; ;; ; ; ; P ; ; ; ; ; ;; ; ; ; P ; ; ; ; ; ;  
kaf;FW Kwf;kpd;dhk;kd;dpa nehpfl;lhNk; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;  
- rghgjp ifNaL 
mwpFwpfs;;;; 
 %l;Lf;fspy; typ 
 tPf;fk; 
 fPy;fs; 
 ehpapd; jiyNghy; fhzg;gLk; 
 ePl;l elf;f KbahJ. 
 
kUj;Jtk;; ;; ;; ; 
%d;wpnyhd;W ah;e;jij Kd;dwpe;J ; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;  
Ke;jpajid nahopj;jpl kUe;jpL; ; ;; ; ;; ; ;  
jzpAk; Nehapd; je;jpukpJNt; ; ;; ; ;; ; ;  
Ngzpf; fzpj;jpbd; gpwtha; gpd;Fzk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
- Neha;ehly; Neha; Kjy;ehly; (ghfk;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;-1) 
The treatment in siddha system includes not only the removal of signs and 
symptoms of a disease but also in total uprootment of the diseases. 
 This is achieved by normalising the deranged mukkutram there by retaining 
body’s natural health.  The recurrence of the disease is prevented by the practice of 
yoga.  According to siddha system line of the treatment is divided into 3 types. 
1. Kappu (Prevention) 
2. Neekam ( Treatment) 
3. Niraivu ( Restoration) 
1. Kappu (Prevention) 
The preventive azhal keel vayu is,  
1. Control the body weight by diet & exercise. 
2. Modify the nature of work which gives stress to a particular joint. 
3. Avoid excess intake of sour, astringent and bitter tasted food. 
  In azhal keel vayu the deranged vatham and other toxic products of digestion 
and metabolism is brought to its normal state by purgation (tpNurdk;)!
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tpNurdj;jhy; thje;; ; ;; ; ;; ; ;jhOk;;;;  
 15ml of vellai ennai is given the luke warm water at early morning before 
starting the treatment with trial drug. 
a. Internal Medicine 
  Eranda moola chooranam  -  3 to 6 gm in two divided doses/day  
       after food. 
  Adjuvant   -  Hot water and Honey 
b. External medicine 
c. Kungilia thylam    -  External application over the  
       affected joints. 
 
3. Complementary therapies 
  Apart from other department, Sirappu Maruthuvam department gives equal 
importance to complementary therapies in siddha system of medicine along with its 
internal & external medicines. 
 There are several complementary therapies followed in siddha system of 
medicine such as Kattu, Pattru, Nasiyam, Attai vidal, Thokkanam, Ottradam, 
Varmam Asanam, Vedhu etc. 
Complementary therapies which are taken into account for this study are: 
 
SIRAPPU MARUTHUVAM FOR AZHAL KEELVAYU 
1. PATTRU 
2. THOKKANAM 
 
1. PATTRU 
   The pattru in siddha is obtained from plant extracts or grinding raw drugs 
with or without processing them and are either heated or not heated ,is made into a 
thick paste and applied, or pasted on the affected area.  
 
Introduction : 
        Pattru (poultice) also called cataplasm is a soft moist mass, often heated and 
medicated that is spread on skin to treat an aching inflamed or painful part of the 
body.   Pattru may also be refered to as porous solid filled with solvent used to 
relieved muscle strain and sprain. Pattru treatment is very successful because ,skin the 
largest organ of the body and one of the first line of defense against disease has 
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greater ability to absorb it. When herbal pattru are applied to the painful area of the 
skin. It absorbs pharmacologically active substance immediately into it. It is a non 
invasive cost effect, and easy procedure. 
 
Mechanism: 
  Whent patru is applied to the painful area of the skin it absorbs the 
pharmacologically active  substance  immediately  into it. The absorption in the skin.  
Is mostly transcellular. It is unlikely that noticeable absorption occurs between cells 
or through sweat pores and hair follicles. Drug with low molecular weight (below 
800dallons)  with  high  water and lipid solubility shows greater penetration. The 
vehicle of the drug also plays a vital role. Acid PH of the stratum corneum decreases 
the permeability of the drugs. So when pattu made of water is applied the stratum 
corneum gets hydrated resulting in better absorption. 
 
Pattru- Thrust Areas  
 Traditionally topical herbal preparations make use¬ of enhancers to facilitate 
the quality and quantity of skin transfer. 
 Herbs high in tannins, like Rheum emodi¬ (Irevalchinni), which have an 
astringent effect, to tighten, and protect the skin and reduce bleeding, prevent 
capillaries rupture, produce contraction of organic tissues. 
 Rhizomes like Ginger, Acorus calamus (Vasambu)¬ are anti-inflammatory, 
when used topically for arthritis, etc., Topical preparations must contain 
compounds that penetrate the skin, inhibit pain receptors such as transient 
receptor potentialaction channels and cyclooxygenase-2, to relieve pain. 
Inhibition of pain in the skin disrupts the pain cycle and avoids exposure of 
internal organs to large amounts of toxic compounds. 
 Poultice can be used for Rashes, Viral infections¬ like herpes, Bacterial 
infections, Fungal infections, Parasitic infections like lice, pigmentation 
disorders, tumours and cancers, trauma due to injury or cut or blow.They act 
as emollient, anti-microbial, antibacterial, anti-fungal etc.  
 They will help to reduce the bacterial load in the¬ area, lowering the chances 
of infection when the boil comes to a head and opens on its own.  
 Poultice act as chemical Cautery. It helps healing¬ in abscess by draining the 
fluid including pus and also degrade pile mass.   
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 Plants like Mirabilis jalapa (Andimalli)tubers do¬ have their effect in wound 
care and removes functional obstructions in the body as "deobstruent"  
 Pattru plays vital role in swelling of filariasis, can¬ be used to soften and 
reduce the swelling of lymphedematous tissues.  In order to increase the 
efficacy of pattru there are¬ varies material used to triturated along with the 
main source material. They are herbal juice, egg white, butter milk, curd, salt, 
ginger, lime juice, hot water and tamarind juice. 
 The plant contains sesquiterpene lactones, (and¬ also steroid saponins, 
alkaloids)  which help to reduce swelling, and flavonoids, which strengthen 
blood vessels reducing the leakage of blood under the skin that occurs with 
bruising. 
 Poultices like sodium chloride  may also be¬ heated and placed on an area[4]/ 
or on application that produces redness of the skin (counter irritant), causing 
dilation of the capillaries and an increase in blood circulation as a 
rubeifacient.  
 Topical agents providing anti-oxidant and antiinflammation effects on the 
diseased tissues after¬ penetrating the skin barrier is now a proven fact. 
 
Therapeutic sources: 
 Herbal drugs 
 Mineral drugs.  
 Animal drugs. 
 Medicated oil’s& tablet’s 
 
Indications 
1. Joint pain 
2. Trauma inflammation & knee inflammation  
3. Muscle tension 
4. Skin disease 
5. Body pain. 
6. Treat blood clot 
7. Headache ,sinusitis,nasalblock . 
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THOKKANAM  
 Thokkanam is the siddha way of touch therapy.  it is the physical 
manipulation of the body usually done with or without oil application.  It is very 
effective for neurological and musculoskeletal problems.  It also promotes mental and 
physical fitness.  According to siddha, disease in the body occur due imbalance of 
three humours that is vatham, pitham and kapham which in turn are governed by five 
fundamental elements – Akayam (Space, vayu (air), Theyu (fire), Appu (water and 
Mann (Earth.  Thokkanam is one of the 32 types of external medicines mentioned in 
siddha literature.  In this technique, the physician uses his hands on the body of the 
patient in 9 different unique ways with or without using medicated oil with acurative 
or palliative point of view.  The 9 different techniques in thokkanam which makes 
siddha medicine unique in all aspects.  They are 
 
1. Thattal or patting technique 
2. Irukkal or tightening 
3. Pidithal or holding 
4. Murukkal or twisting 
5. Kattal or tying 
6. Azhuthal or pressing 
7. Izhuthal or pulling 
8. Mallathuthal or supinating 
9. Asaithal  
 
Benefits of Thokkanam 
 Helps to cure vatha disease even without internal medicines. 
 Chronic disease like spondylosis, lumbago, disc prolapse, hemiplegia, 
neurological conditions etc are managed well through thokkanam. 
 Improve circulation 
 Treats obesity 
 Helps in pain relief 
 Removes indigestion, constipation and flatulence 
 Induce sleep 
 Helps maintain normal blood pressure 
 Restores vatham, pitham and kapham in normal ratio 
 Regulates vatha humour. 
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 Delays the aging process 
 Helps to rejuvenate the body. 
 Helps to increase the quantity of oxygen in the cells. 
 Helps to prevent wrinkles and maintain the complexion of the skin. 
 Tones the muscles 
 Helps to keep the joint flexible 
 Improves the complexion of the skin 
 Improves energy and mental alertness. 
 
Introduction 
 External remedies in siddha are classified as 32 in number.  The unique 
remedy of its kind among all and which is subdivided into nine more procedures in 
thokkanam.  Initially these procedures were used only for royal families to enhance 
rejuvenation and latter turned into a therapeutic application. 
 Thokkanam as a whole focuses on treating disease caused by aggravation of 
‘VATHAM’ the kinetic force of the body.   The humoral theory of siddha states that 
vatham is the acitve force responsible for the physiological functioning of 
neuromuscular as well as musculo skeletal systems.  
 Thokkanam is also useful in disease where pitham as well as kapham is 
deranged.  A simple thokkanam session wipes of sedentary feel which is a kapham 
aggravation. 
Toning the skin, muscles and nerves where vatham lives.  It is synonymously called 
as Marthanam.  Marthanam is performed by mallars (wrestlers) in older days.  As per 
siddha basic principles the meeting points of muscles, nerves, joints and skin 
including hair roots are places of flow of vital vatham energy.  A depletion of vatham 
vital energy may lead to vatham derangements such as pain, altered tone, power, 
twitching, spasticity, rigidity numbness and neuritis. 
 
 
Three humour theory and thokkanam 
 To have a sound knowledge in application of thokkanam clinically it is 
mandatory to know about three humour theory.  Vatham is the force of creation.  
Pitha is the force of maintenance, and kapham is the force of destruction. 
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Vatham takes care of bodily funciton as below 
1. Respiration  - Uyirkal (Pranan) 
2. Excretion  - Keel nokku kaal (Abanan) 
3. Circulation - Paravukal (Vyanan) 
4. Digestion - Nadukkal (Samanan) 
 
Thattal – Friction and Percussive strokes 
    Thattal covers more than 40% of techniques of Marthanam. 
 Friction strokes are used in joints, muscles and in tendons.  Friction strokes 
are usually relaxing when applied gently.  Therapist should not exceed the toleratble 
and pleasurable pressure. 
 Percussive strokes are sub divided into hacking, cupping and pinching – 
plucking. In hacking palms are open and faces each other.   
Cupping is performed effectively in larger areas like trunk, back and abdomen. 
 Lifting little flesh in fingers and sliding them is pinching/plugging. 
Benefits 
1. Improves circulation 
2. Release muscle tension. 
Precautions 
 Precussive strokes directly on spine is to be avoided.  Therapist hands and 
wrist should be held relax. 
Irukkal 
 Irukkal is squeezing type of pressure.  Irukkal is applied in conditions where a 
good nourishment to muscles and nerves is deficit.  It is also called as wringling.  It is 
usually performed across body and limbs.  Wringing is usually applied in the end 
hours of Thokkanam.  Squeeze and roll the muscle between your neck and shoulder.  
It’s hard to tell from the photo that he’s doing anything other than squeezing the 
muscle, But you should in addition to squeezing your muscle also pull or roll the 
muscle between your fingers.  Try it.  first squeeze the muscle, just like you did 
above.  Then pull it a little and roll it in a small circle of back and forth.  Try 7 slow 
squeeze and rolls on your trapezius muscle varying the intensity of each stroke.  Let 
your muscles relax. 
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Purpose 
 Squeezing and Rolling increases your circulation and warms your muscles.                 
  It also gives your fingers a good workout. 
Ilutthal 
  Ilutthal is pulling.  In this type of thokkanam, strokes are used to pull and 
stretch the muscles of the trunk and legs.  Pulling is performed before wringing or 
along. 
Murukkal 
 Murukkal is kneading.  It is performed to release muscle tension and to 
improve circulation kneading is performed in areas which are fleshy.  Action similar 
to that of kneading dough is to be performed here. 
Pidithal 
 Both pressing and draming is performed in this variety.  Press the muscle 
areas gently and drain them slowly.  Draining is performed usually using the heel of 
the hand for larger areas and thumbs for smaller areas.  Pidithal improves circulation 
and relaxes the muscles. 
Aluthal 
 Aluthal is the combination of gliding and gentle pressing.  Usually these two 
procedures initiates massage and repeatedly performed in the whole session gliding is 
the technique used to apply oil all over the body.  Gentle pressing all over the body 
following gliding.  Gliding can be done in longitudinal or circular motion. 
Purpose 
 Gliding is a good beginning for every massage.  It warms your skin and sends 
a message to your body that a massage is coming. 
Tips 
 Velocity, volume and intensity are three variables you can use to change the 
effect each stroke has on you. 
Volume 
 Try covering more skin with each stroke by spreading your fingers wide or 
make a with your hand 
Velocity 
 Try varying the speed of your strokes 
Intensity 
 Try varying the intensity of each stroke 
34 
 
Squeezing 
 Try it interlace your fingers.  Rest the heels of your hands on either side of 
your thigh and  squeeze your hands into your thigh muscles.  Try 7 slow quad 
squeezes, slightly vary the location and intensity of each squeeze.  Now try it on your 
other leg. 
Purpose 
 Squeezing warms muscles, increases circulation and speeds recovery. 
Stroke description 
 Bring pressure to bear on a muscle.  Try squeezing your left biceps with your 
right hands.  It really is a simple as squeezing the muscle.  It should feel good. 
Squeezing & Rolling 
 Try it: Squeeze and roll the muscle between your neck and shoulder.  It’s hard 
to tell from the photo that he’s doing anything other than squeezing the muscle.  But 
you should in addition to the muscle.  Just like you did above.  Then pull it a little and 
roll it in a small circle of back and forth.  Try 7 slow squeeze and Rolls on your 
trapezius muscle varying the intensity of each.  Stroke let your muscles relax. 
Purpose 
 Squeezing and Rolling increases your circulation and warms your muscles.  It 
also gives your fingers a good workout. 
Pressing 
 Try it.  Take off your shoes and socks and give your foot a poke, press your 
thumb into the bottom of your foot and your other four fingers into the top of your 
foot.  Try 7 slow presses.  Experiment by varying intensity and moving your fingers 
slowly over your foot.  Try it on your other foot. 
Purpose 
 The press is powerful because it activates acupoints triggers trigger points,  
jump starts circulation, and sends endorphin cocktails flowing to every cell 
Pressing and Rolling 
 Try it: Starting at your solarplexus.  Press and roll your abs.  Perform a series 
of small circular rolls with your first moving clockwise, until.  You’ve covered your 
entire belly with your first slightly vary the intensity of each stroke.  Alternately, 
relax and flex your abs.  Feel the difference between pressing  and pressing and 
rolling your abs.  It’s like night and day. 
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Purpose 
 Pressing and Rolling activates, acupoints triggers trigger points, jump starts 
circulation and sends endorphin cocktails cruising to stimulate every cell in your 
body. 
Drumming 
 Try it: Drum your quads, use the sides of your hands to tap your thighs.  
Slightly vary the location of each stroke.  Let your leg relax.  focus on the rhythm and 
feeling of each stroke. 
Purpose 
 Drumming is an energizing, stimulating stroke, used to get you moving. 
Note 
 Massage therapists call this stroke trapotement  It means drumming. 
 When you need to target a specific area of your body, switch over to manual 
mode.  Customize your massage and choose from several programs to suit your needs 
for both upper and lower body.  The upper body massages. 
 The thadavu murai is classified into two main parts.  They are 
1. Podhu thadaval murai 
2. Upa thadaval murai 
  The pothu thadaval murai methods do proper alignment of the nerves, blood 
vessels, bones and muscles.  With the help of medicated oils we should do the 
techniques.  After that we have to relign the sara ottam and jeeva ottam in all varma 
points.  By this we can give good health to the patient. 
 After doing this, we should check whether the patient needs uzhlthadaval 
murai or not.  It it is needed we have to align and stimulate the tissues and internal 
organs.  
 In the first three days of treatment we should only do podhu thadaval methods, 
then in the 4th and 5th day podhu thadaval is done followed by uzhlthadaval. 
 Usually the treatment takes seven days.  In the 6th and 7th day.  We should 
only do podhu thadaval. 
 At the end of the thadaval murai in all the days of the treatment. 
 We have to give otradam, after that the patient should take hot water bath.  
After that the patient should take chukku kanji.  The patient may take their food after 
an hour of these treatment methods.  During the treatment days the patient must avoid 
sleep in the day time. 
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  The patient should follow the following food restrictions after the thadaval 
murai.  Chicken, uriddhal, small gram and tamarind during the treatment days.  
Because it may lower the effects of the treatment. 
 The patient should take 3 months rest after the treatment.  Importantly he/she 
should not have sexual contact and severe exercises during the rest periods. 
Massage!)njhf;fzk;); ;; ;; ;  
 thjk; Kjypa Kf;Fw;w gpzpfs; cz;lhf;Fk; typia ntWq;ifahNyh 
(m) ijyk; jltpNah gpbg;gJ. 
  
  “njhf;fzj;jp dhypuj;je; Njhy;C zpitfl;F; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;  
 kpf;F rTf;fpaQ;r kPuZk;ngh ; ; ; P ;; ; ; P ;; ; ; P ; – nka;f;fjpf; ;; ;; ;  
 Gl;bAwf;fk; Gzh;r;rp apit fjpf;Fk;; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ; 
 gl;l miyr;ryWk; ghH; ; ;; ; ;; ; ; ” 
. Njud;;;; 
  of these 2 of the methods are very much beneficial in treating cervical 
spondylosis. 
 
gpbj;jy;; ;; ;; ;  
 “gpbj;jyp aq;Fk; ikjpap De;jFk; gpe;jhNj ; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; – vz;nz;;;  
 ALj;jJ nra;apw; wrtsp A+Dl Ye;jhNj; ; ; ;; ; ; ;; ; ; ;  
 Ntw;wJ ;;; nra;apDQ; #rpif ghhpir tpl;NlhLk; ; ; ; ;; ; ; ;; ; ; ; - Gyp 
 Nghw;wJ thAT kw;WJ Nkdypg; nghl;NlhLk;; ; ; ; ;; ; ; ; ;; ; ; ; ;” 
 
 njhf;fzk; nra;af;$ba 5 epiyfspYk; nra;ayhk;.  ijyk; jltpNah> 
jlthkNyh gpbj;Jtpl thj Neha;fSf;F rpwg;ghf nghUe;Jk</!
!
! It is made on the upper fibers of trapezius muscle and the underlying bone. 
    
,Oj;jy;; ;; ;; ;!(Pulling) 
 ,Oj;jy; fplj;j ypUj;j ypuz;bw;F NkuhNk ; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; – vd;gpy;; ;; ;; ; 
 KOj;jJ tz;Zfq; fhdke; jf;fjp rPuhNk; ; ; ; ; P; ; ; ; ; P; ; ; ; ; P  
 cUTj nyd;gJ kpj;Njhop NyNeuk; G+whfp ; ; ;; ; ;; ; ; – kdk;;;; 
 ntUTW %d tpidfis nka;aL Ntwhfp;;;  
 tsf;FW nkz;nza; NyapJ nra;tJ ty;yhz;ik ; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; – clw;;;; 
 fsf;fQH Nghf;fr; RSf;nfd thtjpj; njhy;yhz;ik; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ;  
 
 ,ij ijyj;ij G+rpNa nra;aNtz;Lk;.  vYk;Gfs; ed;wha;j; 
njhpAkplq;fspYk;> jiyapYk; cUTk;NghJ ke;jkhf nra;aNtz;Lk;. 
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 ,jdhy; euk;gpy; Cwp tWj;Jfpd;w thAf;fs;> gpbg;Gfs;> RSf;Ffs; 
FzkhFk;. 
 Done for sternocleidomastoid muscles. 
 The treatment normally starts with applying the medicated oil on the affected 
area.  It directly acts on lymphatic, muscular, nervous and vascular system. 
 Strengthens muscle and skin 
 Relaxes whole body 
 Regulates nerve function 
 Improve blood circulation 
 Improve sleep 
  Through massage, the medicated oil applied permeates through the skin and 
reaches the tissues under them.  It releives pain and tension by stimulation the sensory 
and motor nerves. 
 
Benefits 
 It reduces the production of some hormones such as cortisol and nor 
epinephrine which are responsible for stress. 
 Brings fresh oxygen to the affected tissues. 
 Swelling and thickening of tissues are reduced 
  The treatment in siddha system includes not only the removal of signs and 
symptoms of a disease but also in total uprootment of the diseases. 
 This is achieved by normalising the deranged mukkutram there by retaining 
body’s natural health.  The recurrence of the disease is prevented by the practice of 
yoga.  According to siddha system line of the treatment is divided into 3 types. 
1. Kappu (Prevention) 
2. Neekam ( Treatment) 
3. Niraivu ( Restoration) 
1. Kappu (Prevention) 
The preventive azhal keel vayu is,  
1. Control the body weight by diet & exercise. 
2. Modify the nature of work which gives stress to a particular joint. 
3. Avoid excess intake of sour, astringent and bitter tasted food. 
  In azhal keel vayu the deranged vatham and other toxic products of digestion 
and metabolism is brought to its normal state by purgation )uqOvsel<* 
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MODERN ASPECT 
KNEE JOINT 
Structure 
  The knee is a modified hinge joint, a type of synovial joint, which is 
composed of three junctional compartments: 
 The patellofemoral articulation, consisting of the patella, or “kneecap” and the 
patellar groove on the front of the femur through which it slides and the medial and 
lateral tibiofemoral articulations linking the femur, or thigh bone, with the tibia, the 
main bone of the lower leg.  The joint is bathed in synovial fluid which is contained 
inside the synovial numbrane called joint capsule.  The posterolateral corner of the 
knee is an area that has recently been the subject of renewed scrutiny and research. 
 The knee is the largest joint and one of the most important joints in the body.  
It plays essential role in movement related to carrying the body weight in horizontal 
(running and walking) and vertical (jumping)directions. 
 At birth, the kneecap is just formed from cartilage, and this will ossify 
between the ages of three and five years.  Because it is the largest sesamoid bone in 
the human body, the ossification process takes significantly longer. 
 
Articular bodies 
 The articular bodies of the femur are its lateral and medial condyles.  These 
diverge slightly distally and posteriorly with the lateral condyle being wider in front 
than at the back while the medial condyle is of more constant width.  The radius of 
the condyles curvature in the sagittal plane becomes smaller toward the back.  this 
diminishing radius produces a series of involute midpoints.  The resulting series of 
transverse axes permit the sliding and rolling motion in the flexing knee while 
ensuring the collateral ligaments are sufficiently lax to permit the rotation associated 
with the curvature of the medial condyle about a vertical axis. 
 The pair of tibial condyles are separated by the intercondyle eminence 
composed of a lateral and a medial tubercle. 
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The patella is inserted into the thin anterior wall of the joint capsule.  On its posterior 
surface  is a lateral and medial articular surface, both of which communicate with the 
patellar surface which unites the two femoral condyles on the anterior side of the 
bone’s distal end. 
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Articular capsule 
 The articular capsule has a synovial and a fibrous membrane separated by 
fatty deposits.  Anteriorly, the synovial membrane is attached on the margin of the 
cartilage both on the femur and the  tibia, but on the femur, the suprapatellar bursa or 
recess extends the joint space proximally.  The suprapatellar bursa is prevented from 
being pinched during extension by the articularis genus muscle.  Behind, the synovial 
membrane is attach to the margins of the two femural condyles which produces tow 
extensions similar to the anterior recess.  Between these two extensions, the synovial 
membrane passes in front of the two cruciate ligaments at the center of the joint, thus 
forming a pocket direct inward. 
 
Ligaments 
 The knee joint is supported by following ligaments. 
1. Fibrous capsule 
2. Ligamentum patellae 
3. Tibial collateral or medial ligament 
4. Fibular collateral or lateral ligament 
5. Oblique popliteal ligament 
6. Arucuate popliteal ligament 
7. Anterior cruciate ligament 
8. Posterior cruciate ligament 
9. Medial meniscus 
10. Lateral meniscus 
11. Transverse ligament 
 
1. Fibrous (Articular) capsule 
 The fibrous capsule is very thin and is deficient anteriorly, where it is replaced 
by the quadriceps femoris, the patella and ligametum patellae. 
 
Femoral attachment 
 It is attached about half to 1cm beyong the articular margins.  The attachment 
has three pscial features. 
a. Anteriorly, it is deficient 
b. Posteriorly, it is attached to the inter condylar line and 
c. Laterlly, it encloses the origin of the popliteus 
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Tibial attachment 
  It is attached about ½ to 1 cm beyond the articular margins.  the attachement 
has three special features. 
a. Anteriorly, it descends along the margins of the condyles to the tibial 
tuberosity, where it is   deficient. 
b. Posteriorly, it is attached to the intercondylar ridge which limits the 
attachement of the posterior cruciate ligament and 
c. Posterior laterally, there is a gap behind the lateral condyle for passage of the 
tendom of the popliteus. 
Home terms applied to parts of the capsule are as follows 
Coronary ligament 
  The fibrous capsule is attached to the periphery of the menisci.  The part of 
the capsule  between the menisci and the tibia is sometimes called the coronary 
ligament. 
 
Short lateral ligament 
  This is a cord like thickening of the capsule deep to the fibular collateral 
ligament.  It extends from the lateral epicondyle of the femur, where it blends with 
the tendon of the popliteus, to the medial border of the apex of the fibula. 
  The capsular ligament is weak, It is stregthened anteriorly by the medial and 
lateral patellar retinaculo, which are extensions from the vastus medialis and lateralis, 
laterally by the iliotibial tract, medially by expansions from the tendons of the 
sartorius and semimembranosus and posteriorly by the oblique popliteal ligament. 
 
2. Ligamentum patellar 
  This is the central portion of the common tendon of insertion of the 
quadriceps femoris, the remaining portions of the tendon from the medial and lateral 
patellar retinaculo.  The ligamentum patellar is about 7.5cm long and 2.5cm broad.  It 
is attached above to the margins and rough posterior surface of the apex of the patella 
and below to the smooth, upper part of the tibial tuberosity.  The superficial fibres 
pass in front of the patella.  The ligamentum patellae is related to the superficial and 
deep infrapatellar bcusae and the infrapatellar pad of fat. 
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3. Tibial collateral or medial ligament 
  This is a long band of great strength superiorly, it is attached to the medial 
epicondyle of the femur just below the adductor tubercle.  Inferiorly, it divides into 
anterior and posterior parts. 
  The anterior or superificial part is about 10cm long and 1.25cm broad, and is 
separated from the capsule by one or two bursae.  It is attached below to the medial 
border and posterior part of the medial surface of the shaft of the tibia.  It covers the 
inferior medial genicular vessels and nerve, and the anterior part of the tendon of the 
semimembranosus and is crossed below by the tendons of the sartorius, gracilis and 
the semitendinosus. The posterior (deep) part of the ligament is short and blends with 
the capsule and with the medial meniscus.  It is attached to the medial condyle of the 
tibia above the groove for the semimembranosus. 
 
4. Fibular collateral or lateral ligament 
  This ligament is strong and cord-like.  It is about 5cm long.  Superiorly, it is 
attached to the lateral epicondyle of the femur just above the popliteal groove.  
Inferiorly it is embraced by the tendon of the biceps fencoris, and is attached to the 
head of the fibular in front of its apex.  It is separated from the lateral meniscus by the 
tendon of the popliteus and by the capsule, the inferior lateral genicular vessels and 
nerve separate it from the capsule 
 
5. Oblique popliteal ligament 
  This is an expansion from the tendon of the semimembranosus.  It runs 
upwards and laterally, blends with the posterior surface of the capsule and is attached 
to the intercondylar line and lateral condyle of the femur.  It is closely related to the 
popliteal artery and is pieced by the middle genicular vessels and nerve and the 
terminal aprt of the posterior division of the obturator nerve. 
 
6.  Arcuate popliteal ligament 
  This is a posterior expansion from the short lateral ligament.  It extends 
backwards from the head of the fibula, arches over the tendon of the popliteus, and is 
attached to the posterior border of the intercondylar area of the tibia. 
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7. Anterior cruciate ligament  and 
8. Posterior cruciate ligament 
  These are very thick and strong fibrous bands, which act as direct bands of 
union between tibia and femur to maintain anteroposterior stability of knee joint.  
They are named according to the attachment on tibia. 
  Anterior cruciate ligament begins from anterior part of intercondylar area of 
tibia, runs upwards, backwards and laterally and is attached to the posterior part of 
medial surface of lateral condyle of femur.  It is taut during extension of knee. 
Posterior cruciate ligament begins from the posterior part of intercondylar area of 
tibia, runs upwards, forwards and medially and is attached to the anterior part of the 
lateral surface of medial condyle of femur.  It is taut during flexion of the knee. 
 
9. Medial and 10. Lateral menisci or semilunar cartilages 
  The menisci are two fibrocartilaginous discs.  They are shaped like crescents.  
They deeper the articular surfaces of the condyles of the tibia, and partially divide the 
joint cavity into upper and lower compartments.  Flexion and extension of the knee 
take place in the upper compartment, whereas rotation takes place, in the lower 
compartment. 
 
Each meniscus has the following 
1. Two ends: Both of which are attached to the tibia. 
2. Two borders: The outer border is thick, convex and fixed to the fibrous 
capsule, while the ‘inner’ border is thin, concave and free. 
3. Two surfaces: The upper surface is concave for articulation with the femur.  
The lower surface is flat and rests on the peripheral 2/3 rd of the tibial 
condyle.  Theperipheral thick part is vascular.  The inner part is avascular and 
is nourished by synovial fluid. 
  The medial meniscus is nearly semicircular, being wider behind than in front. 
The posterior fibres of the anterior end are continuous with the transverse ligament.  
Its peripheral margin is adherent to the deep part of the tibial collateral ligament.  The 
lateral meniscus is nearly circular.  The posterior end of the meniscus is attached to 
the femur through two meniscofemoral  ligament.  The tendon of the popliteus and 
the capsule separate this meniscus from the fibular collateral ligament.  The more 
medial part of the tendon of the popliteus is attached to the lateral meniscus.  The 
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mobility of the posterior end of this meniscus is controlled by the popliteus and by the 
two meniscofemoral ligaments. 
 
Functions of menisci 
1. They help in making the articular surfaces more congruent.  Because of their 
flexibility they can adapt their contour to the varying curvature of the different 
part of the femoral condyles, as the latter glide over the tibia. 
2. The menisci serve as shock absorbers. 
3. They help in lubricating the joint cavity 
4. Because of their nerve supply, they also have a sensory function.  They give 
rise to proprioceptive impulses. 
11. Transverse ligament 
  It connects the anterior ends of the medial and lateral menisci Bursae around 
the knee As many as 13 bursae have been described around the knee-four anterior, 
four lateral and  five medial. 
These bursae are as follows: 
 
Anterior 
1. Subcutaneous prepatellar bursa 
2. Subcutaneous infrapatellar bursa 
3. Deep infrapatellar bursa 
4. Suprapatellar bursa 
Lateral 
1. A bursa deep to the lateral head of the gastrocnemius. 
2. A bursa between the fibular collateral ligament and the biceps femoris. 
3. A bursa between the fibular collateral ligament and the tendon of the 
popliteus. 
4. A bursa between the tendon of the popliteus and the lateral condyle of the 
tibia. 
Medial 
1. A bursa deep to the medial head of the gastrocnemius. 
2. The anserine  bursa is a complicated bursa which separates the tendons of the 
sartorius, the gracilis and the semitendinosus from one another, from the tibia 
and from the tibial collateral ligaments. 
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3. A bursa deep to the tibial collateral ligament. 
4. A bursa deep to the semimembranosus. 
5. Occasionally a bursa is present between the tendons of the semimembranosus 
and the semitendinosus. 
 
Blood supply 
 The femoral artery and the popliteal artery help form the arterial network or 
plexus, surrounding the knee joint.  There are six main branches. 
 Two  superior genicular arteries 
 Two inferior genicular arteries 
 The decending genicular artery 
 The recurrent branch of anterior tibial artery. 
 
Nerve supply 
1. Femoral nerve, through its branches to the vasti, especially the vastus 
medialis. 
2. Sciatica nerve through the genicular branches of the tibial and common 
peroneal nerves. 
3. Obturator nerve, through its posterior division. 
 
Movements of the knee joint 
 Active movements at the knee are flexion, extension, medial rotation and 
lateral rotation. 
Flexion and extension are the chief movements, these take place in the upper 
compartment of the joint, above the menisci.  They differ from the ordinary hinge 
movements in two ways.   
1. The transverse axis around which these two movements take place is not 
fixed.  During extension, the axis moves forwards and upwards, and in the 
reverse direction during flexion. 
2. These movements are invariably accompanied by rotations or conjunct 
rotation.  Medial rotation of the femur occurs during the last 30 degrees if 
extension and lateral rotation of the femur occurs during the initial stages of 
flexion.  When the foot is off the ground, the tibia rotates instead of the femur, 
in the opposite direction. 
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  Rotatory movements at the knee are of a small range.  Rotations take place 
around a vertical axis, and are permitted in the lower compartment of the joint, below 
the menisci.  Rotatory movements may be combined with flexion and extension or 
conjunct rotations or may occur independently in a partially flexed knee, or adjunct 
rotations.  The conjunct rotations are of value in locking and unlocking of the knee. 
 
Osteoarthritis 
 Osteoarthritis is the most common form of arthritis.  It is strongly associated 
with ageing and is a major cause of pain and disability in older people. 
 It is defined as a degenerative, non-inflammatory joint disease characterised 
by destruction of articular cartilage and formation of new bone at the joint surfaces 
and margins. 
 Kellgren (1961) preferred the title ‘osteoarthrosis’ since there is no evidence 
of synovial thickening or inflammatory infiltration in the uncomplicated condition.  
He emphasized that there is a different expression of this disease by the male and the 
female, and this may result from inherited metabolic abnormalities as well as dietary 
and other environmental factors. 
 kellgren described a familial form of osteoarthritis, affecting multiple joints in 
association with Heberden’s nodes, and called it ‘primary generalized osteoarthritis’.  
Primary osteoarthrosis occurs in joints without any previous pathology or any 
predisposing cause. 
 
Aetiological factors in osteoarthritis 
Age 
 This is probably the most consistently associated factor with generalized and 
nodular specific osteoarthritis.  The peak incidence of osteoarthritis is 45 years in the 
interphalangeal joints and first carpometacarpal and that occurs later in the knee and 
latest in the hip. 
 The cervical spine is probably the most commonly affected area in the over 75 
age group with the lumbar spine next. 
Gender 
 The crude prevalence of osteoarthritis is the same in both sexes, but in females 
more joints are affected.  Five or more joint groups were affected in 9% of males and 
12% of females. 
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 At ages above 45 years osteoarthritis appears slightly more frequently in men 
and involves one or more joints.  At ages greater than 55 years osteoarthritis is more 
frequent in women and involves multiple joints. It has been shown that osteoarthritis 
in postmenopausal women was associated with higher body weight, higher 
subcutaneous fat and strong muscles linked to hormonal deficincies. 
Socioeconomic groups 
 In moles in the monarticular form associated with trauma there is a gradient 
between social class and osteoarthritis. 
Occupation 
 Occupations with physical activity involve repetitive use of particular joints 
over long periods of time.  Sports ethusiasts and professional atheletes may be 
conditioned so that their muscles protect their joints, but the manual labourer, factor 
worker or docker may continue to use the joints even after muscular exhaustion. 
Obesity 
 Obesity has been associated with increased bone mass.  The major cause of 
osteoarthritis is the failure of subchondral bone to deform with an impact load, 
leading to increased cartilage damage.  if this is true then disorders where bone is 
stiffer than normal would be associated with higher prevalence of osteoarthritis and 
patients with osteoarthritis would have a higher bone masses than normal. 
Metabolic factors 
  There has been some evidence for a link between diabetes and osteoarthritis, 
possibly through elevated growth hormone levels that alter cartilage metabolism and 
increase bone density.  Hyperuricaemia has been found more frequently in people 
with generalized osteoarthritis. 
Mechanical factors 
  It has been considered that mechanical stress such as single impact stress, 
gross anatomical damage, subtle mechanical derangement (eg. longstanding internal 
derangement of the knee), joint hypermobility and repeated impacts, has been 
associated with osteoarthritis but other factors are also operating.  Indeed direct 
articular cartilage damage is not sole source of change. 
 
 
 
 
48 
 
Developmental factors 
 A substantial proportion of osteoarthritis of the hip may be accounted for by 
developmental diseases of the hip.  The three major developmental abnormalities are 
1. Congenital dislocation of the hip 
2. Perthe’s disease 
3. Slipped femoral epiphysis. 
 
Genetic influence 
 In certain subsets of osteoarthritis there is a hereditary factor present.  This is 
particularly the case with heberden’s nodes which are twice as frequent in first-degree 
relatives to females with the nodes.  A familial trait has also been noted in generalized 
osteoarthritis associated with Heberden’s nodes. 
 
Pathology 
 The primary lesion consists of degeneration of the hyaline cartilage.  As a 
result the cartilage is easily and rapidly ended until ultimately the bone matrix is 
exposed.  The erosion of the cartilage is not uniform, so relatively at first areas of 
bone are exposed in a patchy fashion and there are intervening islands of relatively 
normal cartilage.  The perichondrium and the cartilage round the periphery of the 
joint are stimulated into activity, and as a result, the non-articular areas of the bones 
are elevated above the remainder of the surface, and project cirucumferentially to 
give the appearance known as ‘lipping.  In addition, irregular outgrowths appear in 
this area, at first cartilaginous but eventually becoming ossified to form osteophytes. 
 There is a synovitis with fibrosis involving the capsule and subsynovial 
connective tissues.  There is also a reaction to the presence of cartilage debris shed 
from the joint surface and absorbed between the surface layers of the synovial 
membrane. 
 Harrison (1953) showed that in osteoarthritis there is proliferation of blood 
vessels and probably an increase in blood supply to the subchondral bone with 
thinning of cartilage over the pressure areas, but proliferation of cartilage where there 
is no pressure.  This degenrates and is invaded by larger blood vessels and finally 
replaced by bone.  Venous engorgement with increased pressure in segments of 
osteoarthritic femoral heads has been reported. 
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 Johnson (1959) described that in the formation of subchondral cysts in 
osteoarthritis there is initially an oedema in the subchondral marrow, which is 
followed by the formation of a mucinous fatty marrow and dilatation of surrounding 
sinusoids.  There is a mucoid secretion within the centre of this area and the 
expansion of the cyst cavities by osteoclastic resorption of bony trabecule.  
Surrounding there is some osteoblastic response and a sclerotic wall is formed.  Other 
theories are that these cyst arise from herniation of synovial fluid through cracks 
within the denuded subchordrial bone plate. 
 Johnson believed that the osteophytic lipping may be due to outward cartilage 
growth followed by ossification and local periosteal new bone formation, particularly 
around the capsular attachments. 
 The synovial membrane and capsule are involved in the lateral stage, and are 
the site of inflammation and adhesions.  The synovial tags or polypi are insinuated 
into the joint, and when very exuberant the process is refeued to as ‘lipoma 
arborescens’.  Ocassionally, cartilage formation occurs in these tags and they are then 
liable to the broken off into the joint, when they form loose bodies.  The exposed 
bone ends of the articular surface are subjected to considerable friction, in 
consequence the bone trabaeculae in the immediate neighbourhood fracture and repair 
and the marrow spaces are obliterated.  The change involves only a thin layer abutting 
on the joint, and when the surface of this layer gradually becomes more and more 
smooth and polished as a result of the continual rubbing, the process is known as as 
ehurnation. 
 An osteoarthritic joint rarely, if ever, becomes completely ankylosed, in 
contrast to the rheumatoid in which ankylosis is frequent. 
 
Clinical features 
 The main symptom is pain, causing loss of ability and often stiffness.  “Pain” 
is generally described as a sharp ache or a burning sensation in the association 
muscles and tendons and is typically made worse by prolonged activity and relieved 
by rest.   
  Stiffness is most common in the morning, and typically lasts less that thirty 
minutes after beginning daily activities, but may return after periods of inactivity.  
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Osteoarthritis can cause a crackling noise called “crepitus” when the affected joint is 
moved or touched and people may experience muscle spasms and contractions in the 
tendons.  Ocasionally, the joints may also be filled with fluid. 
 Osteoarthritis commonly affects the hands, feet, spine and the large weight 
bearing joints such as the hips and knees.  As osteoarthritis progresses, movement 
patterns (such as gait) are typically affected.  Osteoarthritis is most common cause of 
a joint effusion of the knee.  
  In smaller joints, such as the fingers, hard bony enlargements, called 
Heberden’s nodes on the distal interphalangeal joints and/or Bouchard’s nodes on the 
proximal interphalangeal joints, may form, and though they are not necessarily 
painful, they do limit the movement of the fingers significantly. 
 
OSTEOARTHIRIS OF KNEE: 
     In osteoarthiristis of the knee major problems are pain , stiffness , Instabilty , 
Deformity and Functional inadequacy 
1. Pain :- Pain is assessed for its character degree, posture and duration pain in 
OA usually noticed when the degenerated it is exposed to compressive forces , 
hyper vascularisation of the neighboring bone.  
2. Tenderness and effusion :- The site and degree recorded 
3. Range of Movements:- passive ROM inclueding the end – feel is recorded . 
4. Deformity :- It is nature and extent are assed at HIP ,Knee , Ankle & foot 
during total weight        bearing. 
5. Stability :- The it is Assessed in supine & with weight bearing affected knee 
alone.Strengh, endurance  & Hamstrings , Glutei should be recorded.  
Differential diagnosis 
 A number of conditions may mimic OA some are. 
I. Rheumatoid arthritis 
 It is an autoimmune disease.  Pain, stiffness and swelling in miner and major 
may herald the onset of rheumatoid disease Morning stiffness more than 1 hour x-
rays show an erosive arthritis with minimal or no osteophytes. 
II. Psoriatic arthritis 
 It is a long term inflammatory arthritis that occurs in people affected by the 
autoimmune disease.  Swelling of entire fingers and toes with a sausage like 
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appearance.  small depressions in the nail(pitting), thickening of the nails and 
detachment of the nail from the nailbed.  It is a seronegative arthritis. 
III. Bursitis 
 It is the inflammation of one or more bursae of synovial fluid in the body.  It 
commonly affects superficial bursae.  Joint , warmth, erythema and stiffness around 
the inflamed bursae. 
Examination of knee 
The examination includes 
 Position 
 Inspection 
 Palpation 
 Motion 
  The latter three steps are often remembered with saying look, feel, move. 
Position 
 Position for most of the exam the patient should be supine and the bed or 
examination table should be flat.  The patient’s hands should remain at his or her 
sides with the head resting on a pillow.  The knees and hips should be in the 
anatomical position. 
Inspection 
 Inspection done while the patient is standing 
 The knee should be examined for  
Baker’s cyst 
 Genu recurvatum 
 Valgus deformity (Konck-kneed) 
 Varus deformity (bow legged) 
 Gaid 
Inspection done while supine 
 The knee should be examined for 
 Scars 
 Lesions 
 Signs of trauma/Previous surgery 
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Masses 
Bursae: Housemaid’s (prepatellar bursitis) 
  Clergyman’s (Infrapatellar bursitis) 
 Bony: Exostosis 
 Tumor of Femur (Tibia 
 Swelling – Effusion 
 Redness 
 Muscle bulk and symmetry (in particular atrophy of the vastus medialis) 
 Displacement of the patella (knee cap) 
Palpation 
 An inflamed knee exhibits 
 Tumor (Swelling) 
 Rubor (redness) 
 Calor (Heat) 
 Dolor (Pain) 
  Swelling and redness should be evident by inspection. 
Temperature change 
 Using the back of the hand one should feel the temperature of the knee below 
the patella, over the patella and above the patella.  Normally, the patella is cool 
relative to above and below the knee.  A complete exam involves comparing the 
knees to one another 
Joint line tenderness 
  This is done by flexing the knee and palpating the joint line with the thumb. 
 Effusion 
 patellofemoral crepitus 
 Thickened synovial membrane – Spongy/boggy feel, edge can be rolled. 
 Effusion:  Fullness of para patellar tendon fossae in flexion. 
Bulge sign: 
 Useful for small effusions 
Patellar tap: 
 Useful for large effusions slide your hand down the patients thigh, pushing 
down over the suprapatellar pouch, on reaching the upper pole of patella, keep your 
hand there and maintain pressure. 
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 Using the index and middle finger of the other hand push the patella down 
gently. If it bounce then positive. 
Ballotment 
  It is defined as a palpatory technique for detecting or examining a floating 
object in the body. 
Patellar Instability 
 Measure Q angle, angle betwen a line from ASIS to center of patella and 
center of patella to tibial tuberosity. 
 Dynamic patellar tracking in sitting- (Positive J sign-lateral subluxation of 
patella in full extension). 
 Active patellar tracking with knee extended – normal patella moves more 
superiorly than laterally.  
If more lateral movements- abnormal. 
 Apprehension test, knee in 20°-30° flexion.  
 Manually subluxate patella laterally 
 Pain and resistance for lateral motion positive test. 
Motion 
 The patient should be asked to move their knee.  Fully range of motion is 0-
135°.  If the patient has full range of motion and can move the knee passively. 
Examination of crepitus - Clicking of the joint with motion. 
Tests for meniscal injury 
Joint line tenderness 
 Medial joint line tenderness medial meniscus tear, lateral joint line tenderness 
lateral meniscus tear. 
McMurray test 
 Knee acutely flexed foxibly, palpable posteromedial margin of joint + knee 
external rotation.  knee extension + click S/o medial meniscus tear.   
Palpable posterolateral margin + internal rotation + knee extension – click s/o lateral 
meniscus tear.  
 Negative mcmurry’s test doesn’t rule out tear. 
  
55 
 
Apley grinding test 
 Prone, knee 90°, anterior thigh flexed against table foot and leg pulled 
upwards/downwards and rotated + joint slowly flexed and extended pain/popping – 
tear. 
LIGAMENT TESTS 
1. Anterior drawer test 
  Tests for anterior cruciate ligament (ACL) 
 Supine position 
 Hip 45°, knee 90° flexed 
 Stabililze the foot 
 Ensure tibia is not sagging behind otherwise false positive result. 
 Not possible in acute painful knee. 
Lachman test 
 Test for anterior cruciate ligament rupture 
 Supine position 
 Knee 45° flexion 
 Slight external rotation 
 Useful in painful knee/door step effect of menisci. 
Pivot shift test 
 Test for anterior cruciate ligament tear 
 Patient in supine position, relaxed. 
 Hip at 30° abduction knee in IR and valgus strain (Subluxates the knee), 
do gradual flexion from extension. 
 See for the reduction of the lateral femoral condyle. 
Sag sign 
Test for posterior cruciate ligament 
 Knee at 90° 
 Support the heel 
 Tibia sags visible posteriorly from effect of gravity 
 Compare silhouette both side. 
Godfrey test 
 Say sign at 90° flexion at hip and knee. 
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Posterior drawer test 
  Test for posterior cruciate ligament 
 At supine position 
 Knee at 90° 
 Excessive posterior laxity/no hard end point felt s/o posterior cruciate 
ligament tear. 
Quadriceps active test 
 Test for posterior cruciate ligament 
 Patient in supine position 
 Knee at 90° 
 Active gentle quadriceps contraction to shift tibia without extending knee. 
 Anterior shift of tibia – posterior cruciate ligament tear. 
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Valgus stress test 
Test for medial collateral ligament 
 At supine position 
 Side of table 
 Abducted of the side of table 
 Knee flexion at 30° 
 Valgus strain 
 External rotation 
 Observe stability 
 
Varus stress test 
Test for lateral collateral ligament 
 Varus strain given similarly at 30° flexion 
 Observe instability 
 Palpate lateral collateral ligament 
 If LCL turn not palpable 
 
Posterolateral corner Injury (PLC) 
 External rotation recurvatum test 
 Dial test : External rotation of tibia is compared at 30° to 90° 
flexion 
 More than 10° increased – Positive  
 Reverse pivot shift test. 
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Citeria and classification of OA Knee 
(American college of Rheumatology – ACR) 
Clinical 
 Knee pain for most days of prior month 
 Crepitus on active joint motion. 
 Morning stiffness equal and more than 30mins in duaration 
 Age equal to more than 38 years. 
 Bony enlargement of the knee on examination. 
 
Clinical and radiological 
 Knee pain for most days of the prior month. 
 Osteophytes at joint margins. 
 Synovial fluid typical of OA knee. 
 Age - 40years 
 Morning stiffness equal and not more than 30 mins. 
 Crepitus on active joint motion. 
 
Investigations 
 Laboratory investigations are usually within normal limits. 
Radiological examination of the knee joint is the most important diagnostic tool. 
 The following are the radiological features seen in osteoarthritis of the knee. 
 Loss of joint space (due to destruction of articular cartilage). 
 Sclerosis (due to increase cellularity and bone deposition) 
 Subchondral cysts (due to synovial) fluid intrusion into the bone). 
 Osteophytes (due to revascularization of remaining cartilage and capsular 
traction). 
 Bony collapse (due to compression of weakened bone) 
 Loose bodies (due to fragmentation of osteochondral surface) 
 Deformity and lalalignment (due to destruction of capsules and ligaments). 
Kellegren and lawrence 
Radiological grading 
Grade I : Doubtful narrowing of joint space and possible  
osteophyte lipping. 
Grade II : Definite osteophytes and possible narrowing of the joint space. 
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Grade III : Moderate multiple osteophytes, definite narrowing  
of joint space and some  sclerosis and possible deformity  
of the bone ends. 
Grade IV : Large osteophytes, marked narrowing of joint space, severe  
sclerosis and definite deformity of the bone ends. 
 
Pitfalls of X-rays in OA knee 
 Not reliable in about 15% of the cases 
 Weight bearing AP and lateral views are desired  
 Only 40% of the people with severe X-ray changes experience pain. 
 
Radiological classification of OA knee (Ahibach)  
AP weight bearing and lateral views 
Type I  : Joint space narrowing 
Type II : Total loss of joint space 
Type III : <5mm tibial erosion but posterior part of the plateau intact. 
Type IV :  >5mm tibial erosion and erosion of posterior plateau 
Type V : Subluxation 
Other investigations 
Arthroscopic examination 
 This allows direct inspection and visualization of the damaged joint surfaces/ 
 Synovial fluid analysis shows non-inflammatory picture. 
 Bone scan shows increased uptake of technetium – 99m 
 MRI, CT scan also helps to diagnose, subchondral cysts, osteophytes etc. 
 
Treatment 
 Before beginning the treatment, the diagnosis of OA is a must. 
 ACR diagnostic criteria for OA knee to be followed. 
Aims of treatment of OA Knee 
  It can be best illustrated by 4R’s 
 Relieve pain 
 Restore function 
 Reduce disability if any 
 Rehabilitation. 
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Methods of treatment 
 The following therapeutic measures are 
1. Drugs 
Analgesics and anti infalmmatory drugs 
 If symptoms do not respond to non-pharmacological measuers, paracetamol 
should be given. 
 Addition of a topical NSAID, and then capsaicin. 
 Opiates may occasionally be required. 
 For temporary benefit of moderate to severe pain, intra-articular injects of 
cortico steroids. 
2. Local physical therapies 
 Heat or cold can sometimes give temporary relilef. 
 Acupuncture and transurtaneous electrical nerve stimulation (TENS) have also 
been effective in knee OA. 
 Antineuropathic drugs such as amitriptyline, gabapentin and pregabolin. 
3. Corticosteroid injections 
 Intra-articular corticosteroid injections are effective in the treatment of knee 
OA and are also used from symptomatic relief in the treatment of OA at the first 
CMC joint. 
 Trial of serial corticosteroid injections every 3 months in knee OA have 
shown efficacy for up to 1 year. 
4. Chondroitin and glucosamine 
 Chondroitin sulphate and glucosamine sulphate have been used alone in 
combination for the treatment of knee OA. 
5. Hyaluronan injections 
 In knee OA, intra-articular injection of one of several forms of hyaluronan 
usually given as a course of weekly injections for 3-5 weeks, may give modest pain 
relief for several months. 
6. Surgical treatment 
 In selected cases, surgery can provide significant relief following are some of 
the surgical procedures. 
Osteotomy 
 Osteotumy near a joint has been known to bring about relief in symptoms, 
especially in arthritic joints with deformities. 
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 A high tibial osteotomy of OA of the knee with genu varum and inter-
trochanteric osteotomy for OA. 
Joint replacement 
 For cases crippled with advanced damage to the joint, total joint replacement 
operation has provided remarkable rehabilitation. 
Joint debridement 
 In this, the affected joint is opened, degenerated cartilage smoothened and 
osteophytes and the hypertrophied synovium excised. 
Arthroscopic procedure 
 Arthroscopic removal of loose bodies, degenerated meniscal tears and other 
such procedures have become popular because of their less invasive in nature. 
COMPLICATION: 
  Possible complications of osteoarthritis include: Rapid, complete breakdown 
of cartilage resulting in loose tissue material in the joint (chondrolysis).Bone death 
(osteonecrosis).Stress fractures (hairline crack in the bone that develops gradually in 
response to repeated injury or stress).Bleeding inside the joint.Infection in the 
joint.Deterioration or rupture of the tendons and ligaments around the joint, leading to 
loss of stability.Pinched nerve (in osteoarthritis of the spine). 
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4. MATERIALS AND METHODS 
 
  Phase  II  clinical observation criteria based study to evaluate the clinical 
efficacy of siddha diherbal formulation of ERANDAMOOLA CHOORANAM 
(Internal) KUNGILIA THYLAM(EXTERNAL)  PATTRU[external therapy]for the 
treatment of AZHAL KEEL VAYU (OSTEO ARTHERITIS). was carried out at post 
graduate department of Sirappu maruthuvam, GOVT. Siddha medical college  
hospital palayamkottai under the observation and guidance of the head of the 
department. In this study 20 cases were admitted in IN patient ward and other 20 
cases were seen in OUT patient ward . 
 
Selection of the patients  
Age : 30 – 60 yrs 
Sex : Both Male and Female 
Clinical findings 
Inclusion criteria 
The patients were selected on the basis of the following clinical findings.   
 Patients having symptoms of joint pain in one or both knee joints, swelling, 
tenderness, stiffness, crepitation, restricted movements of joints. 
 Patients who are willing to give blood samples for laboratory investigation. 
 Patients who are willing to take radiological imaging before and after 
treatment. 
 Patients who are willing to participate in this study with the knowledge of 
potential risks. 
 
EXCLUSION CRITERIA: 
 Cardiac disease 
 Rheumatoid arthritis 
 Use of narcotic drugs 
 Pregnancy and lactation 
 History of trauma 
 Patient with any other serious illness. 
 Benign and malignant neoplasm 
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 Immuno compromised Patients 
 Children, elderly  
 Clinically significant abnormal laboratory values. 
 
WITHDRAWAL CRITERIA: 
 Intolerance to the drug and development of adverse reactions during drug trial. 
 Poor patient compliance & defaulters. 
 Patient turned unwilling to continue in the course of clinical trial. 
 Occurrence of any serious illness. 
 
The detailed history was taken from the patient about 
 Occupation 
 Socio economic status 
 Diet and habits 
 
TESTS AND ASSESSMENTS: 
A. Clinical assessment  
B. Routine investigations 
C. Radiological investigations 
 
A. CLINICAL ASSESSMENT: 
 Pain and swelling in both knee joints 
 Stiffness in both knee joints 
 Crepitus 
 Tenderness 
 Warmth 
 Restricted movements of both the knee joints 
 
IMPROVEMENT ASSESSED BY FOLLOWING ASSESSMENTS 
1. Pain assessment scale 
2. Restricted movement assessment scale 
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UNIVERSAL PAIN ASSESSMENT SCALE 
 
A.   0      :  No Pain 
B.  1 -3   :   Mild pain 
C.  4-6    :   Moderate pain 
D. 7-10   :   Severe pain 
 
 - Reference: Clinical Manual for Nursing Practice. 
(National Institute of Health Warren Grant Magnuson 
Clinical Center ) 
 
RESTRICTED MOVEMENT ASSESSMENT SCALE: 
GRADATION OF MOVEMENTS: 
 G 1 – Fit for all activities, do their work without support. 
 G II – Mild pain present in knee joint, mild restricted movements. 
 G III –Moderate Pain present in knee joint, moderate restricted movements, 
need some assistance to perform. 
 G IV – Severe pain, bed ridden. 
Diagnosis 
 The diagnosis was made by following siddha diagnostic methods kaalam, 
poriaridhal, pulanaridhal, udalthathukkal, Naadi and Envagai Thervugal and the 
diagnosis of Azhal Keel vayu obtained which correlated with modern diagnosis of 
osteoarthritis of knee joints by the x-ray findings. 
 
B.ROUTINE INVESTIGATION: 
BLOOD: 
 Hb 
 Total WBC Count 
 Differential WBC Count 
 Neutrophils 
 Lymphocytes  
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 Eosinophils 
 Monocytes  
 Basophils  
 Total RBC count 
 ESR 
• ½ Hr: 
• 1 Hr 
 
 Blood sugar 
1. Randum:     
2. Fasting:    
3. Postprandial: 
 URINE: 
 Albumin 
 Sugar 
 Deposits 
 C.RADIOLOGICAL INVESTIGATIONS: 
  X -Ray of the knee joints (AP and Lat view) 
INVESTIGATIONS BASED ON SIDDHA SYSTEM 
1. Naa 
2. Niram 
3. Mozhi 
4. Vizhi 
5. Malam 
6. Moothiram 
7. Sparisam 
8. Naadi 
 Neikuri 
 Neerkuri  
LINE OF TREATMENT: 
  They day before the internal medicine started, vellai ennai-15ml was given at 
early morning for purgation to correct the deranged vatham to all the patients.from 
the second day onwards the trail drugs were  administrated. 
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TREATMENT: 
INTERNAL MEDICINE:  
“ERANDA MOOLA CHOORANAM” 
(Ref:ANUBOGA VAITHYA THEVA RAGASIYAM Page No.425)                        
Dosage     :   ¼  to ½ Thola (3 to 6 Gram)(Twice daily) 
Adjuvant  :   water  
Duration : 40days 
 
ETERNAL MEDICINE   
“KUNGILIA THYLUM” 
(Ref:MARUNTHU SEI EYALUM KALAI Page No.160)                        
Dosage:30ml (for external application) 
 
  Standard Operating Procedure for the preparation of ERANDA MOOLA 
CHOORANAM.(Internal.) AND KUNGILIA THYLAM(External.)  
 
  EXTERNALTHERAPY PATTRU  as a complementary therapy for 
OPD& IPD Patient 
 
  All patients were advised to follow the dietary regimens (or) pathiyam. 
 The Bio-Chemical analysis was done in the Biochemistry Department and 
Pharmacological analysis was done in the Pharmacological laboratory of AKL 
college of Pharmacy. 
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5. RESULTS AND OBSERVATION 
1. Gender Distribution 
2. Age Distribution 
3. Kaalam  Distribution 
4. Occupational Status 
5. Seasonal Variations 
6. Thinai 
7. Socio-economic Status 
8. Dietary habits 
9. Precipitating factors 
10. Mode of onset 
11. Duration of conditions 
12. Clinical features 
13. Conflict in Kanmethiriam 
14. Disturbance in Vatham 
15. Disturbance in Pitham 
16. Disturbance in Kabam 
17. Disturbance in Udal kattugal 
18. Envagai Thervugal 
19. Naadi 
20. Neikuri 
21. Selection of patients 
22. Assessment of results 
 
 
 
  
 1. GENDER DISTRIBUTION
S.No 
1 
2. 
 
 
Inference 
 Among the 40 patients selected for this study 47.5% are male and 52.5% are 
female. 
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Table : 1 
 
Gender No of Cases Percentage (%)
Male 19 
Female 21 
Total 40 
 
Female
52.5
Gender distribution
 
47.5 
52.5 
100 
 
Male
Female
  
2. AGE DISTRIBUTION
S.No Age (years)
1 
2. 
3. 
 
 
Inference 
  The prevalence of the diseases is found to be higher in the age group of 51
years. 
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Table : 2 
 No of Cases 
30-40 4 
41-50 13 
51-60 23 
Total 40 
 
41-50 51-60
Percentage (%) 
10 
32.5 
57.5 
100 
 
-60 
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3. KAALAM 
Table : 3 
S.No Kaalam No of Cases Percentage (%) 
1 Vathakaalam (Upto 33 years) 1 2.5 
2. Pithakaalam (33 years to 66 39 97.5 
3. Kabhakaalam (Above 66 years) 0 0 
 Total 40 100 
 
 
 
Inference 
 Out of 40 cases, 97.5% of cases were found to be in pithakaalam. 
           2.5%  of cases were found to be in vadhakaalam. 
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4.OCCUPATION 
 Table : 4 
 
S.no Occupation Number of cases Percentage 
1 Agriculture labours 17 42.5 
2 House wife 13 32.5 
3 Driver 2 5 
4 Hotel worker 3 7.5 
5 Teacher 2 5 
6 Tailors 3 7.5 
 Total 40 100 
  
 
Inference 
42.5% agriculatrual labours, 32.5% Housewifes, 5%  driver, Hotel workers & Tailors 
7.5%, Teacher 5%.  
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5. SEASONAL VARIATIONS 
Table : 5 
 
S.No Seasons No of Cases Percentage (%) 
1 Kaarkaalam (Aug 16- Oct 15) 3 7.5 
2. Koothirkaalam (Oct 16- Dec 15) 4 10 
3. Mupanikaalam (Dec 16- Feb 15) 13 32.5 
4. Pinpani kaalam (Feb 16 – Apr 15) 10 25 
5. Ilavenirkaalam (Apr 16-June15) 5 12.5 
6. Muthuvenilkaalam (June 16 – 5 12.5 
 Total 40 100 
 
 
 
Inference 
 Out of 40 cases, 3 patients (7.5%) were admitted in Kaarkaalam, 4 patients 
(10%) were admitted in Koothirkaalam, 13 patients (32.5%) were admitted in  
Munpanikaalam,.10 (25%) were admitted in Pinpanikaalam, 5(12.5%) were admitted 
in Ilavenilkaalam, 5(12.5%) were admitted in Muthuvenilkaalam. 
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 6. THINAI 
S.No 
1 
2. 
3. 
4. 
5. 
 
 
Inference 
 Among 40 cases, 
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  Table : 6 
Seasons No of Cases
Kurinji (Hill area) 0 
Mullai (Forest area) 0 
Marutham (Fertile area) 35 
Neithal (Coastal area) 5 
Paalai (Desert land) 0 
Total 40 
 
majority were from marutha nilam. 
 
 Percentage 
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 7. SOCIO-ECONOMIC STATUS
S.No 
1 
2. 
3. 
 
 
 
Inference 
 Out of 40 cases 55% of the cases were from poor 
37.5% cases were from middle class families and only 7.5% from Rich background.
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Table : 7 
Class No of Cases 
Rich 3 
Middle - class 15 
Poor 22 
Total 40 
socio
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 8. DIETARY HABITS
S.No 
1 
2. 
 
 
 
Inference 
 Most of the cases have non
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Table : 8 
Dietary No of Cases 
Vegetarian 8 
Non-vegetarian 32 
Total 40 
-vegetarian diet habit. 
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9. PRECIPITATING FACTORS 
Table : 9 
 
 
                 
Inference 
 Among the 40 patients, 10 patients of them (25%) were in the post menopause 
stage, 20 of them (50%) had history of over use of the joints, 9 of them (22.5%) were 
obese, and 1 of them (2.5%) were hereditary. 
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PRICIPITATING FACTORS
Hereditary
Menopause
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Obesity
Trauma
S.No Precipitating factors No of Cases Percentage 
1 Trauma 0 0 
2. Obesity 9 22.5 
3. Occupation related overuse of the joint 20 50 
4. Menopause 10 25 
5. Hereditary 1 2.5 
 Total 40 100 
  
10. MODE OF ONSET
 
S.No 
1 
2. 
 
 
 
Inference 
 According to this study 75% of cases were reported gradual onset of disease.
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Table : 10 
Mode of onset No of Cases 
Acute 10 
Gradual 30 
Total 40 
 
acute
gradual
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 11. DURATION OF CONDITIONS
S.No Duration (Months)
1 
2. 
3. 
4. 
5. 
 
 
Inference 
 Among the 40 cases, 3 cases (17.5%) were come under 0
(25)were come under 4
7 cases (15%) were came under  13
month.   
0
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Table : 11 
 
 No of Cases 
0-3 3 
4-6 10 
7-12 10 
13-24 7 
Above 24 10 
Total 40 
 
-3 months, 10 cases 
-6 months, 10 cases (25%) were come under 7
-24 months. 10 cases (25%) were come beyond 24 
 
4-6 
month
7-12 
month
13-24 
month
Above 
24
25 25
17.5
25
Percentage (%) 
7.5 
25 
25 
17.5 
25 
100 
 
-12 months and 
Above 24
13-24 month
7-12 month
4-6 month
0-3 month
80 
 
12. CLINICAL FEATURES 
Table : 12 
S.No Clinical features No of Cases Percentage (%) 
1 Pain 40 100 
2. Swelling 28 70 
3. Tenderness 30 75 
4. Morning stiffness 8 20 
5. Crepitation 40 100 
6. Deformity 1 2.5 
7. Restricted movements 35 87.5 
8. Sleeplessness 22 55 
 
 
 Inference 
 Pain, crepitation were found in all 40 cases (100%) 
 Swelling was found in 28 cases (70%) 
 Tenderness was found in 30 cases (75%) 
 Restricted movements was found in 35 cases (87.5%) 
 Morning stiffness was found in 8 cases (20%) 
 Sleeplessness was found in 22 cases (55%).  
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13. CONFLICT IN KANMENTHIRIAM 
Table : 13 
 
S.No Kanmenthiriam No of Cases Percentage (%) 
1 Vaai 0 0 
2. Kai 0 0 
3. Kaal 40 100 
4. Eruvai 16 40 
5. Karuvaai 0 0 
 
 
 
 
Inference 
 Among all the kanmenthiriam (Kai, kaal, vai, eruvai, karuvai) kaal was affect 
in all the 40 cases (100%) and Eruvai was affected in 16 cases (40%). 
  
0 0
100
40
0
0
20
40
60
80
100
120
vaai kai kaal eruvai karuvai
p
e
rc
e
n
ta
g
e
%
Kanmenthiriam
82 
 
 
14. TABLE SHOWING THE DISTURBANCES IN VATHAM 
Table : 14 
S.No Vatham No of Cases Percentage (%) 
1 Pranan 0 0 
2. Abanan 16 40 
3. Udhanan 0 0 
4. Viyanan 40 100 
5. Samanan 40 100 
6. Nagan 0 0 
7. Koorman 0 0 
8. Kirukaran 11 27.5 
9. Devathathan 11 27.5 
10. Dhananjeyan 0 0 
 
 
Inference 
 Viyanan and Samanan were affected in all the 40 cases (100%) Abanan were 
affected in 16 cases (40%) and Kirukaran and Devathathan affected in 11cases 
(27.5%). 
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15. DISTURBANCES IN PITHAM 
 
S.No Pitham No of Cases Percentage (%) 
1 Anar pitham 14 35 
2. Ranjaga pitham 15 37.5 
3. Sathaga pitham 40 100 
4. Prasaga pitham 0 0 
5. Alosaga pitham 0 0 
 
 
 
Inference 
 Sathaga Pitham was affected in all 40 cases (100%), Ranjagapitham was 
affected in 15 cases (37.5%) Anarpitham was affected in 14 cases (35%). 
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16. TABLE SHOWING THE DISTURBANCE OF KABAM 
Table : 16 
S.No Kabam No of Cases Percentage (%) 
1 Avalambagam 40 100 
2. Kilethagam 0 0 
3. Bothagam 0 0 
4. Tharpagam 0 0 
5. Santhigam 40 100 
 
 
 
Inference 
 Among all Santhigam and avalambagam was affected in all 40 cases (100%) 
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17. DISTURBANCE IN UDAL KATTUGAL 
Table : 17 
S.No Udal kattugal No of Cases Percentage (%) 
1 Saaram 40 100 
2. Seneer 9 22.5 
3. Oon 0 0 
4. Kozhuppu 40 100 
5. Enbu 40 100 
6. Moolai 0 0 
7. Sukilam/suronidham 0 0 
 
 
 
 
Inference 
 It was diagnosed, during the study that among the seven udalkattukal saaram, 
kozhuppu, Enbu were affected in 40 cases (100%) and seneer is affected in 9 cases 
(22.5%). 
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18. ENVAGAI THERVUGAL 
Table : 18 
S.No Envagai thervugal No of Cases Percentage (%) 
1 Naa 0 0 
2. Niram 0 0 
3. Mozhi 0 0 
4. Vizhi 0 0 
5. Malam 15 40 
6. Moothiram 0 0 
7. Sparisam 0 0 
8. Naadi 40 100 
 
 
 
 
Inference 
  It was learnt during the study that Naadi was noted in all 40 cases (100%) 
Malam was affected in 15 cases (40%) 
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 19. NAADI 
S.No Parameters
1 Vatha pitham
2 Pitha vatham
3 Kaba vatham
 
 
 
Inference 
  Among the 40 cases, Vathapitham 25 cases are affected, Pitha vatham 15 
cases are affected 
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Table : 19 
 No. of patients 
 25 
 15 
 0 
 
Pitha vatham Kaba vatham
No. Of patients
Vatha pitham Pitha vatham Kaba vatham
Percentage(%) 
62.5 
37.5 
0 
 
 20. NEIKURI 
Table 20. Illustrates the neikuri analysis
 Inference 
1 Spreading like 
snake 
2 Spreading like ring
3 Stants like a pearl
4 Others 
5 Total 
 
Inference 
  Among the 40 cases 30 cases are vathaneer, 10 cases are pithaneer
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No. Of patients 
30 
 10 
 0 
0 
40 
 
 
Spreading 
like ring
Stants like 
a pearl
Others
25
0 0
Others
Stants like a pearl
Spreading like ring
Spreading like snake
Percentage(%) 
75 
25 
0 
0 
100 
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21. PROGRESSIVE CHART 
Table : 21 
  
Clinical feature 
Before treatment After treatment 
No.Of 
cases 
Percentage No.Of 
cases 
percentage 
1 Pain 40 100 35 87.5 
2 Swelling 28 70 18 45 
3 Tenderness 30 75 25 62.5 
4 Morning stiffness 8 20 5 12.5 
5 Crepitation 40 100 36 90 
6 Deformity 1 2.5 1 2.5 
7 Restricted movement 35 87.5 25 62.5 
8  Sleeplessness 22 55 18 45 
 
 
Inference 
 Among the 40 cases, 35 patiends had pain,25 patiends had tenderness, 36 
patient s had crepitation , 18 patients had swelling, 5 patients had morning stiffness, 1 
patients had deformity, 25 patients had restricted movement 18 patients had 
sleeplessness.  
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TABLE 22. ASSESSMENT OF CURATIVE EFFECTS IN PATIENTS 
TREATED ONLY WITH TRAIL DRUG 
(INTERNAL AND EXTERNAL MEDICINES ,EXTERNAL THERAPY) 
 Initial readings Final readings 
No of 
patients 
percentage No of 
patients 
Percentage 
No pain 0 0 5 12.5 
Mild 10 25 7 17.5 
Moderate 22 55 25 62.5 
severe 8 20 3 7.5 
 
 
 
 
Inference  
    From the above study, it was inferred that severe pain that was noted in 
patients before treatment had a remarkable decline after treatment similarly moderate 
and mild pain were also observed to have decreased after treatment. 
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23. EFFECT OF THERAPY 
Table 23 
S.no Effect of therapy No. Of patients Percentage(%) 
1 Marked effect 24 60 
2 Moderate effect 7 17.5 
3 Mild effect 8 20 
4 No effect 1 2.5 
 
 
 
 
Inference 
 Thus from the analysis of the data collected during the course of treatment and 
at the end of treatment it is inferred that the overall effect of the therapy (internal, 
external and complementary) had marked effect of 60%, moderate effect of 17.5% 
and mild effect of 20% ,no effect of 2.5%. 
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MEASURMENT OF KNEE JOINTS 
 
S.NO 
 
PATIENT NAME 
 
AGE/SEX 
 
OP/IP NO 
 
BEFORE TREATMENT 
 
AFTER TREATMENT 
Right (cm) Left (cm) Right(cm) Left(cm) 
1 SUNDARAM 55M 1959 35 33 31 30 
2 PECHIYAMMAL 50F 560 38 36 34 33 
3 MEENAMBAL 53F 565 39 38 33 32 
4 ULTHAL 57F 135 34 33 30 30 
5 BEEVIJAN 60F 2028 35 32 33 29 
6 GNAMMAL 60F 3088 36 35 32 31 
7 SUBBAMAL 55F 1749 33 32 29 30 
8 SOKKALINGAM 60M 3099 40 39 35 34 
9 ARUMUGAM 57M 1700 32 35 28 27 
10 GANESHAN 54M 455 31 33 26 28 
11 VELSAMY 56M 1819 41 39 38 37 
12 MARIYAMMAL 60F 90051 38 31 36 33 
13 SAROJA 42F 90210 39 37 36 33 
14 RAJATHI 50F 34431 30 37 28 35 
15 RAMALAKHSMI 49F 39860 24 28 22 26 
16 MADASAMY 37M 58601 33 30 31.5 28 
17 SANGARAMMAL 40F 56730 34 31 33 27 
18 VASANTHA 45F 41910 35 32 31 30 
19 KALYANI 47F 961 37 36 33 30 
20 THANGAM 48F 57280 40 38 38 35.5 
21 RAJKUMAR 55M 42401 38 31 33 27 
22 SAMUTHIRAM 51F 16480 33 32 27 29 
23 LINSY 36F 17411 25 23 20 18 
24 KUMAR 58M 90690 30 32 27 29 
25 MURUGAN 60M 272 29 26 24 22 
26 PANNEERSELVAM 60M 263 29 30 25 26 
INFERENCE:   Knee joint swelling is reduced approximately 2-4 cms after treatment 
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CASE PRESENTATION – SUMMARY OF OUT PATIENTS 
1.ERANDAMOOLA CHOORANAM– INTERNAL    2.KUNGILIA THYLAM– EXTERNAL 
OP CASES CLINICAL IMPROVEMENT 
S.NO IP NO NAME AGE/ SEX OCCUPATION DATE OF ADMISSION DATE OF DISCHARGE DAYS RESULTS 
1 90051 Mariyammal 60F Ryot 31-1O-2018 03-12-2018 34 DAYS MODERATE 
2 90210 Saroja 42F House Wife 01-11-2018 08-12-2018 38DAYS MILD 
3 34431 Rajathi 50F Ryot 11-04-2019 08-05-2019 25 DAYS MARKED 
4 39860 Ramalakhsmi 49F Tailor 30-04-2019 28-5-2019 29 DAYS MARKED 
5 58601 Madasamy 37M Driver 13-07-2018 18-08-2018 37 DAYS MODERATE 
6 56730 Sangarammal 40F House Wife 07-07-2018 13-08-2018 38 DAYS MARKED 
7 41910 Vasantha 45F House Wife O8-05-2019 05-06-2019 29 DAYS MILD 
8 961 Kalyani 47F House Wife 04-01-2019 12-02-2019 40 DAYS MARKED 
9 57280 Thangam 48F Tailor 09-07-2018 05-08-2018 28 DAYS MODERATE 
10 42401 Rajkumar 55M Ryot 09-05-2019 05-06-2019 28 DAYS MARKED 
11 16480 Samuthiram 51F House Wife 14-02-2019 10-03-2019 24DAYS MARKED 
12 17411 Linsy 36F House Wife 16-02-20119 13-03-2019 26 DAYS MILD 
13 90690 Kumar 58M Agricuiture 02-11-2018 02-12-2018 30 DAYS MARKED 
14 90372 Arumugam 49M Agricuiture 01-11-2018 07-12-2018 37 DAYS MARKED 
15 89395 kathiresan 45M Tailor 30-10-2018 30-11-2018 31 DAYS MODERATE 
16 89063 Ganesh 36M Teacher 29-10-2018 01-12-2018 34 DAYS MARKED 
17 56688 Rajalakshmi 58F Teacher 06-07-2018 10-08-2018 36 DAYS MILD 
18 32074 Kaliyammal 50F House Wife 03-04-2019 01-05-2019 29 DAYS MARKED 
19 39768 Uma 50F House Wife 09-05-2019 05-06-2019 28 DAYS MARKED 
20 32101 Vijaya 55F House Wife 03-04-2019 30-04-2019 28DAYS MILD 
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CASE PRESENTATION – SUMMARY OF IN PATIENTS 
1.ERANDAMOOLA CHOORANAM– INTERNAL    2.KUNGILIA THYLAM– EXTERNAL 
S.NO IP NO NAME AGE/ SEX OCCUPATION DATE OF ADMISSION 
DATE OF 
DISCHARGE DAYS RESULTS 
1 1959 SUNDARAM 55M Tailor 01-8-2018 31-8-2018 31 DAYS MARKED 
2 560 PECHIYAMMAL 50F Ryot 05-03-2019 01-04-2019 28DAYS MARKED 
3 565 MEENAMBAL 53F Ryot 05-03-2019 30-03-2019 27 DAYS MODERATE 
4 135 ULTHAL 57F House Wife 23-01-2019 15-02-2019 24DAYS MARKED 
5 2028 BEEVIJAN 60F House Wife 07-08-2018 14-09-2018 39 DAYS MILD 
6 3088 GNAMMAL 60F Ryot 15-12-2018 5-01-2019 22 DAYS MARKED 
7 1749 SUBBAMAL 55F Ryot 10-07-2018 09-08-2018 30 DAYS MODERATE 
8 3099 SOKKALINGAM 60M Farmer 18-12-2018 24-01-2019 37 DAYS MARKED 
9 1700 ARUMUGAM 57M Farmer 4-07-2018 02-08-2018 29 DAYS MILD 
10 455 GANESHAN 54M Hotel worker 22-02-2019 20-03-2019 26 DAYS MARKED 
11 1819 VELSAMY 56M Hotel worker 18-07-2018 13-08-2018 27 DAYS MODERATE 
12 272 MURUGAN 60/F Ryot 07-02-2019 8-03-2019 29 DAYS MARKED 
13 263 PANNEERSELVAM 45/F Ryot 06-02-2019 7-03-2019 29 DAYS MILD 
14 364 MURUGESAN  60 M Farmer 14-02-2019 19-03-2019 34 DAYS MARKED 
15 506 THANUSHKODI driver 27-02-2019 04-04-2019 37 DAYS MARKED 
16 335 THAMBURAN  50M Farme 12-O2-2019 30-03-2019 36 DAYS MARKED 
17 494 MURUGAN 57M Ryot 26-02-2019 20-03-2019 23 DAYS MARKED 
18 14 SUBRAMANIYAN  57M Hotel worker 03-01-2019 05-02-2019 33 DAYS MARKED 
19 1826 ESHWARI  60F House Wife 19-07-2018 20-07-2018 32 DAYS MARKED 
20 2519 ARUMUGAM 57 M Farmer 08-10-2018 05-11-2018 29 DAYS MARKED 
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BLOOD INVESTIGATION BEFORE AND AFTER TREATMENT  OP & IP PATIENTS 
S.No OP/IP No. 
TC DC Hb ESR BL.SUGAR BL.UREA Se.Cr 
BT AT N L E BT AT BT AT F PP BT AT BT AT BT AT BT AT BT AT BT AT BT AT 
1 90051 7,500 7,800 50 60 38 38 2 2 10.2 11 25 20 99 99 130 130 25 24 0.8 0.7 
2 90210 7000 7,800 58 68 29 30 2 1 10.5 11.5 26 17 110 100 138 137 26 24 0.8 0.7 
3 34431 8000 8,600 58 68 32 30 4 2 11 11.5 25 20 102 102 125 120 26 22 0.7 0.6 
4 39860 7,500 8,100 68 64 38 35 4 2 9.6 10.5 25 20 108 102 189 172 36 22 0.3 0.2 
5 58601 8600 8400 69 67 27 27 3 2 9.6 10.1 34 25 96 92 176 140 34 29 0.5 0.3 
6 56730 7800 7900 67 65 25 24 1 1 12.5 12.7 25 20 122 108 154 146 37 31 0.3 0.2 
7 41910 8700 8500 65 65 28 24 4 3 13.5 13.6 31 23 136 127 179 161 22 19 0.2 0.4 
8 961 8800 8000 69 67 27 26 2 1 12.2 12.4 19 11 142 128 165 148 35 32 0.3 0.3 
9 57280 7400 7300 70 66 29 28 3 1 12.8 12.9 32 21 127 167 156 29 34 29 0.4 0.3 
10 42401 7200 7600 65 67 26 24 4 2 11.8 11.9 25 11 99 90 149 132 29 22 0.4 0.3 
11 16480 7800 7600 67 69 28 27 5 3 13.5 13.7 28 19 106 97 167 165 37 34 0.7 0.7 
12 17411 7600 7500 68 68 27 25 3 1 12.2 12.4 27 20 97 92 149 135 28 27 0.7 0.6 
13 90690 8300 8500 64 65 29 29 2 2 11.8 13.6 15 10 129 117 179 161 22 19 0.6 0.7 
14 90372 8400 8700 63 62 28 29 4 2 12.2 12.4 19 11 89 85 149 140 34 29 0.6 0.6 
15 89395 8200 8300 67 65 24 28 6 4 9.5 9.9 34 28 99 90 149 132 29 22 0.8 0.7 
16 89063 8600 7600 65 62 26 29 2 2 13.5 13.7 28 19 136 127 167 156 29 25 0.8 0.8 
17 56688 6800 6700 66 66 26 27 5 3 12.5 12.7 25 19 96 92 176 168 29 22 0.7 0.6 
18 32074 7800 7900 68 65 26 25 4 2 11.8 11.9 25 20 99 90 149 132 29 22 0.5 0.9 
19 39768 7400 7600 69 67 29 28 3 2 12.2 12.4 19 11 136 128 159 139 42 37 0.4 0.8 
20 32101 7400 7300 68 65 28 27 2 1 10.9 11.1 30 19 121 118 172 159 19 15 0.7 0.6 
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BLOOD INVESTIGATION BEFORE AND AFTER TREATMENT  OP & IP PATIENTS 
S.No OP/IP No. 
TC DC Hb ESR BL.SUGAR BL.UREA Se.Cr 
BT AT N L E BT AT BT AT F PP BT AT BT AT BT AT BT AT BT AT BT AT BT AT 
21 1959 8600 8500 66 67 33 31 1 2 13.5 13.7 28 19 99 98 130 133 29 22 0.5 0.9 
22 560 7500 7400 59 61 37 36 4 3 12.2 12.4 27 20 86 90 132 135 37 34 0.8 0.8 
23 565 8800 8500 64 62 33 36 3 2 11.8 13.6 15 10 87 90 126 125 28 27 0.5 0.9 
24 135 7800 7900 65 64 31 32 4 4 9.6 10.1 34 25 80 82 130 132 36 22 0.2 0.2 
25 2028 8600 8800 71 69 24 28 3 3 12.2 12.4 25 20 88 85 132 136 29 25 0.3 0.2 
26 3088 7800 7900 59 61 36 34 5 4 12.2 12.4 19 15 89 87 139 140 29 22 0.5 0.3 
27 1749 8700 8800 64 62 33 36 3 2 9.5 9.9 20 17 79 85 127 128 34 29 0.3 0.2 
28 3099 8800 8900 69 69 28 29 3 2 12.8 12.9 32 21 89 88 130 138 35 32 0.2 0.4 
29 1700 9500 9000 68 66 33 36 3 2 11.8 11.9 25 20 90 88 136 138 34 29 0.3 0.3 
30 455 7200 7600 69 67 28 31 3 2 12.2 12.4 19 11 87 90 120 130 29 22 0.4 0.3 
31 1819 7800 7600 70 70 26 25 4 5 10.9 11.1 30 19 86 88 127 139 30 28 0.4 0.3 
32 263 7600 7500 59 61 37 36 4 3 12.2 12.4 19 11 83 87 130 136 22 19 0.7 0.7 
33 272 8300 8500 63 65 35 34 2 1 12.2 12.4 19 11 79 77 125 126 22 19 0.7 0.6 
34 364 8400 8700 64 63 32 34 4 3 9.5 9.9 34 28 89 85 123 138 34 29 0.6 0.7 
35 506 8200 8300 71 69 24 28 3 3 13.5 13.7 28 19 79 88 130 134 29 22 0.6 0.6 
36 335 8600 8600 59 61 36 34 5 5 12.5 12.7 25 19 89 87 132 137 29 25 0.8 0.7 
37 494 8800 8700 64 62 33 36 3 2 11.8 11.9 25 20 95 92 129 134 29 22 0.8 0.8 
38 14 7800 7900 59 61 36 34 5 5 12.5 12.7 24 23 98 96 130 133 34 29 0.7 0.6 
39 1826 7400 7600 62 64 32 34 6 2 13.5 13.6 31 23 82 90 135 140 37 31 0.5 0.9 
40 2519 7400 7300 61 62 34 34 5 4 11.8 12.2 26 18 81 88 126 130 19 15 0.4 0.8 
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URINE EXAMINATION BEFORE & AFTER TREATMENT – OUT  PATIENTS 
 
S.NO OP.NO BEFORE TREATMENT AFTER TREATMENT ALBUMIN SUGAR DEPOSIT ALBUMIN SUGAR DEPOSIT 
1 90051 NIL NIL NAD NIL NIL NAD 
2 90210 NIL NIL NAD NIL NIL NAD 
3 34431 NIL NIL NAD NIL NIL NAD 
4 39860 TRACE NIL 1-2 PUS CELLS NIL NIL NAD 
5 58601 NIL NIL NAD NIL NIL NAD 
6 56730 NIL NIL NAD NIL NIL NAD 
7 41910 NIL NIL NAD NIL NIL NAD 
8 961 NIL NIL NAD NIL NIL NAD 
9 57280 NIL NIL NAD NIL NIL NAD 
10 42401 NIL NIL NAD NIL NIL NAD 
11 16480 NIL NIL NAD NIL NIL NAD 
12 17411 NIL NIL NAD NIL NIL NAD 
13 90690 NIL NIL NAD NIL NIL NAD 
14 90372 NIL NIL NAD NIL NIL NAD 
15 89395 NIL NIL NAD NIL NIL NAD 
16 89063 TRACE NIL 1-3 PUS CELLS NIL NIL NAD 
17 56688 NIL NIL NAD NIL NIL NAD 
18 32074 NIL NIL NAD NIL NIL NAD 
19 39768 NIL NIL NAD NIL NIL NAD 
20 32101 NIL NIL NAD NIL NIL NAD 
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URINE EXAMINATION BEFORE & AFTER TREATMENT – IN PATIENTS 
S.NO 
 
IP.NO BEFORE TREATMENT AFTER TREATMENT ALBUMIN SUGAR DEPOSIT ALBUMIN SUGAR DEPOSIT 
1 1959 NIL NIL NAD NIL NIL NAD 
2 560 Trace NIL 2-3 pus cells Trace NIL NAD 
3 565 NIL NIL NAD NIL NIL NAD 
4 135 NIL NIL NAD NIL NIL NAD 
5 2028 NIL NIL NAD NIL NIL NAD 
6 3088 NIL NIL NAD NIL NIL NAD 
7 1749 NIL NIL NAD NIL NIL NAD 
8 3099 NIL NIL NAD NIL NIL NAD 
9 1700 NIL NIL NAD NIL NIL NAD 
10 455 NIL NIL NAD NIL NIL NAD 
11 1819 NIL NIL NAD NIL NIL NAD 
12 263 NIL NIL NAD NIL NIL NAD 
13 272 NIL NIL NAD NIL NIL NAD 
14 364 NIL NIL NAD NIL NIL NAD 
15 506 NIL NIL NAD NIL NIL NAD 
16 335 Trace NIL 1-2 pus cells NIL NIL NAD 
17 494 NIL NIL NAD NIL NIL NAD 
18 14 NIL NIL NAD NIL NIL NAD 
19 1826 NIL NIL NAD NIL NIL NAD 
20 2519 NIL NIL NAD NIL NIL NAD 
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X – RAY OF OUTPATIENTS 
 
 
  
Ip No :1700                             Name : Mr .Arumugam     57/m 
Ip. No :  135    Name :Ulthal  60 / F         
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BEFORE TREATMENT  
 
 
AFTER TREATMENT 
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6. DISCUSSION 
  Osteoarthritis is a chronic disorder of synovial joints in which there is 
progressive softening and disintegration of articular cartilage and bone at the joint 
margins (osteophytes), cyst formation and subchondral sclerosis, mild synovitis and 
capsular fibrosis. 
Classified as 
Primary   (localized or generalized)  
Secondary ( Traumatic, congenital, metabolic) Characterized by focal and 
progressive loss of hyaline cartilage of joints, underlying bony changes. 
Symptoms 
 Pain 
 Swelling 
 Stiffness 
  The trial drug given below was used in treating the disease azhal Keel vayu 
the trial drugs are 
 ERANDAMOOLA CHOORANAM (Internal) 
 KUNGILIA THYLAM (External) 
  The clinical approval was done as per the protocol and the data were collected 
by using approved forms.  The disease Azhal Keel vayu (Osteoarthritis of knee joint) 
was considered under various criteria to gather the secondary objectives of the study 
and the results were observed and tabulated.  A variety of criteria and the results were 
discussed here under. 
Gender distribution 
 From the above mentioned tabulation, Among the 40 patients selected, 52.5% 
were female and 47.5% were male. 
Age distribution 
 Among the 40 patients selected this study shows high incidence of Azhal Keel 
vayu (Osteoarthritis of knee joint) was in above 41-50 Yrs (32.5) of Age and  were  
51-60 yrs (57.5%) of age,  Azhal Keel vayu which is compared with osteoarthritis of 
knee joint which is degenerative disease, so the above interference explained it’s 
significant as the age plays an important role upon the degenerative disease. 
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Kaalam distribution 
 From the above mentioned tabulation, Among the 40 patients selected in this 
study.  Its shows the higher incidence was initiated to be pitha kaalam (97.5%). 
Occupational status 
 In this study the rate of incidence is higher in occupational group which 
includes Housewifes (32.5%), Farmer and Labour (42.5%) and Driver (5%),Teacher 
(5%) , Tilor,Hotel worker (7.5)This study shows heavy work housewifes,Agriculture 
Labour are mostly affected. 
Seasonal variations 
 From the above mentioned tabulation 13 patients 32.5% were admitted in 
Munpani kaalam, 4, patients 10% were admitted in Koothirkaalam, 10 patients 25%  
were admitted in Pinpanikaalam, 5, patients 12.5% were admitted in Ilavenil & 
Muthuvenil kaalam, 3 patients 7.5% were admitted in kaarkaalam .  Mostly the 
patients were admitted in Munpani kaalam, Pinpanikaalam. 
Thinai 
 From the above mentioned tabulation.  35 cases (87.5%) were from Marutham 
and 5  cases (12.5%) were from  Neithal thinai. 
 Even though siddha literatures mention Marutham as a disease free zone, most 
of the patients came from Marutham Nilam.  This may be due to the altered lifestyle, 
environment and food habits.  Since this is a single centered study, located in 
Marutham thinai, it may also have influenced the study. 
Socio-economic status 
 From the above mentioned tabulation, Out of 40 patients 55% were from low 
socio-economic status (poor), 37.5% were middle class, and 7.5% were rich.  This 
higher incidence in the low socio-economic status may be due to over usage by 
farmer and manual worker among the poor.  The incidence in the further population 
group may be due to improper nutrition and also the people living in poor sanitation. 
Dietary habits 
 From the above mentioned tabulation patients 80% were reported to have 
mixed diet 8 patients 20% were reported vegetarian.  So this has no statistically 
significant results. 
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Precipitating factor. 
  From the mentioned above tabulation result that the Menopause 25%, the 
occupation relation 50% ,obesity 22.5% and Hereditary 2.5% were the most 
important precipitating factors. 
Mode of onset 
 From the above mentioned tabulation it shows that 75% of the cases were 
reported to be having gradual onset. 
 Since osteoarthritis is a degenerative disorder it usually has a gradual onset of 
symptoms. 
Clinical features 
 According to this study, 100% of them had pain, crepitation, 75% of them had 
tenderness, swelling 70%, Restricted movement 87.5% patient had sleeplessness 
55%,   
Disturbances in kanmenthiriam 
 From the above mentioned tabulation, among 40 patients kaal have been 
affected in 100% of cases and in 16 patients eruvai have been affected (40%). 
Distribution of Three Dhosham 
Derangement in Vatham 
 Viyanan and Samanan were affected in all 40 cases (100%).  Abanan were 
affected in 16 cases (40%) and kirukaran and Devathathan affected in 11 cases 
(27.5%) 
Derangement in Pitham 
 Sathaga pitham was affected in all 40 cases (100%) Ranjagapitham was 
affected in 15 cases (37.5%), Anarpitham was affected in 14 cases (35%). 
Derangement in kabam 
 Avalambagam,Santhigam was affected in all 40 cases (100%). 
Udal kattukal 
 In all 40 cases, among the seven udal kattukal saaram, Kozhuppu, Enbu were 
found affected 100% (Restricted movements, swelling, crepitations present) and and 
senneer  is affected in 9 cases (22.5%). 
Envagai Thervugal 
 The analysis showed the efficacy of this method and the prime importance of 
Naadi. 
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 Among the 40 cases Naadi have been affected in all cases while malam have 
affected in 15 cases (40%)  
Naadi 
 In Naadi, among all 25 cases (62.5%) were vathapitha naadi, 15 cases (37.5%) 
were pithavatha naadi . 
Neikuri 
 In Neikuri analysis, 52.5% of the cases presented with vatha neer, 22.5% with 
pithaneer, and 25% with kabaneer. 
 Laboratory investigations were done in all the cases before and after 
treatment.  The significant variations occur in parameters like Hb, while other 
parameters have insignificant variation. 
Pre-clinical studies 
 The Biochemical study of  ERANDAMOOLA CHOORANAM had revealed 
the presence of Calcium,  sulphate,  Iron (ferrous), Unsaturated compound, Tannic 
acid, Amino acid. 
 Pharmacological studies 
 The pharmalogical studies done in  ERANDAMOOLA CHOORANAM , 
revealed the presence of actions such as 
1. Anti inflammatory action 
2. Analgesic activity. 
Toxicity studies 
 Acute toxicity  studies have done for  ERANDAMOOLA CHOORANAM  in 
rats and it is analyzed that they have no toxicity. 
Treatment 
 The treatment was aimed to retain the deranged dhosham and providing relief 
from symptoms.  Before treatment the patients were advised to take Vellai ennai – 
15ml with hot water during early morning in empty stomach for first day of 
treatment.  The patients was asked to take rest from internal medicine and other 
activities on that day.  From the next day, onward the internal medicine to be given. 
 The author treated the patients with trial drugs ERANDAMOOLA 
CHOORANAM (Internal Medicine) 3- 6gms BD, and  KUNGILIA THYLAM  
(External Medicine).  During treatment, the patients were advised to follow pathiyam 
(avoid tamarind, tubers, meat etc).  But all aspects of pathiyam could not be imposed 
due to practical difficulties. 
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7. SUMMARY 
 Osteoarthritis is the most common form of arthritis.  It causes pain, swelling 
and reduced motion in joints. 
 I have taken this as my dissertation and treated with ERANDAMOOLA 
CHOORANAM as internal medicine and KUNGILIA THYLAM as external 
medicine in azhal keel vayu (Osteo arthritis of knee joint).  
40 cases with azhal keel vayu were diagnosed clinically and admitted in the Inpatient 
ward and Outpatient ward of Post graduate department of Sirappu Maruthuvam, 
Government Siddha Medical College hostpital, Palayamkottai and treated by the trial 
medicines. 
 Laboratory diagnosis of azhal keel vayu was done by siddha diagnostic 
principles and endorsed by modern methods of investigations. 
 The various siddha aspects of examination of the disease were carried out and 
were recorded in the proforma. 
 The trial medicine chosen for both internal and external treatment were 
ERANDAMOOLA CHOORANAM(Internal)  in 3-6 grm twice a day for 
forty eight days as per the severity of the diseases, KUNGILIA THYLAM 
(External). 
 Before starting the treatment careful detailed history was carried out and 
recorded for the forty selected cases. 
 During the period of treatment all the patients were put under pathiyam (A 
specific dietary regimen). 
 A periodical laboratory investigation was made for all the cases along with the 
radiological investigations. 
 The observations made during the clinical study shows that the main internal 
drug ERANDAMOOLA CHOORANAM   is clinically effective. 
 Though there was appreciable clinical improvement, there were not much 
remarkable radiographic changes. 
  The action of external application of KUNGILIA THYLAM  with  PATTRU 
were given best results in patients than the patients were treated with internal 
medicine alone. 
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Treatment 
 The treatment was aimed to retain the deranged dhoshas and providing relief 
from symptoms.  Before treatment the patients were advised to take Vellai ennai-
15ml with hot water in early morning for first day of treatment. 
 From the second day onwards internal medicine  ERANDAMOOLA 
CHOORANAM 3-  6 gms two times day after food and of KUNGILIA THYLAM is 
given as external. 
 At the time of treatment the patients were advised to follow Pathiyam and 
specially advised to avoid foods which increase vadha. 
 Along with the course of treatment the complementary therapies like pattru  
were given additionally to all of them  patients. 
 The outcome of this study is mainly assessed by reduction in pain, swelling, 
stiffness in knee joint.  Increased range of reduction of restricted movements and 
improvement in quality of life universal pain assessment scale was also used to detect 
proper outcome.  No adverse effect was noted for both Internal and External medicine 
along with the course of treatment 
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8. CONCLUSION 
 
  All 40 patients ( OPD and IPD –  patients with trial medicines and external 
therapy) were treated for this dissertation work with ERANDA MOOLA 
CHOORANAM (Internal) 3 to 6gms two times a day and KUNGILIA THYLAM 
(externally) 
 In the pre clinical study pharmacological evaluation of the trial drug shows. 
 Significant analgesic effect 
 Significant Anti inflammatory effect (Internal medicine) 
  In the preclinical study toxicity study of “ERANDA MOOLA 
CHOORANAM” shows that the trial drug had no acute toxicity. 
  The overall effect of the clinical trial drug are  
 Marked effect  - 60% 
 Moderate effect - 17.5% 
 Mild effect  - 20% 
 No effect  - 2.5% 
 This result of the clinical trial illustrates the marked effect of the drugs and 
complementary therapy. 
 The trial drug ERANDA MOOLA CHOORANAM  and external KUNGILIA 
THYLAM is effective.  No adverse effects were noticed during the treatment period.  
So the trial medicine is safe and easily preparable medicine. 
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ERANDA MOOLA CHOORANAM  
(Internal Medicine) 
 
AAMANAKKU VER 
 
 
ERANDA MOOLA CHOORANAM  
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KUNGILIA THYLAM 
(Internal Medicine) 
 
POONAIKAN KUNGILIYAM 
GINGELLY OIL 
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KUNGILIYA THYLAM 
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PATTRU 
 
  
Vasambu 
Vasambu Powder 
Kaichukatti 
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ANNEXURE –I 
STANDARD OPERATING PROCEDURE FOR PREPARATION OF  
ERANDA MOOLA     CHOORANAM AND KUNGILIA THYLAM 
 
SOURCE OF TRIAL MEDICINE: 
            The required drugs for preparation of “ERANDA MOOLA 
CHOORANAM” (INTERNAL), “KUNGILIA THYLAM” (EXTERNAL) are 
purchased from a well reputed country shopand Raw drugs are Authenticated by 
Medical botanist of Govt. Siddha Medical College, Palayamkottai, then  purified and 
the  medicine  is prepared in the  Gunapadam laboratory of Govt. Siddha Medical 
College, Palayamkottai. 
 
INTERNAL MEDICINE:   
  ERANDA MOOLA CHOORANAM 
Ref : ANUBOGA VAITHYA THEVA RAGASIYAM   
 
INGREDIENTS: 
 
S.NO. DRUG 
BOTANICAL 
NAME 
PART 
USED 
AMOUNT 
1. AMANAKKU VER 
RICINUS 
COMMUNIS 
ROOT 35 Gram 
 
PURIFICATION : 
 All above  drugs are purified under the formulation of “Anupoga Vaithiya 
Bramma Ragasiyam and Sarakku Suthi Muraigal” 
 Dose   : ¼ to ½ Thoola (3 to 6 Grams) 
 Duration : 40 days 
 
PREPARATION: 
  The Drug is purified properly and dried in shade and made in to powder  
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DRUG STORAGE: 
 The trial drug ERANDA MOOLA CHOORANAM is stored in clean dry air 
tight container & it is dispensed to the patients in  packets. 
 
   AAMANAKKU VEER 
 
RICINUS COMMUNIS  :  Aamanakku 
FAMILY NAME   :  Euphorbiaceace 
OTHER NAMES  : 
TAMIL NAMES   :  Erandam, Chiththiram , Thalarubam , 
ENGLIESH NAME  :  Castor Oil Plant  
SANSCRIT NAME   :  Yeranda-Vrikshaha   
TELUNKU    :  Amudapu - Chettu 
MALAIYALAM   :  Anakkuav 
HINDI    :  Arand-Ka-Per, Anandi-Ka-Per 
KANNADAM   :  Herald-Gida 
 
Habitat :  
 This plant is common  and quite wild in the jungles in India and is by far the 
largest producer. It is cultivated throughtout India , chiefly in the Madras, Bengal ,and  
Bombay persigancies 
Two varieties of plant are known: 
1. A perennial bushy plant with large fruits and large red seeds which ,yield 
about 40p.c. of oil ; and 
2. A much smaller annual shrub with small grey (white) seeds having brown 
spots and yielding 37 percent of oil 
 Distribution 
  Usually cultivated for oilseeds, sometimes found as an escape in wastelands. 
Bilaspur, Chhatarpur, Damoh, Dhar, Ralpark Raipur, Seoni, Sidhi, Surguja. W. 
Nimar. 
Botanical Description 
  Large shrubs or small trees, with fistular stem and large, palmetly 5 to 10-
lobed leaves. Flowers in p yramidal  panicles . Capsules globose, spiny, of 3- cocci; 
seeds caruncled. 
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Flowering & Fruiting 
  September-May. 
Medicinal Parts 
  Root, Leaves, Flowers, Fruits, Seedis& Seed oil. 
Chemical Constituents 
Plant Contains :  
• Ricinine. 
 
Leaves Contains :  
• Alkaloids, 
• Ricine,  
• Ricinine, And Flavanol Glycosides, 
• Amyrin,         
• Stigmasteorl,  
• Sitosterol 
• Quercetin,  
• Rutin, Hyperoside. 
Flowering Heads Contain:  
• Coumarins, 
• Hyperoside And Flavonoid Rutin,  
• Alkaloid Ricinine.  
• Seeds Yield  Lectin.     
Root Contain : 
• Resin , 
• Tanin 
• Starch., 
• Antimicrobialagents. 
• Calcium, 
• Magnesium,  
• Potassium.,  
• Amino Acid. 
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Seeds Contain : 
• 50 Per Cent Oil, 
• Protein 
• Ricinine, 
• Ricin, 
• Lipate   Enzyme, 
• Fixed Oil. 
Fixed Oil Contains :    
• Glycerides, 
• Ricinolesis, 
• Isoricinoleic Acid,  
• Stearic Acid, 
• Crystals Of Calcium Oxalate, 
• Nitrate. 
• Palmitic,  
• Stearic,  
• Arachidie,  
• Hexadecencic, 
• Oleic, Linoleic,, Linolenic, Ricinoleic And Dihydroxy Stearic Acid. 
 Biological Activities 
• Alterative, 
• Anti-Inflammatory, 
• Aphrodisiac, 
• Carminative, 
• Febrifuge  
• Purgative  
• Stomachic.  
Uses :  
• Castor  oil is used  as a refrigerant This on is laxative. 
• This is very effective in colic pains, ulcer and also in the treatment of irritation 
of Eye, Nose, Ear, and Mouth 
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• The cooked mixture of  leaves and  red gram is an galactogogue . 
• Leaves warmed over a fire and applied to the breasts of woman  induces better 
flow of milk . 
• Leaves applied to the abdomen promote menstrual discharge 
• The mixture of equal quantities of sugar and root is very effective in veneral 
• inflammation. It cures musucular rheumatism, paralysis, asthma and cough. 
• hydrocoel, jaundice, lumbago, piles, rheumatism, sciatica, skin 
• diseases . Leaves-Cough, worms infestation. . 
• A poultice of the crushed seeds is used to promote suppuration, to mature 
boils and to reduce gouty and rheumatie swellings. 
Ammanakku root uses:  
• The root of the plant also useful as an ingredient of valous prescriptions for 
nervous diseases and rheumatic affections such as lumbago, pleuradynia and 
scistica, In pleurodynia or pain in the sides, 
• a decoction of the root is given with the addition of impure carbonate of 
potash(Sharangdhara). 
• Dried root is used us a febrifuge..  
• In affections of the eyes a decoction of the Bark, Leaves And Root of the plant 
in goat's milk and water is recommended for use as a wash-(Chakradatta) 
• Aamanakku Root,leaf, seed- Diseases of vatham, consupation, piles, jaundice,  
intercostal neuralgia, leucorrhoea, dysuria. 
• Decoction of roots given in lumbago 
Active principles : 
• Carrageenan, 
• Bradykinin,  
• Albumin, 
• Ricin, 
• Cademine, 
• Carotinoids, 
• Chelerythirine,  
• Coptisine, 
• Ricenoleic Acid, 
• Txoalbumin. 
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Ammanakku veer : 
Botanical Name : Ricinus Communis 
Family   : Euphorbiaceae. 
Rit   : frg;G 
tPhpak;   : ntg;gk; 
gphpT   : fhHg;G 
nra;if  : thjklf;fp 
 
nghJFzk;;;; 
  “thjj; njhlf;if tunthl;lh kw;gbf;Ff;  
 fhjj;Jf; fg;ghw; fbANk – R+jj;ijg; 
 Nguz;lg; ge;jpf;Fk; Ngjpf;F Neha; fhl;il 
 Nauz;l nkd;gjpdpNa” 
    - Njud; ntz;gh 
 
  tspFw;wj;ijj; jd;dpiygLj;jr; nra;Ak; FbePh;fspYk;> ijyq;fspYk; 
Mkzf;F Nth; Nrh;f;fg;gLfpwJ. 
 
EXTERNAL DRUG: 
KUNGILIA THYLAM 
Ref: MARUNTHU SEI EYALU KALAIUM  
 
S.NO. DRUG 
BOTANICAL 
NAME 
PART 
USED 
AMOUNT 
1 POONAI 
KANKUNGILUM 
PISTACIA 
LENTISCUS 
GUM 10 Gram 
2 GINGELY OIL RICINUS 
COMMUNIS  
SEED 100 Gram 
 
PURIFICATION: 
 All above drugs are purified under the formulation of  “Anupoga Vaithiya 
Bramma Ragasiyam and Sarakku Suthi Muraigal” 
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METHOD OF PREPARATION  
  Make Kungulium in to powder and add gingely oil an heat it and filtered I 
after Kungulium  gets dissolved  
 
INDICATIONS: 
  It is indicated externally for Joint Pain 
 
ey;nyz;nza;; ; ;; ; ;; ; ;: 
 
Botanical Name : Sesamum Indicum 
Family   : Pedaliaceae 
NtWngah;fs;  :  jpyk;> vs;nea; 
gad;gLk;cWg;G : ,iy> G+> fha;> tpij 
Rit   : ,dpg;G 
jd;ik  : ntg;gk; 
gphpT   : ,dpg;G 
 
Therapeutic action: 
 Demulcent 
 Laxative  
 Nutritive 
 Emollient 
  
nghJFzk;;;; 
 
 Gj;jpeadf;Fsph;r;rp G+hpg;G nka;g;GsfQ; 
 rj;Jtq; fe;jp jdpapsik – nkj;jTz;lhq; 
 fz;Nzha; nrtpNeha; fghytoy; fhrNeha; 
 Gz;Nzha;Ngh nkz;nza;ahw; Nghw;Wk;. 
 
  Gj;jpf;Fj; njspT> tpopfSf;Ff; Fsph;r;rp> cly;G+hpg;G> cly;td;ik 
Mfpatw;iwj; jUtNjhL> fz;Nzha;> fhJNeha;> jiyf;nfhjpg;G> nrhwp> 
rpuq;F> Gz; KjypaitfisAk; Nghf;Fk;. 
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nghJFzk;:;;;  
  fz;Zf;F xspiaAk; clYf;F td;ikAk; jUk; 
FUjp ngUf;if cz;lhFk;  
    - mfj;jpaH Fzthflk; 
 
Varieties : 
  Three varieties of sesamum seeds are found. Block ,White, and Red or brown. 
The black variety is the most common and yields the best quality of oil and is also the 
best used for medicinal purposes. But the white variety is richer oil. 
 
Parts Used : 
  Seeds and the fixed oil expressed from the seeds 
 
Chemical constituents 
  Seeds contain fixed oil 50 to 60 u.c., (white black & red varieties about 46 
p.c.) Analysis:-- 
     Moisture:        Oil: 
Black Til        2.0 to 5.2 p.e.    44.6 to 56.9 p.c.   
Red Til           ___________     15.7 to 55.5 p.c 
White Til       2.0 to 4.4 p.       44.9 to 58.2 p.e. 
(Bom. Govt. Agri: Dept. Bulletin). 
  Seeds also contain proteids 22 p.c., carbohydrates 18 p.c. mucilage 4 p.c, 
Woody fibre 4p.c., and ash 4.8 p.c. Oil contains 70 p.c. of liquid fats consisting of the 
glycerides of oleic and  linoleic acids and 12 to 14 p.e. of solid fats, stearin, palmitin 
and myristin; a crystalline substance sesamin and a phenol compound sesamol. 
 Palmitic acid 
 Stearic acid 
 Archidic acid 
 Linoleic acid 
 Oleic acid  
 Vitamin E,  
 Sesamin,  
 Segamolin,  
 Phytosterol. 
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Therapeutic Actions  :   
 Emmlnagogie, 
 Stimulant,  
 Tonic, 
 Diuretic, 
 Galactogogce. 
 Nourishing.  
 Lactagogue  
 Laxative, 
 Emollient And Demuloent; 
 
Uses : 
 Seeds are specially useful in piles, dysentery', scorpion sting and constipation 
,taken in decoction or as sweet meats. 
 A compound decoction of the seeds with linseed is used in cough and as an 
aphrodisiac .  
 Ground to a paste with water, they are given with butter for bleeding piles; if 
taken. large quantities, they are capable of producing abortion. 
 In amenorrhoea and dysmenorrhoea, the administration of powdered seeds in 
ten grain doses three or four times daily 
 
PISTACIA LENTISCUS  
Tamil Name      :          Poonaikan  Kungiliam 
Botanical Name  :   Pistacia Lentiscus 
Family       :        Anacardiaceae 
Other Name         :          Rumimashtaki Kungiliyam  
 English Name     :    Mastiche Tree. 
 Hindi Name        :      Mah. & Guy-Resin) Rumi Mastaki 
Part Used      : Gum Resin 
Rit         :  ifg;G 
tPhpak;     : ntg;gk; 
gphpT      : fhHg;G 
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Habitat :  
 Growing in countries bordering on the Medi terranean; its resin called the 
mastiche and obtained by incisions. made in the bark, is imported into India from 
Asia Minor through Persia and Afghanistan 
 
Constituents. 
Leaves contain :  
 A colouring matter and tannin 
Fruit contains :   
 Bimalate of lume; 
Other Constituents :    
 Resin,  
 Essential Oil (of fruit or leaves?). 
Action- 
 Stimulant,  
 Diuretic. 
 Mastiche Galls Are Acid  
 Astringent.--(Chopra).  
 Stomachic,  
 Diaphoretic,  
 Astrigent,  
 Refrigerant,  
 Emmenagogue, Expectorant 
nghJFzk;: ;;;  
  Fe;jphpf;fk; “euk;G rk;ge;jkhf Neha;fSf;Fk;> thj Neha;fSf;Fk;” 
rpwe;j kUe;jhFk; 
Uses 
 This is smilar to cat’s eye. The resin cures oedema 
 Leaves in infusion or decoction (1 in 10) in doses of  ½ to 1 ounce, or as 
liquid extract in ½  to 1  drachm doses are used. 
 Paste of leaves is also employed in medicine.  
 "Mastiche is used as a masticatory in tooth affections, and by dentists, for 
filling carious teeth. 
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 A solution of 2 parts of mastiche gum dissolved in 1 of either chloroform or 
ether and applied on cotton wool. 
 It contain a trace of volatile oil; two resins – alpha resin or mastachic acid 
90p.c ;  and Beta resin or mastachine  10 p.c also an ethereal oil,  
 Gum mastiche is applied as a paste to the chest in catarrh ,bronchitis, and to 
relive local pain 
 
EXTERNAL THERAPY 
PATTRU 
 Ref :  gunapadam mooligai vaguppu 
PREPARATION  
  Vasambu and kaichukatti grinded with water and applyed it. 
PATTRU 
  The pattru in siddha is obtained from plant extracts or grinding raw drugs with 
or without processing them and are either heated or not heated ,is made into a thick 
paste and applied, or pasted on the affected area.  
           
VASAMBU 
Tamil Name   :  Vasambu 
Botanical Name :  Acorus Calamus 
Family       :  Acoraceae 
Other Names     :  ujs?!Ou{q?!djvh<hie<?!!
hqt<jtlVf<K?!dg<gqvl<. 
Engilsh Name  : Sweet-Flag 
Sanskrit Name : Vacha 
Part Used  :  Rhizome 
Suvai   : Kaarppu 
Thanmai  : Veppam 
Pirivu   : Kaarppu 
 
  Acorus calamus (vasambu) are anti-inflammatory when used topically for 
arthritis , topical preprations must contain compounds that penetrate the skin ,inhibit  
pain receptors such as transient receptor potentialaction channels and 
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cyclooxygenase-2  to relive pain.  Inhibition of pain in the skin disturbs the pain cycle 
and avoids exposure of internal organs to large amounts of toxic compounds. 
 
Constituents  
 Volatile Oil, 
 Asarone 
 Phenylindane Derivative, 
 Phenyl Propane Derivative. 
 Acorin  
 Acoretin, 
 Calamine, 
 Calamen, 
 Calamenol, 
Action  
 Stimulant 
 Nervine Tonic 
 Hypotensive  
 Tranquilizer  
 Sedative  
 Analgesic  
 Anticonvulsant  
 Emetic 
 Antispasmodic 
 Carminative 
 Nervine Sedative 
 Insecticide, 
Active Principles :  
 Beta-Asarone,  
 Asarone,  
 Beta-Isomer, 
 Phenylpropanoids  
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nghJFzk;;;; 
ghk;ghjp eQ;rw; Gjg;Gz; typtplghfq; Fd;kk; 
#k;gh hpuj;jgpj; jk;Kf ehw;wk;td; #iyrd;dp 
tPk;ghk;ig fhrk; gpyPfQ; rpypgjk; tPwpUky; 
jhk;ghq; fpUkp apitNaU khrpt rk;gpidNa. (Nj.F.) 
Uses: 
 Used in dyspepsia ,fever,skin disease,expectorant,stomachic 
 
CATECHU NIGRUM –( Kachukatti) 
Tamil Name   : !! gib<s<Sg<gm<c!!
Botanical Name  :  Acacia Catechu 
Family Name   :  Leguminasae 
Sju!!! ! ;!!! Kui<h<H!
ke<jl!! ! ;!!! sQkl<!
hqiqU!!! ! ;!!! gii<h<H!
osb<jg!! ! ;!!! Kui<h<hq!
 
Habitat  : Burma, India. 
 Black catechu is an extract prepared from the heartwood of Acacia Catechu, 
Willd. (N.O. Leguminosae), a tree indigenous to India and Burmah. 
 It is official in India and the Eastern and North American Colonies for use in 
making official preparations, for which pale catechu (gambier) is directed to 
be used.  
 The bark and sapwood are stripped from the trunk, the red heartwood cut into 
chips and boiled in water in earthen pots.  
 The decoction is strained and boiled down in iron pots to a syrupy 
consistence; this is allowed to cool and is then poured into a wooden mould 
lined with leaves or paper and left to harden 
 . The resulting solid extract forms large masses, which are broken up into 
pieces of irregular shape and exported. 
 Black catechu or cutch occurs in irregular dark brown or nearly black masses, 
to which pieces of leaves or paper are often found adhering.  
 It is brittle, the fractured surface exhibiting numerous small cavities. 
 It yields a reddish-brown powder, with an astringent taste. 
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Catechu is an herb. The leaves, shoots, and wood are used to make medicine. 
 The two types of catechu, black catechu and pale catechu,  Both contain slightly 
different chemicals, but they are used for the same purposes  
Constituents: 
The chief constituents of Black Catechu are Catechu 
 Tannic Acid (25 To 35 Per Cent.) 
 Gallic Acid Oily Mater ( Fat14%) 
 Arecoline 0.07%  
 Arecine 1% 
 Acacatechin (2 To 10 Per Cent.), 
 Quercetin, And Catechu Red;  
 Gum And Colouring Matter are also present in the Drug.  
 Black Catechu differs from Pale Catechu in being devoid of a Fluorescent 
Body. 
Action And Uses : 
  Black Catechu resembles Pale Catechu in its properties, and is employed for 
similar purposes. 
 Osteoarthritis. Early research suggests that taking catechu extract in 
combination with Baikal skullcap seems to reduce pain in people with 
osteoarthritis of the knee. 
 Catechu is most commonly used by mouth for stomach problems such as 
diarrhea, swelling of the colon (colitis), and indigestion.  
 It is also used orally for pain from osteoarthritis and topically to treat pain, 
bleeding, and swelling (inflammation). But there is limited scientific 
evidence to support any of these uses. 
 Injuries. 
 Diarrhea. 
 Swelling of the nose and throat. 
 Swelling in the colon. 
 Bleeding. 
 Cancer. 
 Skin diseases. 
 Hemorrhoids. 
 
127 
 
 
ANNEXURES –II 
QUALITATIVE AND QUANTITATIVE ANALYSIS 
BIO-CHEMICAL ANALYSIS OF ERANDA MOOLA CHOORANAM 
(IN POWDER FORM) 
 
Preparation of the extract 
5 grams of the drug was weighed accurately and placed in a 250ml clean beaker. 
Then 50ml of distilled water added to it and dissolved well. Then it was boiled well 
for about 10 minutes. It was cooled and filtered in a 100ml volumetric flask and then 
it is made upto 100ml with distilled water. This fluid was taken for analysis. 
 
QUALITATIVE ANALYSIS 
S.No. EXPERIMENT OBSERVATION INFERENCE 
1 
TEST FOR CALCIUM 
2ml of the above prepared extract is taken 
in a clean test tube. To this add 2ml of 4% 
Ammonium oxalate solution. 
A white precipitate is 
formed 
Absence of calcium. 
2 
TEST FOR SULPHATE 
2ml of the extract is added to 5% Barium 
Chloride solution 
A white precipitate is 
formed 
Indicates the 
presence of sulphate 
3 
TEST FOR CHLORIDE 
The extract is treated with silver nitrate 
solution. 
A white precipitate is 
formed 
Absence of chloride. 
4 
TEST FOR CARBONATE 
The substance is treated with concentrated 
Hcl. 
No brisk efference is 
formed 
Absence of 
Carbonate 
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5 
TEST FOR STARCH 
The extract is added with weak iodine 
solution 
Blue Colour is 
formed. 
Absence of Starch 
6 
TEST FOR FERRIC IRON 
The extract is acidified with Glacial acetic 
acid and potassium ferro cyanide. 
No blue color is 
formed. 
Absence of ferric 
iron 
7 
TEST FOR FERROUS IRON 
The extract is treated with concentrated 
Nitric acid and Ammonium thiocyanate 
solution. 
Blood red colour is 
formed. 
Indicates the 
presence of ferrous 
Iron. 
8 
TEST FOR PHOSPHATE 
The extract is treated with Ammonium 
Molybdate and concentrated nitric acid 
No yellow precipitate 
is formed 
Absence of 
Phosphate 
9 
TEST FOR ALBUMIN 
The extract is treated with Esbach’s 
reagent 
No yellow precipitate 
is formed. 
Absence of Albumin. 
10 
TEST FOR TANNIC ACID 
This extract is treated with ferric chloride. 
No blue back 
precipitate is formed 
. Indicates the 
presence of tannic 
acid 
11 
TEST FOR UNSATURATION 
Potassium permanganate solution is added 
to the extract. 
It gets decolorized 
Indicates the 
presence of 
unsaturated 
compound 
12 
TEST FOR THE REDUCING SUGAR 
5ml of Benedict’s qualitative solution is 
taken in a test tube and allowed to boil for 
2 minutes and add 8-10 drops of the 
extract and again boil it for 2 minutes 
Colour change occurs 
Absence of reducing 
sugar 
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13 
TEST FOR AMINO ACID 
One or two drops of the extract is 
placed on a filter paper and dried well. 
After drying 1% Ninydrin is sprayed over 
the same and dried it well. 
violet colour is 
formed. 
Indicates the 
presence of Amino 
Acid. 
14 
TEST FOR ZINC 
The extract is treated with Potassium 
Ferro cyanide. 
No white precipitate 
is formed. 
Absence of Zinc. 
 
RESULTS  
 The Bio chemical analysis of the trial drug Erandamoola chooranam was 
tabulated above in table .  The trial drug Eranda moola chooranam contains. 
1. Sulphate 
2. Ferrous Iron 
3. Unsaturated compound 
4. Tannic acid 
5. Amino Acid. 
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ANNEXURE – III 
FTIR ANALYSIS OF ERANDA MOOLA CHOORANAM 
AIM : 
 To identify  the functional group presend in the trial drug , Eranda Moola 
Chooranam by using Fourier transform infrared spectroscopy. 
 
FTIR SPECTRUM ANALYSIS 
  Fourier transform infrared spectroscopy it is an important and more advanced 
technique. It is used to identify the functional group to determine the quality and 
consistency of the sample material and can determine the amount of compound 
present in the sample. 
  In FTIR - infrared is passed from a source through a sample. This infrared is 
absorbed by the sample according to the chemical properties and some are 
transmitted. The spectrum that appears denotes the molecular absorption and 
transmission. It forms the molecular finger print of the sample. It is recorded as 
wavelength and the peaks seen in the spectrum indicate the amount of material 
present. 
 
FIGURE :1 
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INTERPRETATION : 
 
TABLE :1 
S.NO Wave Number 
Vibrational Modes of 
Erandamoola 
Chooranam in IR 
Functional Groups 
1 898.83 C-H  bending 1,2,4, Trisubstituted 
2 1051.20 S=O stretching 
C=O stretching 
Sulfoxide 
Primary Alcohol 
3 1159.22 C=O stretching Tertiary Alcohol 
4 1247.94 C-N stretching 
C-O stretching 
Amine 
Alkyl Aryll Ether 
5 1325.10 S=O stretching 
C-N stretching 
Sulfone 
Aromatic Amine 
6 1375.25 O-H bending 
O-H  bending 
Phenol 
Alcohol 
7 1425.40 O-H  bending Corboxylic Acid 
8 1510.26 N-O stretching Nitro Compound 
9 1643.35 C=C stretching Alkene 
10 1735.93 C=O stretching  Aldehyde 
Ester 
γ  Lactone 
11 2839.22 N-H stretching 
O-H stretching 
Amine Salt 
Carboxylic Acid 
Alcohol 
12 2885.51 C-N stretching 
N-H stretching 
O-H stretching 
Alkane 
Amine Salt 
Alcohol 
13 2943.37 C-H stretching Alkane 
Alkyne 
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DISCUSSION  AND RESULTS 
  In FTIR spectre analysis, this sample analysis Eranda Moola Chooranam 
exhibit the peak value at 898.83, 1051.20, 1159.22, 1247.94, 1325.10,1375.25, 
1425.40, 1510.26, 1643.35 , 1735.93 , 2839.22,  2885.51, 2943.37,  having C-H 
stretching, O-H stretching, C=N stretching, C=O stretching, C-O stretching, C-N 
stretching, S=O stretching, C=C stretching, C-Br stretching, N- H stretching. 
  This indicates the presence of some organic functional groups such as alcohol, 
alkanes, , tertiary alcohol, primary alcohol, sulfoxide, aromatic amine, alkyl  aryl 
ether, ether, lactone carboxylic acid, phenol, nitro compound,amine,1,2,4, 
trisubstituted, aldehyde, amine salt. 
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ANNEXURE-IV 
ANTI-INFLAMMATORY ACTIVITY OF ERANDA MOOLA CHOORANAM 
 
  The anti-inflammatory activities of Eranda moola Chooranam at 200 and 
400 mg/kg doses were evaluated using carrageenan-induced paw oedema method. 
The inflammation was readily produced in the form of edema with the help of irritant 
such as carrageenan. Carrageenan is a sulphated polysaccharide obtained from sea 
weed (Rhodophyceae) and when injected cause the release of prostaglandins by the 
way it produces inflammation and edema. 
 
REQUIREMENTS: 
Animal                        :  Albino rat (180-200 g) 
Drugs and chemicals           :  Carrageenan (1%w/v), Diclofenac  
sodium (standard), 
                                                Carboxy methyl cellulose (1%w/v), 
                                                Plethysmo meter. 
Test compounds                 :    Eranda moola Chooranam. 
 
METHOD: 
  Anti-inflammatory activity was performed by the following procedure of 
Bhandri et al(1) The animals were divided into 4 groups each having six animals. A 
freshly prepared suspension of carrageenan (1% w/v , 0.1 ml) was injected to the 
planter region of left hind paw of each rat. One group was kept as control and the 
animals of the other groups were pretreated with the Eranda moola Chooranam 
200&400mg/kg test Compounds dissolved with 2 ml sterile water given through 
orally and diclofenac sodium 10mg/kg ip 30 min before the carrageenan treatment. 
The paw volumes of the test compounds, standard and control groups were measured 
at 60,240,360 minutes of carrageenan treatment with the help of  plethysmometer . 
Mean increase in paw volume was measured and the percentage of inhibition was 
calculated. 
% Anti-inflammatory activity = (Vc-Vt / Vc) x 100 
  Where, Vt-mean increase in paw volume in rats treated with test compounds, 
Vc-mean increase in paw volume in control group of rats. 
 
* Data are expressed as Mean ± S.E.M. 
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*Data were analyzed by one way ANOVA followed by Newman’s keul’s multiple 
range tests, to determine the significance of the difference between the control group 
and rats treated with the test compounds. 
*a   Values were significantly different from normal control at P< 0.01 
 
TABLE No.1 
ANTI-INFLAMMATORY ACTIVITY OF ERANDA MOOLA CHOORANAM 
 
Dose (mg/kg) 
Paw volume(ml) 
as measured by 
mercury 
displacement at 6 
hour 
Percentage 
inhibition of paw 
edema 
Group I 
Normal saline 
10ml/kg orally 5.50±0.96 - 
Group II 
Std 
10mg/kg 
I.P.Diclofenac 
sodium 
2.40±0.40 56.36% 
Group III EC 
 
200mg/kg.Orally. 3.16±0.48 42.54% 
Group IV 
EC 
400mg/kg.Orally. 2.90±0.52 47.27% 
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RESULTS 
Anti- inflammatory activity 
  EC at 100 and 200 mg/kg doeses were tested for their Anti- inflammatory 
activity by using carrageenan Induced rat paw edema method and the results are 
tabulated in table   The results reveals that   both extracts of EC at 200 and 400 mg/kg 
doses possesses significant Anti- inflammatory activity when compared to control 
group at p<0.01. 
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STUDY OF ANALGESIC ACTIVITY IN RATS USING THE  DRUG 
ERANDA MOOLA CHOORANAM BY HIND – HOT PLATE METHOD 
 
Hot plate method 
Animals  
  Young wister albino rats of either sex aged 4-5 weeks, average weight 100-
150 gm were used for the experiment. The rat were purchased from the animal 
TANVASU . They were kept in standard environmental condition (at 24.0±0°C 
temperature & 55-65% relative humidity and 12 hour light/12 hour dark cycle) for 
one week for acclimation after their purchase and fed ICDDRB formulated rodent 
food and water ad libitum. The set of rules followed for animal experiment were 
approved by the institutional animal ethical committee (Zimmermann, 1983). 
 
  Experimental animals of either sex were randomly selected and divided into 
four groups designated as group-I, group-II, group-III and group-IV consisting of five 
Rats in each group for control, positive control and test sample group respectively. 
Each group received a particular treatment i.e. control (1% Tween-80 solution in 
water, 10ml/kg, p.o.), positive control (Diclofenac sodium 10 mg/kg, p.o.) and the test 
sample (drug of 100 mg/kg, p.o. & 200 mg/kg, p.o. respectively). The animals were 
positioned on Eddy’s hot plate kept at a temperature of 55±0.5 0C. A cut off period of 
15 s (Franzotti et al., 2000) was observed to avoid damage to the paw. Reaction time 
was recorded when animals licked their fore or hind paws, or jumped prior to and 0, 
30, 60 and 90 min after oral administration of the samples (Eddy et al., 1953; 
Kulkarni, 1999; Toma et al., 2003). 
GROUP DOSE 
Mean latency before and after drug administration % inhibition 
0 min 30 min 60  min 90 min 30min 60min 90min 
Group I Vehicle 0.76±0.220 0.95±0.226 0.66±0.198 1.08±0.267 - - - 
Group II 
Diclofenac  10 0.84±0.088 4.12±0.625 7.97±0.645 10.17±1.008 76.94 91.71 89.38 
GROUP 
III(EC ) 200 0.71±0.074 1.77±0.265 3.69±0.776 3.67±0.617 46.32 82.11 70.57 
Group IV 400 0.57±0.018 2.07±0.852 4.84±0.514 4.43±0.465 54.10 86.36 75.62 
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Statistical analysis  
  The results of statistical analysis for animal experiment were expressed as 
mean ± SEM and were evaluated by ANOVA followed by Dunnet’s multiple 
comparisons. The results obtained were compared with the vehicle control group. The 
p<0.05, 0.001 were considered to be statistically significant 
Result  
  Results of hotplate test are presented in Table  for drugs respectively. The 
drug  were found to exhibit a dose dependent increase in latency time when compared 
with control. At 90 minutes, the percent inhibition of two different doses (100 and 
200 mg/kg body weight) was 70.57% & 75.62% respectively. The results were found 
to be statistically significant (p<0.001)  
Discussion 
  Sidhha is the first system of medicine to emphasize health as the perfect state 
of physical, psychological, social and spiritual components of a human being. The 
fundamental principle of this medicine successfully eliminates the evil side effects 
without losing the beneficial medicinal properties. Diclofenac was used as a reference 
drug in the current study as it has both central, peripheral actions and can 
significantly treat nociceptive pain as in this model.  In the current study, pain 
threshold increased significantly during the period of observation in all the drug 
treated groups, with maximum effect observed in the Eranda moola Choranam  at a 
dose of 200mg/kg as shown in table 1. The analgesic activity of drug was comparable 
to diclofenac at 30 ,60,120minutes appears to be a significant finding and suggests 
that this drug has a slow onset of analgesic action 
0
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GROUP III(ERANDAMOOLA 
CHOORANAM )
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ANNEXURE -V 
TOXICITY STUDIES 
EVALUATION OF ACUTE TOXICITY STUDY OF ERANDA MOOLA 
CHOORANAM 
Effect of Acute Toxicity Study (14 Days) of ERANDAMOOLA CHOORANAM 
Table No –1   PHYSICAL AND BEHAVIORAL EXAMINATIONS. 
 
Group no. Dose(mg/kg) Observation sign No. of animal affected. 
Group-I 5mg/kg Normal 0 of 3 
Group- II 50mg/kg Normal 0 of 3 
Group-III 300mg/kg Normal 0 of 3 
Group-IV 1000mg/kg Normal 0 of 3 
Group-V 2000mg/kg Normal 0 of 3 
 
Table No-2    HOME CAGE ACTIVITY 
Functional 
and 
Behavioural 
observation 
Observation 
5mg/kg 
Group 
(G-I) 
50mg/kg 
(G-II) 
300mg/kg 
(G-III) 
 
1000mg/kg 
(G-IV) 
2000mg/kg 
(G-V) 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Body 
position Normal 3 3 3 3 3 
Respiration Normal 3 3 3 3 3 
Clonic 
involuntary 
Movement 
Normal 3 3 3 3 3 
Tonic 
involuntary 
Movement 
Normal 3 3 3 3 3 
Palpebral 
closure Normal 3 3 3 3 3 
Approach 
response Normal 3 3 3 3 3 
Touch 
response Normal 3 3 3 3 3 
Pinna reflex Normal 3 3 3 3 3 
Tail pinch 
response Normal 3 3 3 3 3 
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Table No-3 
HAND  HELD  OBSERVATION 
Functional 
and 
Behavioral 
observatio
n 
Observation Contr
ol 
5 mg/ 
kg 
(G-I) 
50 
mg/kg 
(G-II) 
300mg/
kg 
(G-III) 
1000mg/
kg 
(G-IV) 
2000mg/
kg 
(G-V) 
Femal
e n=3 
Femal
e n=3 
Femal
e n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Reactivity Normal 3 3 3 3 3 3 
Handling Normal 3 3 3 3 3 3 
Palpebral 
closure 
Normal 3 3 3 3 3 3 
Lacrimation Normal 3 3 3 3 3 3 
Salivation Normal 3 3 3 3 3 3 
Piloerection Normal 3 3 3 3 3 3 
Pupillary 
reflex 
Normal 3 3 3 3 3 3 
Abdominal 
tone 
Normal 3 3 3 3 3 3 
Limb tone Normal 3 3 3 3 3 3 
 
TABLE NO-4 
MORTALITY 
Group no Dose no(mg/kg) Mortality 
Group-I 5(mg/kg) 0 of 3 
Group-II 50(mg/kg) 0 of 3 
Group-III 300(mg/kg) 0 of 3 
Group-IV 1000(mg/kg) 0 of 3 
Group-V 2000(mg/kg) 0 of 3 
 
RESULT: 
  From acute toxicity study it was observed that the administration of 
ERANDAMOOLA CHOORANAM at a dose of 2000 mg/kg to the rats do not produce 
drug-related toxicity and mortality. So No-Observed-Adverse-Effect- Level 
(NOAEL) of ERANDAMOOLA CHOORANAM is 2000 mg/kg. 
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DISCUSSION 
  ERANDAMOOLA CHOORANAM was administered single time at the dose 
of 5mg/kg, 50mg/kg , 300mg/kg, 1000mg/kg and 2000mg/kg to rats and observed for 
consecutive 14 days after administration. Doses were selected based on the pilot 
study and literature review. All animals were observed daily once for any abnormal 
clinical signs. Weekly body weight and food consumption were recorded. No 
mortality was observed during the entire period of the study. Data obtained in this 
study indicated no significance physical and behavioural signs of any toxicity due to 
administration of ERANDAMOOLA CHOORANAM at the doses of 5mg/kg, 
50mg/kg , 300mg/kg, 1000mg/kg and 2000mg/kg to rats.  
  At the 14th day, all animals were observed for functional and behavioral 
examination. In functional and behavioral examination, home cage activity, hand held 
activity were observed. Home cage activities like Body position, Respiration, Clonic 
involuntary movement, Tonic involuntary movement, Palpebral closure, Approach 
response, Touch response, Pinna reflex, Sound responses, Tail pinch response were 
observed. Handheld activities like Reactivity, Handling, Palpebral closure, 
Lacrimation, Salivation, Piloercetion, Papillary reflex, abdominaltone, Limb tone 
were observed. Functional and behavioral examination was normal in all treated 
groups.Food consumption of all treated animals was found normal as compared to 
normalgroup. 
  Body weight at weekly interval was measured to find out the effect of 
ERANDAMOOLA CHOORANAM on the growth rate. Body weight change in drug 
treated animals was found normal. 
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ANNEXURE –VI 
SUB-ACUTE TOXICITY STUDY IN WISTAR RATS TO EVALUATE 
TOXICITY PROFILE OF ERANDAMOOLA CHOORANAM 
 
Table No :1 
EFFECT OF SUB- ACUTE DOSE (28 DAYS)OF ERANDAMOOLA 
CHOORANAM ON BODY WEIGHT IN GRAM 
 
GROUP CONTROL 
 
LOW MID HIGH 
1st day 131.3±1.03 132±1.543 133.3±4.231 134.3±4.23 
7th day 141.1±1.03 142.3±2.343 143±4.113 148±2.11 
14th day 141.1±1.004 142.3±3.12 143.4±4.012 144.4±4.012 
21st day 143.3±2.120 141.4±3.501 142±3.131 143±3.13 
28th day 143.3±1.041 144.3±3.202 145±4.0405 146±4.040 
 
Values are expressed as mean ± SEM Statisticalsignificance (p) calculated by one 
way ANOVA followed by Dennett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groupswith control group. 
 
EFFECT OF SUBACUTE DOSE (28 DAYS)OF ERANDAMOOLA 
CHOORANAM 
Table  No: 2 
GROUP CONTROL LOW  MID HIGH 
HEART 0.45±0.06 0.36±0.04 0.33±0.11 0.43±0.02 
LIVER 2.35± 0.27 2.35±0.23 2.22±0.01 2.25± 0.23 
LUNGS 1.33±0.14 1.33±0.14 1.02±0.24 1.45±0.10 
KIDNEY L 1.45±0.06 1.54±0.03 1.45±0.02 1.43±0.02 
 R 1.43±0.028 1.16±0.02 1.43±0.024 0.44±0.024 
 
Values are expressed as mean ± SEM Statisticalsignificance (p) calculated by one 
way ANOVA followed by Dennett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groupswith control group.  
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Table No- 3 
EFFECT OF SUB- ACUTE DOSE (28 DAYS) OF ERANDAMOOLA 
CHOORANAM ON HAEMATOLOGICAL PARAMETERS 
 
Drug 
treat
ment 
RBC 
millio
n 
cells/c
mm 
WBC  
cells/cm
m 
Haemoglo
bingm % Differential count % 
    
Neutop
hils 
Eosino
phils 
Mono
cyte 
Limpho
cyte 
Contro
l 
5.20±.
40 
4251.40±
23.32 
11.39±0.45 30.26±
1.20 
0.53±0.
11 
4.44±0
.15 
32.12±3
.32 
LOW  5.46±0
.20 
4333.03±
23.22 
11.19±0.43 34.53±
1.41 
0.09±0.
14 
4.11±0
.30 
32.21±3
.51 
MID 5.32±0
.21 
4303.24±
32.35 
11.10±1.03 28.31±
2.22 
0.43±0.
12 
4.31±.
40 
28.12±3
.32 
HIGH 5.25±0
.21 
4870.24±
32.35 
12.10±1.03 34.31±
2.22 
0.49±0.
12 
4.33±0
.40 
24.12±3
.32 
 
Values are expressed as mean ± SEM Statisticalsignificance (p) calculated by one 
way ANOVA followed by Dennett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groupswith control group.  
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Table :4 
EFFECT OF SUB- ACUTE DOSE(28 DAYS)OF ERANDAMOOLA 
CHOORANAM ON BIOCHEMICAL PARAMETERS 
 
Drug 
Treatment 
SGPT 
(IU/L) 
SGOT(IU/L) ALP(IU/L) 
Urea 
(mg/dl) 
Creatinine(mg/dl) 
Control 41.13±3.02 14.23±4.31 42.11±11.32 24.34±3.00 0.53±0.03 
LOW 41.12±3.22 10.22±4.01 25.10±12.42 19.52±2.42 0.69±0.04 
MID 39.20±4.44 13.30±2.21 24.44±4.14 18.11±2.22 0.64±0.04 
HIGH 41.20±4.44 13.90±2.21 23.44±4.14 19.11±2.22 0.65±0.04 
 
Table No- 5 
EFFECT OF SUB- ACUTE DOSE (28 DAYS) OF ERANDAMOOLA 
CHOORANAM BIOCHEMICAL PARAMETERS 
 
GROUP CONTROL 
ERANDAMOOLA 
CHOORANAM(20
0mg/kg) 
ERANDAMOOLA 
CHOORANAM(40
0mg/kg) 
ERANDAM
OOLA 
CHOORANA
M 
(600mg/kg) 
TOTAL 
BILIRU
BIN 
(mg/dl) 
0.508±0.
27 0.8±0.27 0.8±0.76 0.84±0.199 
  
Values are expressed as mean ± SEM Statisticalsignificance (p) calculated by one-
way ANOVA followed by Dennett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groupswith control group.  
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Table No:6 
EFFECT OF SUB- ACUTE DOSE (28 DAYS) OF ERANDAMOOLA 
CHOORANAM ON FOOD INTAKE IN GRAM 
 
GROUP CONTROL Low mid high 
1st DAY 17.32±13.5110 18.1671±14.3 11.09±21.71 16.4±7.62 
7th DAY 14.4±11.65 9.862±12.67 15.72±9.853 10.16±14.41 
14th DAY 17.82±8.72 9.82±14.28 9±13.96 18.71±8.981 
21st DAY 10.86±12.4 14±8.466 14.87±9.43 18.16±8.02 
28th DAY 11.09±11.38 17.37±11.50 9±8.90 9±7.57 
 
Values are expressed as mean ± SEM Statisticalsignificance (p) calculated by one-
way ANOVA followed by Dennett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groupswith control group 
      
Table No :7. 
EFFECT OF SUB- ACUTE DOSE (28 Days) Of  ERANDAMOOLA 
CHOORANAM ON WATER INTAKE IN ML 
GROUP CONTROL EC (200mg/kg) EC (400mg/kg) EC(600mg/kg) 
1st DAY 98.38±13.10 89.12±14.26 102.10±21.79 67.5±7.03 
7th DAY 85.5±11.78 100.83±12.70 76.63±9.863 81.67±14.50 
14th 
DAY 
58.33±8.77 90.83±14.2 80±13.92 89.1672±8.881 
21st DAY 91.87±12.49 85±8.466 65.38±9.450 89.17±8.02 
28th 
DAY 
82.10±11.30 88.48±11.5 80±8.91 70±7.53 
 
Values are expressed as mean ± SEM Statisticalsignificance (p) calculated by one-
way ANOVA followed by Dennett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groupswith control group 
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     Table No: 8  
 EFFECT OF SUB ACUTE DOSES (28 DAY) OF ERANDAMOOLA 
CHOORANAM ON ELECTROLYTES: - 
 
Values are expressed as mean ± SEM Statisticalsignificance (p) calculated by one-
way ANOVA followed by Dennett’s(n=6); NS- non-significant, *p<0.05, **p<0.01, 
***p<0.001,  
 
6.0 RESULTS: 
CLINICAL SIGNS: 
  All animals in this study were free of toxic clinical signs throughout the 
dosing   period of 28 days. 
 Mortality: 
  All animals in control and in all the treated dose groups survived throughout 
the dosing period of 28 days. 
Body weight: 
  Results of body weight determination of animals from control and different 
dose groups exhibited comparable body weight gain throughout the dosing period of 
28 days. 
 Food consumption: 
  During dosing and the post-dosing recovery period, the quantity of food 
consumed by animals from different dose groups was found to be comparable with 
that by control animals. 
  
GROUP CONTROL 
ERANDAMOOLA 
CHOORANAM 
(200mg/kg) 
ERANDAMOOLA 
CHOORANAM 
(400mg/kg) 
ERANDAMOOLA 
CHOORANAM 
(600mg/kg) 
Sodium (mg/dl) 
144.10±0.6855 144.30±0.92 141±0.7571 151.80±0.70 
Calcium(mg/dl) 7.80±0.189 7.20±0.83*** 6.7±0.19*** 6.180±0.1* 
Phosphorus 
(U/L) 5.8±0.17 6.3±0.915ns 4.350±0.51ns 5.037±0.2* 
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Organ Weight: 
  Group Mean Relative Organ Weights (% of body weight) are recorded in 
Table Comparison of organ weights of treated animals with respective control 
animals on day 29 was found to be comparable similarly. 
Hematological investigations: 
  The results of hematological investigations conducted on day 29 revealed 
following significant changes in the values of different parameters investigated when 
compared with those of respective controls; however, the increase or decrease in the 
values obtained was within normal biological and laboratory limits or the effect was 
not dose dependent. 
Biochemical Investigations: 
  Results of Biochemical investigations conducted on the day 29th and recorded 
in Table  revealed the following significant changes in the values of hepatic serum 
enzymes studied. When compared with those of respective control. However, the 
increase or decrease in the values obtained was within normal biological and 
laboratory limits. 
 
INTERPRETATION: 
1)  All the animals from control and all the treated dose groups up to 15ml/kg 
survived throughout the dosing period of 28 days. 
2)  No signs of toxicity were observed in animals from different dose groups during 
the dosing period of 28 days. 
3)  Animals from all the treated dose groups exhibited comparable body weight gain 
with that of controls throughout the dosing period of 28 days. 
4) Food consumption of control and treated animals was found to be comparable 
throughout the dosing period of 28 days 
5)   Haematological analysis conducted at the end of the dosing period on day 29th, 
revealed no abnormalities attributable to the treatment. 
6) Biochemical analysis conducted at the end of the dosing period on day 29th, no 
abnormalities attributable to the treatment. 
7) Organ weight data of animals sacrificed at the end of the dosing period was found 
to be comparable with that of respective controls. 
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ANNEXURE –VII 
ASSESSMENT FORMS 
 
FORM I  :  Screening form 
FORM II  :  Consent form 
FORM III  :  History Proforma 
FORM IV  :  Clinical Assessment  
FORM V   :  Laboratory investigation 
FORM VI  :  Drug Compliance Form  
FORM VII  :  Adverse Reaction form 
FORM VIII  :  Patient withdrawal form 
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GOVERNMENT SIDDHA MEDICALCOLLEGE& HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT. 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL STUDY TO EVALUATE THE  THERAPEUTIC EFFICACY 
OF SIDDHA MONOHERBAL MEDICINE ERANDA MOOLA CHOORANAM 
[INTERNAL],KUNGILIA THYLAM  [EXTERNAL]AND PATTRU [EXTERNAL 
THERAPY] FOR THE TREATMENT OF AZHAL KEEL 
VAYU[OSTEOARTHRITIS]. 
     FORM-I 
(SCREENING AND SELECTION PROFORMA) 
1.OPD/IPD No: ___________     2.Date: _____3.SI.No: ________4.Name:  
_________ 
5. Age:       6.Gender:         7. Phone No:. 
INCLUSION CRITERIA: 
 Age 30-60Yrs 
 Sex : Both male and female 
 Patients having symptoms of joint pain of both knee joints, swelling, 
tenderness,  stiffness, crepitation, restricted movements of both knee joints. 
 Patients who are willing to give blood samples for laboratory investigation . 
 Patients who are willing to take X-ray before and after treatment.  
 Patients who are willing to participate in this study with the knowledge of 
potential risks. 
 
EXCLUSION CRITERIA: 
 Cardiac disease 
 Hypertension 
 Rheumatoid arthritis 
 Use of narcotic drugs 
 Pregnancy women and lactating mother 
 History of trauma 
 Patient with any other serious illness. 
 Clinically significant abnormal laboratory values. 
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WITHDRAWAL CRITERIA: 
 Intolerance to the drug and development of adverse reactions during drug trial 
 Poor patient’s compliance and defaulters. 
 Patient turned unwilling to continue in the course of clinical trial. 
 Occurrence of any serious illness. 
 
DATE  : 
STATION :    Signature of the Investigator 
 
 
 
 
 
      Signature of the Guide/HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT. 
DEPARTMENT OF  SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL STUDY TO EVALUATE THE  THERAPEUTIC EFFICACY 
OF SIDDHA MONOHERBAL MEDICINE ERANDA MOOLA 
CHOORANAM[INTERNAL],KUNGILIA THYLAM [EXTERNAL]AND 
PATTRU[EXTERNAL THERAPY] FOR THE TREATMENT OF AZHAL KEEL 
VAYU[OSTEOARTHRITIS]. 
FORM-II 
CONSENT FORM 
Certificate by Investigator 
   I certify that I have disclosed all details about the study in the terms readily 
understood by the patient. 
Date: ……………..     Signature of the 
Signature of the Investigator: ……………..  Guide/HOD: ……………………. 
Name: ……………………………..            Name: …………………………… 
Consent by Patient 
    I have been informed to my satisfaction, by the attending physician, the 
purpose of the clinical trial, and the nature of drug treatment and follow-up including 
the laboratory investigations to be performed to monitor and safeguard my body 
functions. 
    I am aware of my right to withdraw from the trial at any time during the 
course of the trial without having to give the reasons for doing so. 
 I, exercising my free power of choice, hereby give my consent to be included 
as a clinical trial of  ERANDA MOOLA CHOORANAM 
[INTERNAL],KUNGILIA THYLAM [EXTERNAL]AND PATTRU [EXTERNAL 
THERAPY] IN AZHAL KEEL VAYU[OSTEOARTHRITIS]. 
Date: ………………..  Signature: ………………………………… 
Name: …………………………………….  
Date: ………………..           Signature of Witness: ……………………. 
Name………….. ……………………Relationship: ………………………….. 
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murpdH rpj;jkUj;Jtf; fy;Yhhp kw;Wk; kUj;Jtkid; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ;  
ghisaq;Nfhl;il; ;; ;; ;  
gl;l Nkw;gbg;G rpwg;G kUj;Jtj;Jiw; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;  
 
‘Vuz;l %y #uzk;; ;; ;; ;” kw;Wk; ; ;; ;; ; ‘Fq;fpypa ijyk; ; ;; ;; ; - gw;W;;; ” ,tw;wpd; ghpfhpg;Gj; ; ; ; ;; ; ; ;; ; ; ;
jpwidf; fz;lwpAk; kUj;Jt Ma;T xg;Gjy; gbtk; Ma;thsuhy; ; ; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ; ;
rhd;wspf;fg;gl;lJ.; ; ; ;; ; ; ;; ; ; ;  
 
  ehd; ,e;j Ma;itf; Fwpj;j midj;J tpguq;fisAk; Nehahspf;F 
GhpAk; tifapy; vLj;Jiuj;Njd; vd cWjpaspf;fpNwd;. 
 
Njjp  :       Jiwj;jiytu;  
,lk; :        ifnahg;gk;: 
Ma;thsh;ifnahg;gk;:     ngaH: 
ngau;: 
 
Nehahspapd; xg;Gjy;; ; ;; ; ;; ; ; 
 vd;dplk; ,e;j kUj;Jt Ma;tpd; fhuzj;ijAk; kUe;jpd; jd;ik 
kw;Wk; kUj;Jt topKiwiag; gw;wpAk; njhlHe;J vdJ cly; ,af;fj;ij 
fz;fhzpf;fTk;> mjidg; ghJfhf;fTk; gad;gLk; kUj;Jt Ma;Tf;$l 
ghpNrhjidfs; gw;wpAk; jpUg;jp mspf;Fk; tifapy; Ma;TkUj;Jtuhy; 
tpsf;fpf; $wg;gl;lJ. 
 ehd; ,e;j kUj;Jt Ma;tpd;NghJ fhuzk; vJTk; $whky; vg;nghOJ 
Ntz;LkhdhYk; ,e;j Ma;tpypUe;J vd;id tpLtpj;Jf; nfhs;Sk; chpikia 
njhpe;jpUf;fpd;Nwd;. 
 ehd; vd;Dila Rje;jpukhfj; NjHTnra;Ak; chpikiaf; nfhz;L moy; 
fPy; thA vd;Dk; Neha;f;fhd Vuz;l %y #uzk;” kw;Wk; ‘Fq;fpypa ijyk; - 
gw;W Mfpatw;wpd; ghpfhpg;Gj; jpwidf; fz;lwpAk; kUj;Jt Ma;tpw;F vd;id 
cl;gLj;jpf;nfhs;s xg;Gjy; mspf;fpNwd;. 
 
Njjp :       ifnahg;gk;: 
,lk; :       ngaH :  
       rhl;rpf;fhuHifnahg;gk;: 
       ngaH:  
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT. 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL STUDY TO EVALUATE THE  THERAPEUTIC EFFICACY 
OF SIDDHA MONOHERBAL MEDICINE ERANDA MOOLA CHOORANAM 
[INTERNAL], KUNGILIA THYLAM [EXTERNAL]AND PATTRU [EXTERNAL 
THERAPY] FOR THE TREATMENT OF AZHAL KEEL 
VAYU[OSTEOARTHRITIS]. 
FORM III 
HISTORY PROFORMA ON ENROLLMENT 
 
1. Serial No of the case:   _______________                 2. OPD/IPD No:_________ 
 
 
3.Name: ____________                                         4. Gender:  
 
 
5. Age (years): _________   DOB    
      Date       Month            Year 
 
6.Address: -------------------------------------- 
             -------------------------------------- 
  -------------------------------------- 
 
7.A. Occupation:    -----------------------------                         B. Income ----------------- 
 
 
8. Educational Status:   A) Illiterate                  B)Literate  
 
 
9. Height: ----------cms                10.Weight:----------kg 
 
11. Complaints and Duration: 
 
 
12. Past History                     
 Hypertension    ______________      
 Diabetes mellitus ______________      
 Asthma  ______________      
 PT   ______________ 
Other   ______________ 
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13. HABITS 
 
A) Smoking  : 1. Yes                 duration ________ years;    Number- _____     2.No  
 
B) Alcoholism:1. Yes               duration ________ years;    Quantity- ____ ml 2.No  
   
C) Tobacco chewing:  1. Yes                duration ________ years                   2.No 
 
D) Betel chewing     :  1. Yes                duration ________ years                 2.No 
 
14. Dietary style:   A.Pure vegetarian              B.Non-vegetarian                C. Mixed diet 
 
15. Drug history:Had the patient been treated before with allopathy drug?  
  A) Yes                                    2) No                                     
 
16 Marital status:1.Married         2.Unmarried                                                  
 
17. Family history : 
 
      Whether this problem runs in family?             1. Yes                               2.No   
 
(If yes, mention the relationship)  
 
18. Bowel habits & micturition:      Normal                     Abnormal 
 
(Details of an abnormality) 
 
 
19. Psychological state:      Normal                    Anxiety                   Depression            
 
 
 
 
 
 
 
 
 
Signature of the Investigator                                      Signature of the Guide/ HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL STUDY TO EVALUATE THE  THERAPEUTIC EFFICACY 
OF SIDDHA MONOHERBAL MEDICINE ERANDA MOOLA 
CHOORANAM[INTERNAL],KUNGILIA THYLAM[EXTERNAL]AND 
PATTRU[EXTERNAL STHERAPY] FOR THE TREATMENT OF AZHAL KEEL 
VAYU[OSTEOARTHRITIS]. 
 
FORM IV 
CLINICAL ASSESSMENT ON ENROLLMENT AND ON VISITS 
 
1. S.No:  _______2. OPD/IPD No: __________ 
3.  Name: _______________________4. Gender      : __________ 
5. Date of assessment : _____________  
SIDDHA SYSTEM OF EXAMINATION 
1.NILAM: [ LAND WHERE PATIENT LIVED MOST] 
Kurinji   Mullai      Marutham    Neithal           Palai 
(Hilly terrain)           (Forest range)        (Plains)                  (Coastal belt)        (Arid 
regions)  
2. KAALAM: 
Kaarkalam  -                      Pinpanikalam- 
Koothirkalam  -                            Ilavenil - 
Munpanikalam -                          Muthuvenil - 
 
3.THEGI: 
 
4. GUNAM: 
Sathuvam   -    Rasatham -                         Thamasam  - 
5.IMPORIGAL (SENSORY ORGANS) : 
Mei (Skin) : 
Vai (Buccal Cavity): 
Kan(Eyes) : 
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Mooku(Nose): 
Sevi(Ears) : 
6.KANMENDRIYAM (MOTOR ORGANS) : 
Kai (Upper limb): 
Kaal(Lower limb): 
Vai(Buccal Cavity): 
Eruvai(Excretory organs): 
Karuvai(Reproductive organs): 
 
7.UYIR THATHUKKAL: 
A)VATHAM: 
Pranan: 
Abanan: 
Viyanan: 
Udhanan: 
Samanan: 
Nagan: 
Koorman: 
Kirukaran: 
Devathathan: 
Dhananjeyan: 
 
B)PITHAM: 
Analpitham: 
Ranjagam: 
Sathagam: 
Prasagam: 
Aalosagam: 
 
C)KABAM: 
Avalambagam: 
Kilaethagam: 
Pothagam: 
Tharpagam: 
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Santhigam: 
8.UDAL THATHUKKAL: 
Saaram[Chyme]: 
Senneer[Blood]: 
Oon[Muscle]: 
Kozhuppu[Fat]: 
Enbu[Bone]: 
Moolai[Bone Marrow]: 
Sukkilam/Suronitham 
[Genital Discharges] : 
9.ENVAGAI THERVUGAL: 
Naadi: 
Sparisam: 
Naa: 
Niram: 
Mozhi: 
Vizhi: 
Malam: 
Moothiram: 
10.NEER KURI: 
Niram: 
Manam: 
Nurai: 
Edai: 
Enjal: 
11.NEI KURI: 
 
GENERAL EXAMINATION: 
Conscious level: 
Body weight: 
Height: 
BMI: 
Built: 
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Nourishment: 
Temperature: 
Blood Pressure: 
Pulse rate: 
Heart rate: 
Respiratory rate: 
Anaemia: 
Jaundice: 
Clubbing: 
Cyanosis: 
Pedal oedema: 
Significant Lymphadenopathy: 
SYSTEMIC EXAMINATIONS: 
Central Nervous System: 
Cardio Vascular System: 
Respiratory System: 
Gastro Intestinal System: 
Genito Urinary System: 
EXAMINATION OF JOINTS: 
Joints Involvement : 
Morning Stiffness : 
Pain type : Recurrent attack / Episodic / Flitting or Migratory 
Inspection: 
Spinal deformities: Kyphosis/ Scoliosis/ Lordosis / None 
Swelling: 
Deformity: 
Palpation: 
Tenderness: 
Heat: 
Fluid accumulation: 
Crepitus: 
Movements: 
Specific examinations: 
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CLINICAL ASSESSMENT: 
S.NO SIGNS & SYMPTOMS BEFORE 
TREATMENT 
AFTER 
TREATMENT 
1. PAIN   
2. SWELLING   
3. REDNESS   
4. HEAT   
5. RESTRICTED 
MOVEMENTS 
  
6. CRIPITUS   
 
PAIN ASSESSMENT: 
 
UNIVERSAL PAIN ASSESSMENT SCALE 
 
A.   0    : No Pain 
B. 1 -3  :  Mild pain 
C. 4-6  :  Moderate pain 
D. 7-10 :  Severe pain 
Reference: Clinical Manual for Nursing Practice. (National Institute of Health Warren 
Grant Magnuson Clinical Center) 
 
GRADATION: 
Grade 1: Fit for all activities to do their work without support (Normal)  
Grade 2: Mild Pain and Mild restriction of Movements  
Grade 3: Moderate Pain and Moderate restriction of Movements  
Grade 4: Severe Pain and Severe restriction of Movement  
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S.NO ASSESSMENT BEFORE 
TREATMENT 
AFTER 
TREATMENT 
1 Pain Assessment   
2 Gradation   
 
 
OVERALL ASSESSMENT CRITERIA OF THE STUDY  
 
 
 
 
 
Signature of the Investigator   Signature of the Guide/HOD
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT. 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL STUDY TO EVALUATE THE  THERAPEUTIC EFFICACY 
OF SIDDHA MONOHERBAL MEDICINE ERANDA MOOLA 
CHOORANAM[INTERNAL],KUNGILIA THYLAM[EXTERNAL]AND 
PATTRU[EXTERNAL THERAPY] FOR THE TREATMENT OF AZHAL KEEL 
VAYU[OSTEOARTHRITIS]. 
FORM  V 
LABORATORY INVESTIGATION FORM 
SI.No: 
OPD/IPD No: 
Name: 
Age/Sex: 
I.BLOOD 
  Before Treatment After Treatment 
1 
 
TC (cells/mm)   
2 
 
DC (%)   
 a)Neutrophils  
 
 
 b)Lymphocytes  
 
 
 c)Monocytes  
 
 
 d)Eosinophils  
 
 
3 
 
ESR(mm)   
 a)1/2 hour  
 
 
 b)1 hour  
 
 
4 
 
Haemoglobin   
5 
 
Blood glucose   
6 
 
Blood urea/ creatinine   
7 Serum cholesterol   
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II.URINE 
 
  
 
Before Treatment After Treatment 
1 
 
Albumin 
 
  
2 Sugar 
 
  
3 Epithelial cells 
 
  
4 Pus cells 
 
  
5 Red blood cells 
 
  
    
 
 
Date :       
Station : 
 
Signature of the Investigator   Signature of the Guide/HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT. 
DEPARTMENT OF SIRAPPUMARUTHUVAM 
AN OPEN CLINICAL STUDY TO EVALUATE THE  THERAPEUTIC EFFICACY 
OF SIDDHA MONOHERBAL MEDICINE ERANDA MOOLA 
CHOORANAM[INTERNAL],KUNGILIA THYLAM [EXTERNAL]AND 
PATTRU[EXTERNAL THERAPY] FOR THE TREATMENT OF AZHAL KEEL 
VAYU[OSTEOARTHRITIS]. 
FORM VI 
                                               (DRUG COMPLIANCE FORM) 
OPD/ IPD No : ____________ DOA   : ___________      
Name : _____________________ Age/Sex : ___________   S.No : _________  
Name Of The Drug : ERANDA MOOLA CHOORANAM 
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DATE: 
 
Signature of the investigator:    Signature of the guide/hod: 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT. 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL STUDY TO EVALUATE THE  THERAPEUTIC EFFICACY 
OF SIDDHA MONOHERBAL MEDICINE ERANDA MOOLA 
CHOORANAM[INTERNAL],KUNGILIA THYLAM [EXTERNAL]AND 
PATTRU[EXTERNAL THERAPY] FOR THE TREATMENT OF AZHAL KEEL 
VAYU[OSTEOARTHRITIS]. 
FORM  VII 
ADVERSE DRUG REACTION FORM 
Name: ________________________       OPD/ IPD No : __________ 
Age: ________            Gender: ________        
Date of trial commencement: ___________ 
Date of withdrawal from trial: ___________ 
Description of adverse reaction: ________________________________________ 
___________________________________________________________________ 
Date: 
Station:  
SIGNATURE  OF THE  INVESTIGATOR         
 
SIGNATURE  OF THE GUIDE/   HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT. 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL STUDY TO EVALUATE THE  THERAPEUTIC 
EFFICACY OF SIDDHA MONOHERBAL MEDICINE ERANDA MOOLA 
CHOORANAM[INTERNAL],KUNGILIA THYLAM[EXTERNAL]AND 
PATTRU[EXTERNAL THERAPY] FOR THE TREATMENT OF AZHAL KEEL 
VAYU[OSTEOARTHRITIS]. 
FORM VIII 
WITHDRAWAL FORM 
Name: ________________________       OPD/ IPD Number: __________ 
Age   : ________              Gender   : ________      
Date of trial commencement: ___________ 
Date of withdrawal from trial: ___________ 
Reasons for withdrawal:     YES     NO 
• Long absence in without  reporting      :      
• Irregular treatment        :                   
• Shift of locality                                              :                   
• Increase in severity of symptoms          \:                   
• Development of severe adverse drug reactions  :                   
 
 
Date    :      
Station : 
 
Signature ofthe  investigator          Signature of the guide/hod 
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